0001739566false12/31Q32023P1Y00017395662023-01-022023-10-010001739566us-gaap:CommonClassAMember2023-11-06xbrli:shares0001739566utz:CommonClassVMember2023-11-0600017395662023-10-01iso4217:USD00017395662023-01-010001739566us-gaap:CommonClassAMember2023-10-01iso4217:USDxbrli:shares0001739566us-gaap:CommonClassAMember2023-01-010001739566utz:CommonClassVMember2023-01-010001739566utz:CommonClassVMember2023-10-0100017395662023-07-032023-10-0100017395662022-07-042022-10-0200017395662022-01-032022-10-020001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-020001739566us-gaap:CommonStockMemberutz:CommonClassVMember2022-01-020001739566us-gaap:AdditionalPaidInCapitalMember2022-01-020001739566us-gaap:RetainedEarningsMember2022-01-020001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-020001739566us-gaap:ParentMember2022-01-020001739566us-gaap:NoncontrollingInterestMember2022-01-0200017395662022-01-020001739566us-gaap:AdditionalPaidInCapitalMember2022-01-032022-07-030001739566us-gaap:ParentMember2022-01-032022-07-0300017395662022-01-032022-07-030001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-032022-07-030001739566us-gaap:RetainedEarningsMember2022-01-032022-07-030001739566us-gaap:NoncontrollingInterestMember2022-01-032022-07-030001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-032022-07-030001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-07-030001739566us-gaap:CommonStockMemberutz:CommonClassVMember2022-07-030001739566us-gaap:AdditionalPaidInCapitalMember2022-07-030001739566us-gaap:RetainedEarningsMember2022-07-030001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-030001739566us-gaap:ParentMember2022-07-030001739566us-gaap:NoncontrollingInterestMember2022-07-0300017395662022-07-030001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-07-042022-10-020001739566us-gaap:AdditionalPaidInCapitalMember2022-07-042022-10-020001739566us-gaap:ParentMember2022-07-042022-10-020001739566us-gaap:RetainedEarningsMember2022-07-042022-10-020001739566us-gaap:NoncontrollingInterestMember2022-07-042022-10-020001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-042022-10-020001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-10-020001739566us-gaap:CommonStockMemberutz:CommonClassVMember2022-10-020001739566us-gaap:AdditionalPaidInCapitalMember2022-10-020001739566us-gaap:RetainedEarningsMember2022-10-020001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-020001739566us-gaap:ParentMember2022-10-020001739566us-gaap:NoncontrollingInterestMember2022-10-0200017395662022-10-020001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-010001739566us-gaap:CommonStockMemberutz:CommonClassVMember2023-01-010001739566us-gaap:AdditionalPaidInCapitalMember2023-01-010001739566us-gaap:RetainedEarningsMember2023-01-010001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-010001739566us-gaap:ParentMember2023-01-010001739566us-gaap:NoncontrollingInterestMember2023-01-010001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-022023-07-020001739566us-gaap:AdditionalPaidInCapitalMember2023-01-022023-07-020001739566us-gaap:ParentMember2023-01-022023-07-0200017395662023-01-022023-07-020001739566us-gaap:RetainedEarningsMember2023-01-022023-07-020001739566us-gaap:NoncontrollingInterestMember2023-01-022023-07-020001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-022023-07-020001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-07-020001739566us-gaap:CommonStockMemberutz:CommonClassVMember2023-07-020001739566us-gaap:AdditionalPaidInCapitalMember2023-07-020001739566us-gaap:RetainedEarningsMember2023-07-020001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-020001739566us-gaap:ParentMember2023-07-020001739566us-gaap:NoncontrollingInterestMember2023-07-0200017395662023-07-020001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-07-032023-10-010001739566us-gaap:AdditionalPaidInCapitalMember2023-07-032023-10-010001739566us-gaap:ParentMember2023-07-032023-10-010001739566us-gaap:RetainedEarningsMember2023-07-032023-10-010001739566us-gaap:NoncontrollingInterestMember2023-07-032023-10-010001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-032023-10-010001739566us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-10-010001739566us-gaap:CommonStockMemberutz:CommonClassVMember2023-10-010001739566us-gaap:AdditionalPaidInCapitalMember2023-10-010001739566us-gaap:RetainedEarningsMember2023-10-010001739566us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-010001739566us-gaap:ParentMember2023-10-010001739566us-gaap:NoncontrollingInterestMember2023-10-010001739566srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2023-10-010001739566us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2023-10-010001739566srt:MinimumMemberus-gaap:TransportationEquipmentMember2023-10-010001739566srt:MaximumMemberus-gaap:TransportationEquipmentMember2023-10-010001739566srt:MinimumMemberus-gaap:BuildingMember2023-10-010001739566srt:MaximumMemberus-gaap:BuildingMember2023-10-0100017395662023-01-012023-01-010001739566us-gaap:LandMember2023-10-010001739566us-gaap:LandMember2023-01-010001739566us-gaap:BuildingMember2023-10-010001739566us-gaap:BuildingMember2023-01-010001739566us-gaap:MachineryAndEquipmentMember2023-10-010001739566us-gaap:MachineryAndEquipmentMember2023-01-010001739566us-gaap:LandImprovementsMember2023-10-010001739566us-gaap:LandImprovementsMember2023-01-010001739566us-gaap:BuildingImprovementsMember2023-10-010001739566us-gaap:BuildingImprovementsMember2023-01-010001739566us-gaap:ConstructionInProgressMember2023-10-010001739566us-gaap:ConstructionInProgressMember2023-01-010001739566utz:ManufacturingClosureMemberutz:BirminghamFacilityMember2023-07-032023-10-010001739566us-gaap:EmployeeSeveranceMemberutz:BirminghamFacilityMember2023-07-032023-10-010001739566utz:NonCashExpensesMemberutz:BirminghamFacilityMember2023-07-032023-10-010001739566us-gaap:FacilityClosingMemberutz:BirminghamFacilityMember2023-10-010001739566utz:BluffingtonIndianaManufacturingFacilityMember2023-07-032023-10-010001739566utz:HanoverPALandMember2023-07-032023-10-010001739566us-gaap:CustomerRelationshipsMember2023-10-010001739566us-gaap:CustomerRelationshipsMember2023-01-010001739566us-gaap:TrademarksMember2023-10-010001739566us-gaap:TrademarksMember2023-01-010001739566us-gaap:TradeNamesMember2023-10-010001739566us-gaap:TradeNamesMember2023-01-010001739566utz:RoutesPreAcquisitionMember2023-10-010001739566utz:RoutesPreAcquisitionMember2023-01-010001739566us-gaap:DistributionRightsMember2023-01-022023-10-010001739566us-gaap:DistributionRightsMember2022-01-032022-10-020001739566utz:IONotesReceivableMembersrt:MinimumMember2023-01-022023-10-01xbrli:pure0001739566utz:IONotesReceivableMembersrt:MaximumMember2023-01-022023-10-010001739566utz:IONotesReceivableMemberus-gaap:NotesReceivableMember2023-10-010001739566utz:IONotesReceivableMemberus-gaap:NotesReceivableMember2023-01-010001739566utz:IONotesReceivableMemberus-gaap:NotesReceivableMember2023-01-022023-10-010001739566us-gaap:NotesReceivableMember2023-10-010001739566us-gaap:NotesReceivableMember2023-01-010001739566utz:OtherNotesReceivableMember2023-01-010001739566utz:OtherNotesReceivableMember2023-10-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2022-09-220001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-10-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-01-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-01-022023-10-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-07-200001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMember2023-07-200001739566us-gaap:StandbyLettersOfCreditMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-10-010001739566us-gaap:StandbyLettersOfCreditMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-01-010001739566utz:BridgeCreditAgreementMemberus-gaap:LineOfCreditMember2020-12-142020-12-140001739566utz:BridgeCreditAgreementMemberus-gaap:LineOfCreditMemberutz:LondonInterbankOfferedRateLIBOR1Member2020-12-142020-12-140001739566utz:TermLoanBMemberus-gaap:SecuredDebtMember2021-01-200001739566utz:TermLoanBMemberus-gaap:SecuredDebtMemberutz:LondonInterbankOfferedRateLIBOR1Member2021-01-202021-01-200001739566utz:BridgeCreditAgreementMemberus-gaap:SecuredDebtMember2021-01-200001739566utz:TermLoanBMemberus-gaap:SecuredDebtMember2021-06-222021-06-220001739566utz:TermLoanBMemberus-gaap:SecuredDebtMember2021-06-220001739566utz:RealEstateTermLoanMember2022-10-120001739566utz:RealEstateTermLoanMember2022-10-122022-10-120001739566utz:RealEstateTermLoanMember2023-10-010001739566utz:RealEstateTermLoanMember2023-09-012023-09-300001739566utz:RealEstateTermLoanMember2023-09-300001739566utz:TermLoanBMemberus-gaap:SecuredDebtMember2023-10-010001739566utz:TermLoanBMemberus-gaap:SecuredDebtMember2023-01-010001739566us-gaap:RealEstateLoanMember2023-10-010001739566us-gaap:RealEstateLoanMember2023-01-010001739566utz:EquipmentLoansMember2023-10-010001739566utz:EquipmentLoansMember2023-01-010001739566us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMember2023-10-010001739566us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMember2023-01-010001739566utz:TermLoanBMember2023-10-010001739566utz:EquipmentLoansMember2023-01-022023-10-010001739566srt:MinimumMemberutz:EquipmentLoansMember2023-10-010001739566srt:MaximumMemberutz:EquipmentLoansMember2023-10-010001739566utz:SecuredOvernightFinancingRateMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMember2023-01-022023-10-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberutz:LondonInterbankOfferedRateLIBOR1Member2023-01-022023-10-010001739566srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberutz:LondonInterbankOfferedRateLIBOR1Member2023-01-022023-10-010001739566srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberutz:LondonInterbankOfferedRateLIBOR1Member2023-01-022023-10-010001739566us-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2023-01-022023-10-010001739566srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2023-01-022023-10-010001739566srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2023-01-022023-10-010001739566srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2023-10-010001739566srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberutz:ABLFacilityMemberus-gaap:LineOfCreditMemberutz:LondonInterbankOfferedRateLIBOR1Member2023-10-010001739566us-gaap:NotesPayableToBanksMember2023-10-010001739566us-gaap:NotesPayableToBanksMember2023-01-010001739566us-gaap:NotesPayableOtherPayablesMember2023-10-010001739566us-gaap:NotesPayableOtherPayablesMember2023-01-010001739566utz:NotesPayableMember2023-10-010001739566utz:NotesPayableMember2023-01-010001739566utz:IONotesPayableMember2023-10-010001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-09-062019-09-060001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-09-060001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-210001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-122022-10-120001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-120001739566us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CommodityContractMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel1Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel2Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel3Member2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMember2023-10-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CommodityContractMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel1Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel2Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel3Member2023-01-010001739566us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivatePlacementMember2023-01-010001739566utz:CommonwealthOfPennsylvaniaTaxAssessmentMember2021-01-042022-01-0200017395662022-01-072022-01-070001739566us-gaap:PaymentGuaranteeMemberutz:CadenceBankMember2023-10-010001739566us-gaap:PaymentGuaranteeMemberutz:CadenceBankMember2023-01-010001739566utz:CadenceBankMember2023-10-010001739566us-gaap:PaymentGuaranteeMemberutz:BankOfAmericaMember2023-10-010001739566us-gaap:PaymentGuaranteeMemberutz:BankOfAmericaMember2023-01-010001739566utz:BankOfAmericaMember2023-10-010001739566utz:MTBankMember2023-10-010001739566us-gaap:PaymentGuaranteeMemberutz:MTBankMember2023-10-010001739566us-gaap:PaymentGuaranteeMemberutz:MTBankMember2023-01-010001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-020001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-032022-07-030001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-030001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-042022-10-020001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-10-020001739566us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2022-10-020001739566us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-10-020001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-010001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-022023-07-020001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-020001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-032023-10-010001739566us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-10-010001739566us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2023-10-010001739566us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-10-010001739566us-gaap:OtherCurrentLiabilitiesMember2023-10-010001739566us-gaap:OtherNoncurrentLiabilitiesMember2023-10-010001739566us-gaap:WarrantMember2023-01-022023-10-010001739566utz:ForwardPurchaseWarrantMember2023-01-022023-10-010001739566utz:PrivatePlacementWarrantsMember2023-01-022023-10-010001739566utz:PrivatePlacementWarrantsMember2023-10-010001739566utz:PrivatePlacementWarrantsMember2023-01-010001739566utz:CommonClassVMember2023-01-022023-10-010001739566us-gaap:WarrantMember2022-07-042022-10-020001739566us-gaap:WarrantMember2022-01-032022-10-020001739566us-gaap:RestrictedStockUnitsRSUMember2022-07-042022-10-020001739566us-gaap:RestrictedStockUnitsRSUMember2022-01-032022-10-020001739566us-gaap:PerformanceSharesMember2022-07-042022-10-020001739566us-gaap:PerformanceSharesMember2022-01-032022-10-020001739566us-gaap:EmployeeStockOptionMember2022-07-042022-10-020001739566us-gaap:EmployeeStockOptionMember2022-01-032022-10-020001739566utz:CommonClassVMember2022-07-042022-10-020001739566utz:CommonClassVMember2022-01-032022-10-020001739566us-gaap:WarrantMember2023-07-032023-10-010001739566us-gaap:WarrantMember2023-01-022023-10-010001739566us-gaap:RestrictedStockUnitsRSUMember2023-07-032023-10-010001739566us-gaap:RestrictedStockUnitsRSUMember2023-01-022023-10-010001739566us-gaap:PerformanceSharesMember2023-07-032023-10-010001739566us-gaap:PerformanceSharesMember2023-01-022023-10-010001739566us-gaap:EmployeeStockOptionMember2023-07-032023-10-010001739566us-gaap:EmployeeStockOptionMember2023-01-022023-10-010001739566utz:CommonClassVMember2023-07-032023-10-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 1, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
 
  
Utz Brands, Inc.
(Exact name of registrant as specified in its charter)
  
Delaware 001-38686 85-2751850
(State or other jurisdiction
of incorporation)
 (Commission File Number) (IRS Employer
Identification No.)
 
900 High Street
Hanover, PA 17331
(Address of principal executive offices, including zip code)
 
Registrant’s telephone number, including area code: (717) 637-6644

N/A
(Former name or former address, if changed since last report)
  
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share
UTZ
New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No



As of November 6, 2023, 81,141,417 shares of Class A Common Stock, par value $0.0001 per share, and 59,349,000 shares of Class V Common Stock, par value $0.0001 per share, were issued and outstanding.
INTRODUCTORY NOTE
On August 28, 2020 (the "Closing Date"), Utz Brands, Inc. (formerly Collier Creek Holdings) (the "Company"), consummated a business combination (the "Business Combination") with Utz Brands Holdings, LLC ("UBH") pursuant to the terms of the Business Combination Agreement, dated as of June 5, 2020 (the "Business Combination Agreement"), entered into by and among the Company, UBH, and Series U of UM Partners, LLC ("Series U") and Series R of UM Partners, LLC ("Series R" and together with Series U, the "Continuing Members"). Additional information about the Business Combination can be found in our Annual Report on Form 10-K for the year ended January 1, 2023.
Throughout this Quarterly Report on Form 10-Q, unless otherwise noted the "Company," "we," "us," "our," "UBI" and "Utz" refer to Utz Brands, Inc. and its consolidated subsidiaries.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations for future financial performance, business strategies or expectations for the Company’s business. Specifically, forward-looking statements may include statements relating to:
The financial position, capital structure, indebtedness, business strategy and plans and objectives of management for future operations;
The benefits of acquisitions, dispositions and similar transactions;
The future performance of, and anticipated financial impact on, the Company;
Expansion plans and opportunities;
The benefits and risks of our network optimization initiatives;
Expenses and other charges related to the Manufacturing Closure (as defined in Note 3 to our unaudited consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q);
The impact of inflation and supply chain disruptions on the Company's business; and
Other statements preceded by, followed by or that include the words "may," "can," "should," "will," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "target" or similar expressions.
These forward-looking statements are based on information available as of the date of this Quarterly Report on Form 10-Q and the Company management’s current expectations, forecasts and assumptions, and involve a number of judgments, known and unknown risks and uncertainties and other factors, many of which are outside the control of the Company and its directors, officers and affiliates. Accordingly, forward-looking statements should not be relied upon as representing the Company’s views as of any subsequent date. The Company does not undertake any obligation to update, add or to otherwise correct any forward-looking statements contained herein to reflect events or circumstances after the date they were made, whether as a result of new information, future events, inaccuracies that become apparent after the date hereof or otherwise, except as may be required under applicable securities laws.
As a result of a number of known and unknown risks and uncertainties, the Company’s results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ are described under Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended January 1, 2023 (“Annual Report on Form 10-K”). There have been no material changes to our risk factors since the filing of the Annual Report on Form 10-K.






PART I – FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

Utz Brands, Inc.
CONSOLIDATED BALANCE SHEETS
October 1, 2023 and January 1, 2023
(In thousands)
 
As of
October 1, 2023
As of January 1, 2023
 (Unaudited)
ASSETS
Current Assets
Cash and cash equivalents$60,094 $72,930 
   Accounts receivable, less allowance of $2,638 and $1,815, respectively
132,038 136,985 
Inventories116,674 118,006 
Prepaid expenses and other assets44,196 34,991 
Current portion of notes receivable5,553 9,274 
Total current assets358,555 372,186 
Non-current Assets
Property, plant and equipment, net329,846 345,198 
Goodwill915,295 915,295 
Intangible assets, net1,070,691 1,099,565 
Non-current portion of notes receivable13,246 12,794 
Other assets109,267 95,328 
Total non-current assets2,438,345 2,468,180 
Total assets$2,796,900 $2,840,366 
LIABILITIES AND EQUITY
Current Liabilities
Current portion of term debt$20,649 $18,472 
Current portion of other notes payable8,317 12,589 
Accounts payable135,931 114,360 
Accrued expenses and other62,714 92,012 
Total current liabilities227,611 237,433 
  Non-current portion of term debt and revolving credit facility895,172 893,335 
  Non-current portion of other notes payable19,496 20,339 
  Non-current accrued expenses and other75,551 67,269 
  Non-current warrant liability28,944 45,504 
  Deferred tax liability114,059 124,802 
Total non-current liabilities1,133,222 1,151,249 
Total liabilities1,360,833 1,388,682 
Commitments and Contingencies
Equity
Shares of Class A Common Stock, $0.0001 par value; 1,000,000,000 shares authorized; 81,141,417 and 80,882,334 shares issued and outstanding as of October 1, 2023 and January 1, 2023, respectively
8 8 
Shares of Class V Common Stock, $0.0001 par value; 61,249,000 shares authorized; 59,349,000 shares issued and outstanding as of October 1, 2023 and January 1, 2023
6 6 
Additional paid-in capital938,898 926,919 
Accumulated deficit (265,743)(254,564)
Accumulated other comprehensive income 32,682 30,777 
Total stockholders' equity705,851 703,146 
Noncontrolling interest730,216 748,538 
Total equity1,436,067 1,451,684 
Total liabilities and equity$2,796,900 $2,840,366 
The accompanying notes are an integral part of these consolidated financial statements.
1


Utz Brands, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
For the thirteen and thirty-nine weeks ended October 1, 2023 and October 2, 2022
(In thousands, except share information) (Unaudited)
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Net sales$371,852 $362,818 $1,086,138 $1,053,732 
Cost of goods sold252,583 244,545 744,980 720,123 
Gross profit119,269 118,273 341,158 333,609 
Selling, distribution, and administrative expenses
Selling and distribution70,973 69,263 202,888 226,169 
Administrative34,531 33,182 123,155 110,549 
Total selling, distribution, and administrative expenses105,504 102,445 326,043 336,718 
(Loss) gain on sale of assets, net(8,488)(823)(9,275)919 
Income (loss) from operations5,277 15,005 5,840 (2,190)
Other income (expense)
Interest expense(15,537)(11,648)(44,934)(31,478)
Other income, net392 205 2,279 80 
Gain (loss) on remeasurement of warrant liability 15,984 (3,672)16,560 4,032 
Other income (expense), net839 (15,115)(26,095)(27,366)
Income (loss) before taxes6,116 (110)(20,255)(29,556)
Income tax benefit(10,099)(1,595)(13,435)(1,688)
Net income (loss)16,215 1,485 (6,820)(27,868)
Net (income) loss attributable to noncontrolling interest(222)(2,373)9,562 12,589 
Net income (loss) attributable to controlling interest$15,993 $(888)$2,742 $(15,279)
Earnings (loss) per Class A Common stock: (in dollars)
Basic $0.20 $(0.01)$0.03 $(0.19)
Diluted$0.19 $(0.01)$0.03 $(0.19)
Weighted-average shares of Class A Common stock outstanding
Basic81,141,417 80,812,835 81,060,961 79,852,137 
Diluted83,444,275 80,812,835 83,567,756 79,852,137 
Net income (loss)$16,215 $1,485 $(6,820)$(27,868)
Other comprehensive income:
Change in fair value of interest rate swap4,047 19,655 3,294 50,475 
Comprehensive income (loss)20,262 21,140 (3,526)22,607 
Net comprehensive (income) loss attributable to noncontrolling interest(1,932)(10,696)8,173 (8,981)
Net comprehensive income attributable to controlling interest$18,330 $10,444 $4,647 $13,626 
The accompanying notes are an integral part of these consolidated financial statements.
2


Utz Brands, Inc.
CONSOLIDATED STATEMENTS OF EQUITY
For the thirteen and thirty-nine weeks ended October 1, 2023 and October 2, 2022
(In thousands, except share data) (Unaudited)
Class A Common StockClass V Common StockAdditional Paid-in CapitalAccumulated (Deficit)Accumulated Other Comprehensive IncomeTotal Stockholders' EquityNon-controlling InterestTotal Equity
SharesAmountSharesAmount
Balance at January 2, 202277,644,645 $8 59,349,000 $6 $912,574 $(236,598)$3,715 $679,705 $754,968 $1,434,673 
Payments of tax withholding requirements for employee stock awards— — (6,217)— — (6,217)— (6,217)
Share-based compensation1,062,817 — — 5,779 — — 5,779 — 5,779 
Issuance of common stock in connection with private placement sale2,105,373 — — 28,000 — — 28,000 — 28,000 
Tax impact arising from share issuance— — (561)— — (561)— (561)
Net loss— — — (14,391)— (14,391)(14,962)(29,353)
Other comprehensive income— — — — 17,573 17,573 13,247 30,820 
Cash dividends declared ($0.108 per share of Class A Common Stock)
— — — (8,604)— (8,604)— (8,604)
Distribution to noncontrolling interest— — — — — — (6,410)(6,410)
Balance at July 3, 202280,812,835 8 59,349,000 6 939,575 (259,593)21,288 701,284 746,843 1,448,127 
Stock-based compensation— — 1,800 — — 1,800 — 1,800 
Net (loss) income— — — (888)— (888)2,373 1,485 
Other comprehensive income— — — — 11,332 11,332 8,323 19,655 
Cash dividends declared ($0.054 per share of Class A Common Stock)
— — — (4,364)— (4,364)— (4,364)
Distribution to noncontrolling interest— — — — — — (3,205)(3,205)
Balance at October 2, 202280,812,835 $8 59,349,000 $6 $941,375 $(264,845)$32,620 $709,164 $754,334 $1,463,498 
Balance at January 1, 202380,882,334 $8 59,349,000 $6 $926,919 $(254,564)$30,777 $703,146 $748,538 $1,451,684 
Share-based compensation259,083 — — 8,939 — — 8,939 — 8,939 
Payments of tax withholding requirements for employee stock awards— — (589)— — (589)— (589)
Net loss— — — (13,251)— (13,251)(9,784)(23,035)
Cash dividends declared ($0.114 per share of Class A Common Stock)
— — — (9,296)— (9,296)— (9,296)
Other comprehensive loss— — — — (432)(432)(321)(753)
Distribution to noncontrolling interest— — — — — — (6,766)(6,766)
Balance at July 2, 202381,141,417 8 59,349,000 6 935,269 (277,111)30,345 688,517 731,667 1,420,184 
Stock-based compensation— — 3,629 — — 3,629 — 3,629 
Net income (loss)— — — 15,993 — 15,993 222 16,215 
Other comprehensive income— — — — 2,337 2,337 1,710 4,047 
Cash dividends declared ($0.057 per share of Class A Common Stock)
— — — (4,625)— (4,625)— (4,625)
Distribution to noncontrolling interest— — — — — — (3,383)(3,383)
Balance at October 1, 202381,141,417 $8 59,349,000 $6 $938,898 $(265,743)$32,682 $705,851 $730,216 $1,436,067 
The accompanying notes are an integral part of these consolidated financial statements.
3


Utz Brands, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the thirty-nine weeks ended October 1, 2023 and October 2, 2022
(In thousands)
(Unaudited)
Thirty-nine weeks ended October 1, 2023
Thirty-nine weeks ended October 2, 2022
Cash flows from operating activities
Net loss$(6,820)$(27,868)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment and other charges9,548 4,678 
Depreciation and amortization60,114 66,345 
Gain on remeasurement of warrant liability (16,560)(4,032)
Loss (gain) on sale of assets9,275 (919)
Share-based compensation11,808 7,579 
Deferred taxes(10,743)(1,315)
Deferred financing costs1,084 1,047 
Changes in assets and liabilities:
Accounts receivable, net4,947 (12,628)
Inventories644 (27,866)
Prepaid expenses and other assets(20,183)(18,308)
Accounts payable and accrued expenses and other6,016 21,358 
Net cash provided by operating activities49,130 8,071 
Cash flows from investing activities
Acquisitions, net of cash acquired (75)
Purchases of property and equipment(45,707)(68,708)
Proceeds from sale of property and equipment8,794 4,100 
Proceeds from sale of routes21,683 16,819 
Proceeds from the sale of IO notes4,094 5,017 
Proceeds from insurance claims for capital investments 3,935 
Notes receivable, net(26,369)(14,028)
Net cash used in investing activities(37,505)(52,940)
Cash flows from financing activities
Line of credit borrowings, net 20,324 40,390 
Borrowings on term debt and notes payable4,273 33,969 
Repayments on term debt and notes payable(23,744)(20,692)
Payment of debt issuance cost(655)(1,471)
Payments of tax withholding requirements for employee stock awards(589)(6,217)
Proceeds from issuance of shares 28,000 
Dividends (13,921)(12,793)
Distribution to noncontrolling interest(10,149)(6,410)
Net cash (used in) provided by financing activities(24,461)54,776 
Net (decrease) increase in cash and cash equivalents(12,836)9,907 
Cash and cash equivalents at beginning of period72,930 41,898 
Cash and cash equivalents at end of period$60,094 $51,805 
The accompanying notes are an integral part of these consolidated financial statements.
4


Utz Brands, Inc.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation – The accompanying consolidated financial statements comprise the financial statements of Utz Brands, Inc. ("UBI" or the "Company", formerly Collier Creek Holdings ("CCH")) and its wholly owned subsidiaries. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). They do not include all information and notes required by U.S. GAAP for annual financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Company’s financial statements for the year ended January 1, 2023. The balance sheet as of January 1, 2023 has been derived from the audited combined financial statements as of and for the year ended January 1, 2023. In the opinion of management, such financial information reflects all normal and recurring adjustments necessary for a fair presentation of the financial position and the results of operations for such interim periods in accordance with the U.S. GAAP. Operating results for the interim period are not necessarily indicative of the results that may be expected for any future period or for the full year. The consolidated interim financial statements, including the Company's significant accounting policies, should be read in conjunction with the audited combined financial statements and notes thereto for the year ended January 1, 2023.
All intercompany transactions and balances have been eliminated in consolidation.
Reclassification – Certain prior year amounts have been reclassified for consistency with the current year presentation.
Operations – The Company through its subsidiary, Utz Quality Foods, LLC ("UQF"), has been a premier producer, marketer and distributor of snack food products since 1921. The Company has steadily expanded its distribution channels to where it now sells products to supermarkets, mass merchants, club stores, dollar and discount stores, convenience stores, independent grocery stores, drug stores, food service, vending, military, and other channels in most regions of the United States through routes to market, that include direct-store-delivery, (“DSD”), direct to warehouse, and third-party distributors. The Company manufactures and distributes a full line of high-quality salty snack items, such as potato chips, tortilla chips, pretzels, cheese balls, pork skins, party mixes, and popcorn. The Company also sells dips, crackers, dried meat products and other snack food items packaged by other manufacturers.
Cash and Cash Equivalents – The Company considers all highly-liquid investments purchased with an original maturity of three months or less to be cash equivalents. The majority of the Company’s cash is held in financial institutions with insurance provided by the Federal Deposit Insurance Corporation ("FDIC") of $250,000 per depositor. At various times, account balances may exceed federally insured limits.
Accounts Receivables – Accounts receivable are reported at net realizable value. The net realizable value is based on Company management’s estimate of the amount of receivables that will be collected based on analysis of historical data and trends, as well as review of significant customer accounts. Accounts receivable are considered to be past due when payments are not received within the customer’s credit terms. The Company’s methodology to measure the provision for credit losses requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include current market conditions, delinquency trends, aging behavior of receivables, and customer classes or individual customers.
The Company’s estimates are reviewed and revised periodically based on the ongoing evaluation of credit quality indicators. Historically, actual write-offs for uncollectible accounts have not significantly differed from prior estimates.
Inventories – Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventory write-downs are recorded for shrinkage, damaged, stale and slow-moving items.
5


Property, Plant and Equipment – Property, plant and equipment are stated at cost net of accumulated depreciation. Major additions and betterments are recorded to the asset accounts, while maintenance and repairs, which do not improve or extend the lives of the assets, are charged to expense accounts as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in operations in the disposal period. Depreciation is determined utilizing the straight-line method over the estimated useful lives of the various assets, which generally range from 2 to 20 years for machinery and equipment, 3 to 10 years for transportation equipment and 8 to 40 years for buildings. Assets held for sale are reported at the lower of the carrying amount or fair value less costs to sell. The Company assesses for impairment on property, plant and equipment upon the occurrence of a triggering event.
Income Taxes – The Company accounts for income taxes pursuant to the asset and liability method of Accounting Standards Codification (“ASC”) 740, Income Taxes, which requires it to recognize current tax liabilities or receivables for the amount of taxes it estimates are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible.
The Company follows the provisions of ASC 740-10 related to accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.
The benefit of tax positions taken or expected to be taken in the Company’s income tax returns is recognized in the financial statements if such positions are more likely than not capable of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits". A liability is recognized (or the amount of net operating loss carryover or the amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and penalties related to unrecognized tax benefits are required to be calculated, if applicable. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as selling, distribution, and administrative expenses. As of October 1, 2023 and January 1, 2023, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next fiscal year.
Goodwill and Other Identifiable Intangible Assets – The Company allocates the cost of acquired companies to the identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount classified as goodwill. The identification and valuation of these intangible assets and the determination of their estimated useful lives at the time of acquisition, as well as the completion of impairment tests, require significant management judgments and estimates. These estimates are made based on, among other factors, review of projected future operating results and business plans, economic projections, anticipated highest and best use of future cash flows and the cost of capital. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of goodwill and other intangible assets, and potentially result in a different impact to the Company’s results of operations. Further, changes in business strategy and/or market conditions may significantly impact these judgments and thereby impact the fair value of these assets, which could result in an impairment of the goodwill or intangible assets.
Finite-lived intangible assets consist of distribution/customer relationships, technology, certain master distribution rights and certain trademarks. These assets are being amortized over their estimated useful lives. Finite-lived intangible assets are tested for impairment only when management has determined that potential impairment indicators are present.
Goodwill and other indefinite-lived intangible assets (including certain trade names, certain master distribution rights and Company-owned sales routes) are not amortized but are tested for impairment at least annually and whenever events or circumstances change that indicate impairment may have occurred. The Company tests goodwill for impairment at the reporting unit level. The Company has identified the existing snack food operations as its sole reporting unit.
In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2017-04, Intangibles - Goodwill and Other ("Topic 350"): Simplifying the Test for Goodwill Impairment, the Company is required to record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value.
6


Topic 350 also permits an entity to first assess qualitative factors to determine whether it is necessary to perform quantitative impairment tests for goodwill and indefinite-lived intangibles. If an entity believes, as a result of each qualitative assessment, it is more likely than not that the fair value of goodwill or an indefinite-lived intangible asset exceeds its carrying value then a quantitative impairment test is not required.
For the latest qualitative analysis performed, which took place on the first day of the fourth quarter of 2022, the Company took into consideration all the events and circumstances listed in Topic 350 in addition to other entity-specific factors that had taken place. The Company determined that there was no significant impact that affected the fair value of the reporting unit through October 1, 2023. Therefore, the Company determined that it was not necessary to perform a quantitative goodwill impairment test for the reporting unit.
Fair Value of Financial Instruments – Financial instruments held by the Company include cash and cash equivalents, accounts receivable, hedging instruments, warrants, purchase commitments on commodities, accounts payable and debt. The carrying value of all cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to their short-term nature. The carrying value of the debt is also estimated to approximate its fair value based upon current market conditions and interest rates. The fair values of the hedging instruments are revalued at each reporting period.
Revenue Recognition – The Company’s revenues primarily consist of the sale of salty snack items to customers, including supermarkets, mass merchants, club stores, dollar and discount stores, convenience stores, independent grocery stores, drug stores, food service, vending, military, and other channels. The Company sells its products in most regions of the United States primarily through its DSD network, direct to warehouse shipments, and third-party distributors. These revenue contracts generally have a single performance obligation. Revenue, which includes shipping and handling charges billed to the customer, is reported net of variable consideration and consideration payable to customers, including applicable discounts, returns, allowances, trade promotion, consumer coupon redemption, unsaleable product, and other costs. Amounts billed and due from customers are classified as accounts receivables and require payment on a short-term basis and, therefore, the Company does not have any significant financing components.
The Company recognizes revenue when (or as) performance obligations are satisfied by transferring control of the goods to customers. Control is transferred upon delivery of the goods to the customer. Shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. Applicable shipping and handling are included in customer billing and are recorded as revenue as control of the products’ is transferred to customers. The Company assesses the goods promised in customer purchase orders and identifies a performance obligation for each promise to transfer a good that is distinct.
The Company offers various forms of trade promotions and the methodologies for determining these provisions are dependent on local customer pricing and promotional practices, which range from contractually fixed percentage price reductions to provisions based on actual occurrence or performance. The Company’s promotional activities are conducted either through the retail trade or directly with consumers and include activities such as in store displays and events, feature price discounts, consumer coupons, and loyalty programs. The costs of these activities are recognized at the time the related revenue is recorded, which normally precedes the actual cash expenditure. The recognition of these costs therefore requires management judgment regarding the volume of promotional offers that will be redeemed by either the retail trade customer or consumer. These estimates are made using various techniques including using historical data on performance of similar promotional programs. The Company has reserves in place of $21.9 million as of October 1, 2023, which include adjustments taken by customers of $12.4 million that are awaiting final processing, and reserves of $46.3 million as of January 1, 2023, which include adjustments taken by customers of $32.8 million that are awaiting final processing. Differences between estimated expense and actual redemptions are recognized as a change in management estimate as actual redemptions are incurred.
Business Combinations – The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset acquisition. If the screen is not met, further determination is required as to whether or not the Company has acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is accounted for as a business combination or an acquisition of assets.
The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the Company’s financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill.
7


Distributor Buyouts - During 2022, the Company bought out and terminated the contracts of multiple third-party distributors who had previously been providing services to the Company. These transactions were accounted for as contract terminations and resulted in expense of $23.0 million for thirty-nine weeks ended October 2, 2022, and are included within selling and distribution expense on the Consolidated Statement of Operations and Comprehensive Income (Loss).
Use of Estimates – Management uses estimates and assumptions in preparing the consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Some examples, but not a comprehensive list, include sales and promotional allowances, customer returns, allowances for doubtful accounts, inventory valuations, useful lives of fixed assets and related impairment, long-term investments, hedge transactions, goodwill and intangible asset valuations and impairments, incentive compensation, income taxes, self-insurance, contingencies, litigation, and inputs used to calculate deferred tax liabilities, tax valuation allowances, and tax receivable agreements. Actual results could vary materially from the estimates that were used.
2.INVENTORIES
Inventories consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Finished goods$76,881 $67,386 
Raw materials30,740 42,204 
Maintenance parts9,053 8,416 
Total inventories$116,674 $118,006 
3.PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Land$32,448 $30,582 
Buildings126,413 129,824 
Machinery and equipment236,280 255,505 
Land improvements3,828 3,756 
Building improvements4,131 3,709 
Construction-in-progress48,756 21,934 
 451,856 445,310 
Less: accumulated depreciation(122,010)(100,112)
Property, plant and equipment, net$329,846 $345,198 
Depreciation expense was $10.0 million and $12.0 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $30.9 million and $37.1 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. Depreciation expense is classified in Cost of goods sold and Selling, distribution, and administrative expenses on the Consolidated Statements of Operations and Comprehensive Income (Loss).
The Company recorded expenses of $8.9 million in connection with the closure of the Company's manufacturing facility in Birmingham, Alabama (the "Manufacturing Closure"), which included $1.3 million in severance and related costs and $7.6 million of asset impairments related to fixed assets. The severance and related expenses are recorded in the cost of goods sold line on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the thirty-nine weeks ended October 1, 2023. The fixed asset impairments are recorded in the administrative expenses line on the Consolidated Statement of Operations and Comprehensive Income (Loss). In addition, during the thirty-nine weeks ended October 1, 2023, the Company recognized expense of $1.9 million related to the impairment of property, plant, and equipment unrelated to the Manufacturing Closure.
8


During the thirteen weeks ended October 1, 2023, the Company completed the sale of the Company's manufacturing facility in Bluffton, Indiana, which resulted in a loss on sale of the assets of $13.4 million. Additionally, the Company entered into a supply agreement with the buyer pursuant to which the buyer is obligated to co-manufacture certain products at below market rates for up to one year. The Company recorded a tolling asset of $0.6 million for the difference between the rate charged and the market rate for these services. If the buyer defaults on its obligations to manufacture any of the committed products, a financial penalty will be assessed based on the contractual terms required in the supply agreement. In a separate transaction, the Company completed the sale of land in Hanover, Pennsylvania to a separate third-party for a gain of $4.0 million.
4.GOODWILL AND INTANGIBLE ASSETS, NET
There were no changes to goodwill during the thirty-nine weeks ended October 1, 2023.
Intangible assets, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Subject to amortization:  
Distributor/customer relationships$677,930 $677,930 
Trademarks63,850 63,850 
Amortizable assets, gross741,780 741,780 
Accumulated amortization(110,989)(82,738)
Amortizable assets, net630,791 659,042 
Not subject to amortization:
Trade names434,513 434,513 
Route assets5,387 6,010 
Intangible assets, net$1,070,691 $1,099,565 
Previously, the Company was granted certain exclusive distribution rights for certain products manufactured by another manufacturer. During the first fiscal quarter of 2022, the Company shifted the relationship with that manufacturer and converted that shelf space to Company-branded products. As a result, the Company recorded impairment expense of $2.0 million and the amortizable master distribution rights decreased by $2.2 million during the thirty-nine weeks ended October 2, 2022. There were no significant changes to intangible assets during the thirty-nine weeks ended October 1, 2023, other than those which arise from the normal course of business of buying and selling of Company-owned route assets and amortization.
Amortization of the distributor/customer relationships, technology, and trade names amounted to $9.4 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, and $28.3 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022. The expense related to the amortization of intangibles is classified in administrative expenses on the Consolidated Statements of Operations and Comprehensive Income (Loss).
5.NOTES RECEIVABLE
The Company has undertaken a program in recent years to sell Company-managed DSD distribution routes to independent operators (“IOs”). Contracts are executed between the Company and the IOs for the sale of the product distribution routes, including a note in favor of the Company, in certain cases. The notes bear interest at rates ranging from 0.00% to 10.40% with terms ranging, generally, from one to ten years. The notes receivable balances due from IOs at October 1, 2023 and January 1, 2023 totaled $18.7 million and $22.0 million, respectively, and are collateralized by the routes for which the loans are made. During the thirty-nine weeks ended October 1, 2023, the loss recorded by the Company on note receivables for which the Company reclaimed the collateral due to credit losses was less than $0.1 million. The Company has a corresponding notes payable liability, related to the IOs notes receivables, of $16.9 million and $21.1 million as of October 1, 2023 and January 1, 2023, respectively. The related notes payable liability is discussed in further detail within Note 7. "Long-Term Debt."
Other notes receivable totaled $0.1 million as of both October 1, 2023 and January 1, 2023.
9


6.ACCRUED EXPENSES AND OTHER
Current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Accrued compensation and benefits$18,300 $38,974 
Operating right of use liability14,868 12,389 
Insurance liabilities8,090 6,701 
Accrued manufacturing related costs3,622 10,817 
Acquisition tax consideration854 1,131 
Accrued dividends and distributions8,006 7,989 
Accrued interest691 1,151 
Other accrued expenses8,283 12,860 
Total accrued expenses and other$62,714 $92,012 
Non-current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Operating right of use liability$44,349 $35,331 
Tax Receivable Agreement liability24,536 25,426 
Supplemental retirement and salary continuation plans6,666 6,512 
Total accrued expenses and other$75,551 $67,269 
7.LONG-TERM DEBT
Revolving Credit Facility
On November 21, 2017, UBH entered into an asset based revolving credit facility (as amended, the "ABL facility"), pursuant to the terms of that certain First Lien Term Loan Credit Agreement, dated November 21, 2017 (the "Credit Agreement"). On September 22, 2022, the ABL facility was amended to further increase the credit limit to $175.0 million and replaced the interest rate benchmark from London Interbank Offered Rate (“LIBOR”) to Term SOFR Screen Rate (“SOFR”). Availability under the ABL facility is based on a monthly accounts receivable and inventory borrowing base certification, which is net of outstanding letters of credit. As of October 1, 2023 and January 1, 2023, $149.3 million and $163.0 million, respectively, was available for borrowing, net of letters of credit. The ABL facility is also subject to unused line fees (0.5% at October 1, 2023) and other fees and expenses. On July 20, 2023, the ABL facility was further amended to increase the credit limit to $225.0 million and extend the maturity through the earlier of July 20, 2028, or 91 days prior to the maturity of the Term Loan B (as defined below). The Company incurred fees of $0.7 million in connection with the amendment to the ABL facility.
Standby letters of credit in the amount of $12.2 million and $12.0 million have been issued as of October 1, 2023 and January 1, 2023, respectively. The standby letters of credit are primarily issued for insurance purposes.
Term Loans
On December 14, 2020, the Company entered into a Bridge Credit Agreement with a syndicate of banks, led by Bank of America, N.A. (the "Bridge Credit Agreement"). The Company used $490.0 million from the proceeds of the Bridge Credit Agreement to finance the acquisition of Truco Holdco Inc. ("Truco" and such acquisition, the "Truco Acquisition") and certain intellectual property from OTB Acquisition, LLC (the "IP Purchase"). The Bridge Credit Agreement bears interest at an annual rate based on 4.25% plus 1-month LIBOR with scheduled incremental increases to the base rate, as defined in the Bridge Credit Agreement.
10


On January 20, 2021, the Company entered into Amendment No. 2 to the Bridge Credit Agreement ("Amendment No. 2") which provided additional operating flexibility and revisions to certain restrictive covenants. Pursuant to the terms of Amendment No. 2, the Company raised $720 million in aggregate principal of Term Loan B ("Term Loan B") which then bore interest at LIBOR plus 3.00%, and extended the maturity of the Bridge Credit Agreement to January 20, 2028. The proceeds were used, together with cash on hand and proceeds from the Company's exercised warrants, to redeem the outstanding principal amount of Term Loan B and Bridge Credit Agreement of $410 million and $358 million, respectively. The refinancing was accounted for as an extinguishment. The Company incurred debt issuance costs and original issuance discounts of $8.4 million.
On June 22, 2021, the Company entered into Amendment No. 3 to the Bridge Credit Agreement (“Amendment No. 3”). Pursuant to the terms of Amendment No. 3, the Company increased the principal balance of Term Loan B by $75.0 million to bring the aggregated balance of Term Loan B proceeds to $795.0 million. The Company incurred additional debt issuance costs and original issuance discounts of $0.7 million related to the incremental funding.
On October 12, 2022, the Company, through its subsidiaries UQF, Kennedy Endeavors, LLC (“Kennedy”) and Condor Snack Foods, LLC (together with UQF and Kennedy, the “Real Estate Financing Borrowers”), entered into a loan agreement (the “Real Estate Term Loan”) with City National Bank which was secured by a majority of the Real Estate Financing Borrowers’ real estate assets. The Real Estate Term Loan initially held a principal balance of $88.1 million, with net proceeds of approximately $85.0 million after transaction fees and expenses. The Company used a portion of the proceeds from the Real Estate Term Loan to pay off the ABL facility. The Real Estate Term Loan contains a single financial maintenance covenant consisting of a fixed charge coverage ratio that is tested quarterly only during a covenant trigger period consistent with the existing ABL facility. Concurrent with the closing of the Real Estate Term Loan, UQF entered into an interest rate swap transaction to fix the effective interest rate at approximately 5.929%, as discussed in further detail within Note 8. “Derivative Financial Instruments and Purchase Commitments”. In September 2023, the Company made an additional $4.4 million paydown of the Real Estate Term Loan using net proceeds from the sale of land to a third-party, as discussed within Note 3. “Property, Plant, and Equipment, Net”, as well as cash on hand. Following such paydown, the loan will amortize approximately $3.3 million in principal annually through maturity, subject to any additional advanced paydowns.
The Term Loan B and the ABL facility are collateralized by substantially all of the assets and liabilities of UBH and its subsidiaries, excluding the real estate assets, which secure the Real Estate Term Loan and including equity interests in certain of UBH’s subsidiaries. The credit agreements contain certain affirmative and negative covenants as to operations and the financial condition of UBH and its subsidiaries. UBH and its subsidiaries were in compliance with its financial covenants as of October 1, 2023.
Debt (in thousands)
Issue DatePrincipal BalanceMaturity DateOctober 1, 2023January 1, 2023
Term loan B (1)
June-21$795,000 January-28$773,323 $779,286 
Real Estate Term LoanOctober-2288,140 October-3281,019 88,140 
Equipment loans (2)
50,360 54,053 
ABL facility(3)
October-2720,362  
Net impact of debt issuance costs and original issue discounts(9,243)(9,672)
Total long-term debt915,821 911,807 
Less: current portion(20,649)(18,472)
Long term portion of term debt and financing obligations$895,172 $893,335 
(1) On September 22, 2022, the Company entered into Amendment No. 4 to the Bridge Credit Agreement ("Amendment No. 4"), which replaced the interest rate benchmark from LIBOR to SOFR. The weighted average interest rate on the Term Loan B debt, without consideration of the hedge, was 8.36% for the thirteen weeks ended October 1, 2023.
(2) The Company has finance lease obligations with Banc of America Leasing & Capital, LLC, which are treated as secured borrowing. The Company made a series of draws upon these agreements totaling $4.3 million in fiscal year 2023. These draws bear interest ranging from 3.26% through 7.25% and have varying maturities up through 2028.
(3) The facility bore interest at an annual rate based on LIBOR, or SOFR plus a 0.10% credit spread adjustment after the amendment on September 22, 2022, plus an applicable margin of 1.75% (ranging from 1.50% to 2.00% based on availability) or the prime rate plus an applicable margin of 0.75% (ranging from 0.50% to 1.00%). The Company generally utilizes the prime
11


rate for amounts that the Company expects to pay down within 30 days. The interest rate on the facility as of October 1, 2023 would have been 9.25%, under the prime rate. The Company elected to use the LIBOR, prior to the amendment on September 22, 2022 which changed the reference rate to SOFR as described above, for balances that were expected to be carried longer than 30 days. The interest rate on the ABL facility as of October 1, 2023 was 7.17%.
Other Notes Payable and Finance Leases
Amounts outstanding under notes payable consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Note payable – IO notes$16,879 $21,098
Finance lease obligations10,734 10,995
Other200 835
Total notes payable27,813 32,928
Less: current portion(8,317)(12,589)
Long term portion of notes payable$19,496 $20,339
From time to time, the Company sells notes receivable from IOs to a financial institution. During the thirty-nine weeks ended October 1, 2023, the Company sold $4.1 million of notes receivable from IOs to a financial institution. Due to the structure of these transactions, they did not qualify for sale accounting treatment and the Company has recorded the notes payable obligation owed by the IOs to the financial institution as well as the corresponding notes receivable on the Company's books. The Company services the loans for the financial institution by collecting principal and interest from the IOs and passing it through to the institution. The Company partially guarantees the outstanding loans, as discussed in further detail within Note 10. "Contingencies." These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon any event of default.
Interest Expense
Interest expense consisted of the following:
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Company’s term loans, ABL facility, and other long-term debt$14,582 $10,916 $42,971 $29,320 
Amortization of deferred financing fees633 344 1,084 1,028 
IO loans322 388 879 1,130 
Total interest$15,537 $11,648 $44,934 $31,478 
8.DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS
Derivative Financial Instruments
To reduce the effect of interest rate fluctuations, the Company entered into a three-year interest rate swap contract on September 6, 2019, with an effective date of September 30, 2019, with a counter-party to make a series of payments based on a fixed interest rate of 1.339% and receive a series of payments based on the greater of LIBOR or 0.00%. Both the fixed and floating payment streams were based on a notional amount of $250 million. On December 21, 2021, the Company entered into an accreting interest rate swap contract with a counter-party, with an effective date of December 31, 2021, to make a series of payments based on a fixed interest rate of 1.3885% and receive a series of payments based on the greater of LIBOR or 0.00%. Both the fixed and floating payment streams were based on a notional amount of $250 million and have accreted to $500 million, and mature on September 30, 2026. Effective on September 30, 2022, the Company amended the swap contract to reference the 1-month SOFR plus a credit spread adjustment (“CSA”) of 11.448 basis points, as well as setting the new fixed rate to 1.408%. Under the amended swap agreement, the Company will receive a series of payments based on the greater of SOFR plus CSA, or 0.00%.
12


On October 12, 2022, the Company entered into a 10-year swap contract, with an effective date of November 1, 2022, with a counter-party to make a series of payments based on a fixed interest rate of 3.83% and receive a series of payments based on the greater of the 1-month SOFR or 0.00%. The agreement covers $85.5 million as of October 1, 2023. This swap effectively fixes the rate of the Real Estate Term Loan to 5.93%. The balance that the hedge covers is designed to abate as principal payments on the Real Estate Term Loan are made. The Company entered into these transactions to reduce its exposure to changes in cash flows associated with the Real Estate Term Loan and has designated this derivative as a cash flow hedge.
As of October 1, 2023, the effective fixed interest rate on the long-term debt hedged by these contracts was 5.81%. For further treatment of the Company’s interest rate swap, refer to Note 9. “Fair Value Measurements” and Note 11. “Accumulated Other Comprehensive (Loss) Income.”
Warrant Liabilities
The Company has outstanding warrants which are accounted for as derivative liabilities pursuant to ASC 815-40. See Note 14. "Warrants" for additional information on the Company's warrant liabilities. A reconciliation of the changes in the warrant liability during the thirty-nine weeks ended October 1, 2023 is as follows:
(in thousands)
Fair value of warrant liabilities as of January 1, 2023$45,504 
Gain on remeasurement of warrant liability(576)
Fair value of warrant liabilities as of July 2, 2023$44,928 
Gain on remeasurement of warrant liability(15,984)
Fair value of warrant liabilities as of October 1, 2023$28,944 
Purchase Commitments
The Company has outstanding purchase commitments for specific quantities at fixed prices for certain key ingredients to economically hedge commodity input prices. These purchase commitments totaled $84.4 million as of October 1, 2023. The Company accrues for losses on firm purchase commitments in a loss position at the end of each reporting period to the extent that there is an active observable market. The Company has recorded purchase commitment gains (losses) totaling $(1.7) million and $1.0 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $(1.9) million and $0.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
9.FAIR VALUE MEASUREMENTS
The Company follows the guidance relating to fair value measurements and disclosures with respect to financial assets and liabilities that are re-measured and reported at fair value each reporting period, and with respect to non-financial assets and liabilities that are not required to be measured at fair value on a recurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to the valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable pricing inputs (Level III). A financial asset or liability’s level within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are described below:
Level I - Valuations are based on unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities;
Level II - Valuations are based on quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active. Financial assets or liabilities which are included in this category are securities where all significant inputs are observable, either directly or indirectly; and
Level III - Financial assets or liabilities which are included in this category have prices or valuations that are unobservable or there is little, if any, market activity for these financial assets or liabilities. The inputs into the determination of fair value inputs for these investments require significant management judgment or estimation. The availability of observable inputs can vary depending on the financial asset or liability and is affected by a wide variety of factors. To the extent that valuation is based on inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.
13


The fair values of the Company’s Level 2 derivative instruments were determined using valuation models that use market observable inputs including interest rate curves and both forward and spot prices for commodities. Derivative assets and liabilities included in Level 2 primarily represent commodity and interest rate swap contracts.
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of October 1, 2023:
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$60,094 $ $ $60,094 
Commodity contracts 560  560 
Interest rate swaps 48,651  48,651 
Total assets$60,094 $49,211 $ $109,305 
Liabilities:
Commodity contracts$ $867 $ $867 
Private placement warrants 28,944  28,944 
Debt 915,821  915,821 
Total liabilities$ $945,632 $ $945,632 
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of January 1, 2023: 
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$72,930 $ $ $72,930 
Commodity contracts 1,586  1,586 
Interest rate swaps 45,088  45,088 
Total assets$72,930 $46,674 $ $119,604 
Liabilities:
Private placement warrants$ $45,504 $ $45,504 
Debt 911,807  911,807 
Total liabilities$ $957,311 $ $957,311 
10.CONTINGENCIES
Litigation Matters
The Company is involved in litigation and other matters incidental to the conduct of its business, the results of which, in the opinion of management, are not likely to be material to the Company’s financial condition, results of operations or cash flows.
Tax Matters
The Company received an assessment from the Commonwealth of Pennsylvania pursuant to a sales and use tax audit for the period from January 1, 2014 through December 31, 2016. As of January 2, 2022, the Company had a reserve of $1.3 million to cover the assessment. On January 7, 2022, the Company settled the audit with the Commonwealth of Pennsylvania for $0.9 million.
14


Guarantees
The Company partially guarantees loans made to IOs by Cadence Bank for the purchase of routes. The outstanding balance of loans guaranteed was $0.8 million and $1.5 million as of October 1, 2023 and January 1, 2023, respectively, all of which was recorded by the Company as off balance sheet arrangements. The maximum amount of future payments the Company could be required to make under the guarantees equates to 25% of the outstanding loan balance up to $2.0 million. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company partially guarantees loans made to IOs by Bank of America for the purchase of routes. The outstanding balance of loans guaranteed that were issued by Bank of America was $49.6 million and $36.0 million as of October 1, 2023 and January 1, 2023, respectively, which are off balance sheet arrangements. As discussed in Note 7. "Long-Term Debt", the Company also sold notes receivable on its books to Bank of America during fiscal years 2019, 2021, and 2022, which the Company partially guarantees. The outstanding balance of notes purchased by Bank of America as of October 1, 2023 and January 1, 2023 was $15.3 million and $17.9 million, respectively. Due to the structure of the transactions, the sale did not qualify for sale accounting treatment, and as such the Company records the notes payable obligation owed by the IOs to the financial institution as well as the corresponding note receivable on the Company's Consolidated Balance Sheets. The maximum amount of future payments the Company could be required to make under these guarantees equates to 25% of the outstanding loan balance on the first day of each calendar year plus 25% of the amount of any new loans issued during such calendar year. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company guarantees loans made to IOs by M&T Bank for the purchase of routes. The agreement with M&T Bank was amended in January 2020 so that the Company guaranteed up to 25% of the greater of the aggregate principal amount of loans outstanding on the payment date or January 1st of the subject year. The outstanding balance of loans guaranteed was $2.5 million and $3.4 million as of October 1, 2023 and January 1, 2023, respectively, all of which were included in the Company's Consolidated Balance Sheets. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
11.ACCUMULATED OTHER COMPREHENSIVE INCOME
Total accumulated other comprehensive income was $54.3 million as of October 1, 2023 and $51.0 million as of January 1, 2023. Total accumulated other comprehensive income consists solely of unrealized gains from the Company’s derivative financial instruments accounted for as cash flow hedges.
Changes to the balance in accumulated other comprehensive income were as follows:
(in thousands)Gain on
Cash Flow Hedges
Balance as of January 2, 2022$3,715 
Unrealized gain on cash flow hedges30,820 
Balance as of July 3, 202234,535 
Unrealized gain on cash flow hedges19,655 
Balance as of October 2, 2022$54,190 
Less balance attributable to noncontrolling interest as of October 2, 202221,570 
Balance attributable to controlling interest as of October 2, 2022$32,620 
Balance as of January 1, 2023$50,994 
Unrealized loss on cash flow hedges(753)
Balance as of July 2, 202350,241 
Unrealized gain on cash flow hedges4,047 
Balance as of October 1, 2023$54,288 
Less balance attributable to noncontrolling interest as of October 1, 202321,606 
Balance attributable to controlling interest as of October 1, 2023$32,682 
15


12.SUPPLEMENTARY CASH FLOW INFORMATION
(in thousands)Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Cash paid for interest$44,310 $29,682 
Refunds related to income taxes$387 $4,630 
Payments for income taxes$5,022 $5,463 
13.INCOME TAXES
The Company is subject to federal and state income taxes with respect to our allocable share of any taxable income or loss of UBH, as well as any standalone income or loss the Company generates. UBH is treated as a partnership for federal income tax purposes, and for most applicable state and local income tax purposes, and generally does not pay income taxes in most jurisdictions. Instead, UBH's taxable income or loss is passed through to its members, including the Company. Despite its partnership treatment, UBH is liable for income taxes in those states not recognizing its pass-through status and for certain of its subsidiaries not taxed as pass-through entities. The Company has acquired various domestic entities taxed as corporations, which are now wholly-owned by us or our subsidiaries. Where required or allowed, these subsidiaries also file and pay taxes as a consolidated group for federal and state income tax purposes. The Company anticipates this structure to remain in existence for the foreseeable future.
The Company recorded income tax (benefit) for the thirteen and thirty-nine weeks ended October 1, 2023 of $(10.1) million and $(13.4) million, respectively. Comparably, the Company recorded income tax (benefit) for the thirteen and thirty-nine weeks ended October 2, 2022 of $(1.6) million and $(1.7) million, respectively. The effective tax rates for the thirteen and thirty-nine weeks ended October 1, 2023 were (165.1)% and 66.3%, respectively. Comparably, the effective tax rates for the thirteen and thirty-nine weeks ended October 2, 2022 were 1450.0% and 5.7%, respectively. The Company’s effective tax rates differ from the federal statutory rate of 21% primarily due to the impact of UBH, which is a partnership, is not taxed at the Company level, and is required to allocate some of its taxable results to the Continuing Members, as well as state taxes and the fair value impact of warrant liabilities. The Company’s effective tax rate for the thirteen and thirty-nine weeks ended October 1, 2023 were 88.5% and 33.0%, respectively, before consideration of any discrete items. During the thirteen and thirty-nine weeks ended October 1, 2023, the effective tax rate was impacted by return to provision items, statutory state tax rate and apportionment changes, and updated apportionment estimates in response to network optimization efforts that included the sale of the Bluffton, Indiana facility which resulted in a discrete tax (benefit) of $(1.4) million and $(1.3) million, respectively.
The Company regularly evaluates valuation allowances established for deferred tax assets (“DTA's”) for which future realization is uncertain. The Company assessed the available positive and negative evidence to estimate whether future taxable income would be generated to permit use of the existing DTA's. As of October 1, 2023, a significant piece of objective negative evidence evaluated was the twelve-quarter cumulative loss before taxes. Such objective evidence limits the ability to consider other subjective evidence, such as projections for future growth. The Company determined that there is uncertainty regarding the utilization of certain DTA's such as the investment in UBH, federal operating losses subject to annual limitations due to “change in ownership” provisions, and state net operating losses where the Company does not expect to continue to have nexus. Therefore, a valuation allowance has been recorded against the DTA's for which it is more likely than not they will not be realized. The Company has DTA’s related to its investment in the partnership that are expected to be realized in the ordinary course of operations or generate future net operating losses for which a portion will have an indefinite carryforward period. Additionally, the Company has deferred tax liabilities (“DTL’s”) related to its investment in the partnership that will not reverse in the ordinary course of business and will only reverse when the partnership is sold or liquidated. The Company has no intention of disposing of or liquidating the partnership and therefore has not considered the indefinite lived DTL as a source of income to offset other DTA’s. In weighing positive and negative evidence, both objective and subjective, including its twelve-quarter cumulative loss, the Company has recorded a valuation allowance against its DTA’s related to net operating losses and deductible book/tax differences and recorded a DTL primarily related to the book over tax basis in the investment in the partnership that will not reverse in the ordinary course of business. The Company considered that an indefinite lived DTL may be considered as a source of taxable income for an indefinite lived DTA; however, given our indefinite lived DTL will only reverse upon sale or liquidation, the Company determined that it was more appropriate to record a valuation allowance against a portion of its DTA’s. The amount of DTA considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as projections for growth.
16


As of October 1, 2023, tax years 2020 through 2023 remain open and subject to examination by the Internal Revenue Service and in the majority of the states where the Company has nexus, and tax years 2018 through 2023 remain open and subject to examination in selected states that have a longer statute of limitations.
Upon audit, tax authorities may challenge all or part of a tax position. A tax position successfully challenged by a taxing authority could result in an adjustment to our provision for income taxes in the period in which a final determination is made. The Company did not maintain any unrecognized tax benefits as of October 1, 2023 and January 1, 2023.
Tax receivable agreement liability
Pursuant to an election under section 754 of the Internal Revenue Code, the Company obtained an increase in its share of the tax basis in the net assets of UBH when it was deemed to purchase UBH units from third party members and purchased UBH units from the Continuing Members per the Business Combination. Following the Business Combination, the Continuing Members may exchange UBH units along with the forfeiture of a corresponding number of Class V Common Stock of the Company for Class A Common Stock of the Company. The Company intends to treat any such exchanges as direct purchases for U.S. federal income tax purposes, which is expected to further increase its share of the tax basis in the net assets of UBH. The increases in tax basis may reduce the amounts the Company would otherwise pay in the future to various tax authorities. They may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.
Pursuant to the Business Combination Agreement, the Company entered into the Tax Receivable Agreement in connection with the Business Combination (the “TRA”) , which provides for the payment by the Company of 85% of the amount of any tax benefits realized as a result of (i) increases in the share of the tax basis in the net assets of UBH resulting from the Business Combination and any future exchanges by the Continuing Members of UBH units for UBI common stock; (ii) tax basis increases attributable to payments made under the TRA; and (iii) tax amortization deductions attributable to the acquisition of Kennedy Endeavors, LLC and the election to treat the transaction as an asset deal for tax purposes. The rights of each party under the TRA other than the Company are assignable, subject to certain restrictions. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the timing and amount of taxable income generated by the Company each year, as well as the tax rate then applicable, among other factors.
As of October 1, 2023 and January 1, 2023, the Company had a liability of $24.6 million and $25.4 million, respectively, related to its projected obligations under the TRA. The liability is reflected as current and non-current accrued expenses of $0.1 million and $24.5 million in the Consolidated Balance Sheets, respectively.
14.WARRANTS
Prior to the Business Combination, CCH issued 15,833,332 warrants that were initially sold by CCH in its initial public offering of securities (the "Public Warrants"), including 1,166,666 warrants issued at the closing of the Business Combination (“Forward Purchase Warrants”) pursuant to those certain Forward Purchase Agreements entered into by CCH, CCH's Sponsor (the "Sponsor"), and the independent directors of CCH (the "Forward Purchase Agreements"), and 7,200,000 warrants initially sold to the Sponsor simultaneously with the closing of its initial public offering (the "Private Placement Warrants," collectively, with the Public Warrants and Forward Purchase Warrants, the "Warrants"). As a result of the Business Combination, the Company assumed the Warrants and such Warrants are now exercisable for shares of UBI Class A Common Stock instead of Class A ordinary shares of CCH. All other features of the Warrants remain unchanged. On December 14, 2020, the Company provided notice to the holders of the Public Warrants and Forward Purchase Warrants that their warrants would be redeemed in accordance with the original terms on January 14, 2021. As of October 1, 2023 and January 1, 2023, there were 7,200,000 Private Placement Warrants outstanding and all Public Warrants and Forward Purchase Warrants have been exercised (except for the Public Warrants that were redeemed by the Company on January 14, 2021).
The Private Placement Warrants and the shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis, at the holder’s option, and are non-redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Warrants are accounted for as derivative liabilities in accordance with ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity ("ASC 815-40"), due to certain settlement provisions in the corresponding warrant agreement that do not meet the criteria to be classified in stockholders’ equity. Pursuant to ASC 815-40, the Warrants are now classified as a
17


liability at fair value on the Company’s Consolidated Balance Sheet, and the change in the fair value of such liability in each period is recognized as a non-cash gain or loss in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). The Warrants are deemed equity instruments for income tax purposes, and accordingly, there is no tax accounting relating to changes in the fair value of the Warrants recognized.
The remeasurement of the warrant liability resulted in a gain (loss) of $16.0 million and $(3.7) million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and of $16.6 million and $4.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
15.EQUITY
Class A Common Stock
The Company is authorized to issue 1,000,000,000 shares of Class A Common Stock, par value $0.0001 per share, of which 81,141,417 and 80,882,334 shares of UBI were issued and outstanding as of October 1, 2023 and January 1, 2023, respectively.
Class V Common Stock
The Company is also authorized to issue 61,249,000 shares of Class V Common Stock, par value of $0.0001 all of which were issued to the Continuing Members in connection with the closing of the Business Combination. Each of the Continuing Members' common limited liability company units of UBH along with a share of Class V Common Stock may be exchanged for one share of Class A Common Stock of the Company upon certain restrictions being satisfied. As of October 1, 2023 and January 1, 2023, there were 59,349,000 shares of Class V Common Stock outstanding.
16.EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share is based on the weighted average number of shares of Class A Common Stock issued and outstanding during the periods. Diluted earnings (loss) per share is based on the weighted average number shares of Class A Common Stock issued and outstanding and the effect of all dilutive common stock equivalents and potentially dilutive share-based awards outstanding during the periods.
The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:
(in thousands, except share data)Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 2, 2022
Basic and diluted earnings per share:
Numerator:
Net loss attributable to common stockholders$(888)$(15,279)
Denominator:
Weighted average Class A Common Stock shares, basic80,812,835 79,852,137 
Basic and diluted earnings (loss) per share$(0.01)$(0.19)
Anti-dilutive securities excluded from diluted earnings per share calculation:
Warrants2,093,271 1,772,271 
RSUs168,081 61,946 
PSUs75,866 53,290 
Stock options  
Total2,337,218 1,887,507 
Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net income (loss) attributable to noncontrolling interest$2,373 $(12,589)
18


(in thousands, except share data)Thirteen weeks ended October 2, 2023Thirty-nine weeks ended October 2, 2023
Basic and diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Basic earnings per share$0.20 $0.03 
Diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Dilutive securities included in diluted earnings per share calculation:
Warrants1,828,748 2,142,492 
RSUs338,373 242,903 
PSUs135,737 121,083 
Stock options 317 
Total83,444,275 83,567,756 
Diluted earnings per share$0.19 $0.03 
Weighted average Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net (income) loss attributable to noncontrolling interest$(222)$9,562 
The diluted earnings (loss) per share computation excludes the effect of certain restricted stock units ("RSUs"), performance stock units ("PSUs"), and stock options granted to directors and management which convert to Class A Common Stock upon vesting or being exercised, as their inclusion would have been anti-dilutive.
Shares of the Company’s Class V Common Stock do not participate in earnings or losses of the Company and, therefore, are not participating securities. The PSUs and RSUs, were not considered participating securities in the Successor period despite the holders of these stock-based compensation awards being entitled to participate in dividends declared on Class A Common Stock, if and when declared, on a one-to-one per-share basis, because the dividends are only payable upon full vesting the awards, and as such, the dividend is forfeitable. As of October 1, 2023 and January 1, 2023, the Continuing Members held all 59,349,000 shares of Class V Common Stock issued and outstanding and also held an equal number of common limited liability company units of UBH, which comprise the noncontrolling interest.
17.SUBSEQUENT EVENTS
The Company performed a review of events subsequent to the balance sheet date through the date the financial statements were issued and determined that there were no such events requiring recognition or disclosure in the financial statements.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following management's discussion and analysis of our financial condition and results of operations ("MD&A") should be read in conjunction with our unaudited combined interim consolidated financial statements as of and for the thirteen and thirty-nine weeks ended October 1, 2023, together with our audited combined consolidated financial statements for our most recently completed fiscal year set forth under Item 8 of our Annual Report on Form 10-K for the year ended January 1, 2023 (“Annual Report on Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified under “Cautionary Note Regarding Forward-Looking Statements” contained elsewhere in this Quarterly Report on Form 10-Q and those discussed in Item 1A "Risk Factors" of our Annual Report on Form 10-K and other filings under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
19


Our fiscal year end is the Sunday closest to December 31. Our fiscal year 2022 ended January 1, 2023 and was a fifty-two-week fiscal year, our fiscal year 2023 will end on December 31, 2023 and is a fifty-two-week fiscal year. Our fiscal quarters are comprised of thirteen weeks each, except for fifty-three-week fiscal years for which the fourth quarter is comprised of fourteen weeks, and end on the thirteenth Sunday of each quarter (fourteenth Sunday of the fourth quarter, when applicable).
Overview
We are a leading U.S. manufacturer of branded salty snacks. We produce a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Our iconic portfolio of authentic, craft, and "better for you" brands, which includes Utz®, On The Border®, Zapp’s®, Golden Flake®, Good Health®, Boulder Canyon®, Hawaiian® Brand, and TORTIYAHS!®, among others, enjoys strong household penetration in the U.S., where our products can be found in approximately 48% of U.S. households as of October 1, 2023. We operate 14 manufacturing facilities across the U.S. with a broad range of capabilities. As of the end of the third fiscal quarter, our products are distributed nationally to grocery, mass merchant, club, convenience, drug and other retailers through direct shipments, distributors, and approximately 2,200 DSD routes. Our company was founded in 1921 in Hanover, Pennsylvania, and benefits from over 100 years of brand awareness and heritage in the salty snack industry. We have historically expanded our geographic reach and product portfolio organically and through acquisitions. Based on 2022 retail sales, we are the second-largest producer of branded salty snacks in our core geographies and ranked number four nationally.
Key Developments and Trends
Our management team monitors a number of developments and trends that could impact our revenue and profitability objectives.
Long-Term Demographics, Consumer Trends, and Demand – We participate in the attractive and growing $38 billion U.S. salty snacks category, within the broader approximately $126 billion market for U.S. snack foods as of October 1, 2023. A 2023 study from Circana cites that 54% of consumers eat snacks to add excitement to their daily diet, up two points versus two years ago and that 49% of consumers snack three or more times per day, up four points versus two years ago. Additionally, the salty snacks category has historically benefited from favorable competitive dynamics, including low private label penetration and category leaders competing primarily through marketing and innovation. We expect these consumer trends to continue to drive consistent retail sales growth for salty snacks for the foreseeable future.
For the thirteen weeks ended October 1, 2023, U.S. retail sales for salty snacks based on Circana data increased by 5.9% versus the comparable prior year period and in the same period, our retail sales increased 3.2%.
Competition – The salty snack industry is highly competitive and includes many diverse participants. Our products primarily compete with other salty snacks but also compete more broadly for certain eating occasions with other snack foods. We believe that the principal competitive factors in the salty snack industry include taste, convenience, product variety, product quality, price, nutrition, consumer brand awareness, media and promotional activities, in-store merchandising execution, customer service, cost-efficient distribution, and access to retailer shelf space. We believe we compete effectively with respect to each of these factors.
Operating Costs – Our operating costs include raw materials, labor, manufacturing overhead, and selling, distribution, and administrative expenses. We manage these expenses through annual cost saving and productivity initiatives, sourcing and hedging programs, pricing actions, refinancing and tax optimization. Additionally, we maintain ongoing efforts led by our project management office, to expand our profitability, including implementing significant reductions to our operating cost structure in both supply chain and overhead costs.
Taxes – On March 27, 2020, The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was enacted which included various tax provisions with retroactive effect. The CARES Act is an approximately $2 trillion emergency economic stimulus package in response to the coronavirus outbreak, which among other things contains numerous income tax provisions. Some of these tax provisions are effective retroactively for years ending before the date of enactment. We deferred $7.8 million of payroll tax deposits per the CARES Act. The deferred payroll taxes were deposited in two installments, with the first installment of $3.9 million paid as of December 31, 2021, and the remaining $3.9 million paid at the start of fiscal year 2023. We continue to evaluate the impact of the CARES Act; however, we believe it is unlikely to have a material effect on our consolidated financial position, results of operations, and cash flow.
20


On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. The Company continues to evaluate the impact of the Inflation Reduction Act of 2022; however, we believe it is unlikely to have a material effect on our consolidated financial position, results of operations, and cash flow.
Financing Costs and Exposure to Interest Rate Changes – As of October 1, 2023, we had $854.3 million in variable rate indebtedness, down from $867.4 million as of January 1, 2023. As of October 1, 2023 our variable rate indebtedness was benchmarked to the Term SOFR Screen Rate (‘SOFR”). As of October 1, 2023, we have entered into interest rate hedges covering $585.5 million of debt, of which, $500.0 million is covered through September 30, 2026 and a hedge that covers the outstanding principal balance of the Real Estate Term Loan (defined below) through September 2032. Our interest rate hedge strategy has limited some of our exposure to changes in interest rates. We regularly evaluate our variable and fixed-rate debt. We continue to use low-cost, short- and long-term debt to finance our ongoing working capital, capital expenditures and other investments and dividends. Our weighted average interest rate for the thirty-nine weeks ended October 1, 2023 was 5.8%, up from 4.3% during the thirty-nine weeks ended October 2, 2022. We have used interest rate swaps to help manage some of our exposure to interest rate changes, which can drive cash flow variability related to our debt. Refer to Note 7. "Long-Term Debt" and Note 8. "Derivative Financial Instruments and Purchase Commitments" to our unaudited condensed consolidated financial statements included under Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information on debt, derivative and purchase commitment activity. The Company has experienced the effect of increased interest rates on the portion of its debt that is not hedged and continued rising interest rates could negatively impact our net income.
Recent Developments and Significant Items Affecting Comparability
Commodity Trends
We regularly monitor worldwide supply and commodity costs so we can cost-effectively secure ingredients, packaging and fuel required for production. A number of external factors such as weather, which may be impacted in unanticipated ways due to climate change, commodity market conditions, and the effects of governmental, agricultural or other programs affect the cost and availability of raw materials and agricultural materials used in our products. We address commodity costs primarily through the use of buying-forward, which locks in pricing for key materials between three and 18 months in advance. Other methods include hedging, net pricing adjustments to cover longer term cost inflation, and manufacturing and overhead cost control. Our hedging techniques, such as forward contracts, limit the impact of fluctuations in the cost of our principal raw materials; however, we may not be able to fully hedge against commodity cost changes, where there is a limited ability to hedge, and our hedging strategies may not protect us from increases in specific raw material costs. Toward the end of fiscal year 2020, we began to experience an increase in pricing in certain commodity costs that continued to rise throughout fiscal years 2021 and 2022, and through the third quarter of 2023. Continued commodity cost increases may adversely impact our net income. Additionally, the Company has experienced rising costs related to fuel and freight rates as well as rising labor costs which have negatively impacted profitability. Transportation costs have been on the rise since 2021 and may continue to rise which may also adversely impact net income. The Company looks to offset rising costs through increasing manufacturing and distribution efficiencies as well as through price increases to our customers, although it is unclear whether historic customer sales levels will be maintained at these higher prices. Due to competitive market conditions, planned trade or promotional incentives, or other factors, our pricing actions may also lag commodity cost changes.
While the costs of our principal raw materials fluctuate, we believe there will continue to be an adequate supply of the raw materials we use and that they will generally remain available from numerous sources. Market factors including supply and demand may result in higher costs of sourcing those materials.
Independent Operator Conversions
Our DSD distribution is executed via Company-owned routes operated by route sales professionals ("RSPs"), and third-party routes managed by IOs. We have used the IO and RSP models for more than a decade. In fiscal year 2017, we embarked on a multi-year strategy to convert all company-owned RSP routes to the IO model. The mix between IOs and RSPs was approximately 95% and 5%, respectively, as of October 1, 2023 versus 91% and 9% ratio for IOs and RSPs, respectively, as of October 2, 2022. We anticipate completing substantially all remaining RSPs conversions during fiscal year 2023. The conversion process involves selling distribution rights of a defined route to an IO. As we convert a large number of routes in a year, there is a meaningful decrease in the selling, distribution, and administrative costs that we previously incurred on RSPs and a corresponding increase in discounts paid to IOs to cover their costs to distribute our product. The net impact is a reduction in selling and distribution expenses and a decrease in net sales and gross profit. Conversions also impact our balance sheet resulting in cash proceeds to us as a result of selling the route to an IO, or by creating notes receivable related to the sale of the routes.
21


Results of Operations
Overview
The following tables present selected unaudited financial data for the thirteen and thirty-nine weeks ended October 1, 2023 and October 2, 2022:
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Net sales$371,852 $362,818 $1,086,138 $1,053,732 
Cost of goods sold252,583 244,545 744,980 720,123 
Gross profit119,269 118,273 341,158 333,609 
Selling, distribution, and administrative expenses
Selling and distribution70,973 69,263 202,888 226,169 
Administrative34,531 33,182 123,155 110,549 
Total selling, distribution, and administrative expenses105,504 102,445 326,043 336,718 
(Loss) gain on sale of assets, net(8,488)(823)(9,275)919 
Income (loss) from operations5,277 15,005 5,840 (2,190)
Other income (expense)
Interest expense(15,537)(11,648)(44,934)(31,478)
Other income, net392 205 2,279 80 
Gain (loss) on remeasurement of warrant liability 15,984 (3,672)16,560 4,032 
Other income (expense), net839 (15,115)(26,095)(27,366)
Income (loss) before taxes6,116 (110)(20,255)(29,556)
Income tax benefit(10,099)(1,595)(13,435)(1,688)
Net income (loss)16,215 1,485 (6,820)(27,868)
Net (income) loss attributable to noncontrolling interest(222)(2,373)9,562 12,589 
Net income (loss) attributable to controlling interest$15,993 $(888)$2,742 $(15,279)
Thirteen weeks ended October 1, 2023 versus thirteen weeks ended October 2, 2022
Net sales
Net sales was $371.9 million and $362.8 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively. Net sales for the thirteen weeks ended October 1, 2023 increased $9.0 million, or 2.5%, over the comparable period in 2022. The increase in net sales for the thirteen weeks ended October 1, 2023 was primarily related to the flow through of pricing action that were taken in 2022 in response to inflationary pressures which accounted for a 3.7% increase in net sales, partially offset by volume/mix decline of 0.6%, which was driven by SKU rationalization that the Company estimated impacted net sales by 3.3%, as well as 0.6% decline in net sales related to continued IO conversions.
IO discounts increased to $45.4 million for the thirteen weeks ended October 1, 2023 from $41.2 million for the corresponding thirteen weeks ended October 2, 2022. Excluding the impacts of increased IO discounts related to RSP to IO conversion, organic net sales increased 3.1% for the thirteen weeks ended October 1, 2023 versus the corresponding period in 2022.
22


Net sales are evaluated based on brand classification as a Power or Foundation brand. Power brands include our iconic heritage Utz® brand and iconic On The Border® brand; craft brands such as Zapp’s®, Golden Flake® Pork Skins, TORTIYAHS!, and Hawaiian®; "better for you" brands such as Good Health® and Boulder Canyon®; and select licensed brands such as TGI Fridays®. Our Foundation brands are comprised of several regional brands, including Bachman®, Golden Flake® Chips and Cheese, Tim’s Cascade® Snacks, Snyder of Berlin®, and "Dirty" Potato Chips®, R.W. Garcia®, as well as other partner and private label brands.
For the thirteen weeks ended October 1, 2023, Power brand sales increased by approximately 9.7%, while Foundation brand sales, which includes co-manufacturing, private label and partner brands sales, decreased by approximately 16.6% from the thirteen weeks ended October 2, 2022. The increase in Power brand sales was due primarily to favorable pricing action and increased volumes, partially offset by continued IO conversions. Foundation brand sales decrease was primarily driven by volume decline and continued IO conversion, partially offset by certain pricing initiatives. The Company's volume decline for the thirteen weeks ended October 1, 2023 was driven by SKU rationalization focused on a reduction in private label, co-manufactured and partner brand products.
Cost of goods sold and Gross profit
Gross profit was $119.3 million and $118.3 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively. The increase in gross profit for thirteen weeks ended October 1, 2023 was driven by the impact of productivity and pricing initiatives which were put in place to help reduce the impact of continued commodity and wage inflation which hindered gross profit. Also impacting gross profit was the decline in volume which was further impacted by SKU rationalization focused on a reduction in private label and partner brand products. During the thirteen weeks ended October 2, 2022, gross profit was benefited by $4.0 million recorded as a reduction of cost of goods sold related to proceeds received from a partial settlement of business interruption insurance, which reimbursed certain expenses as we shifted production to other facilities, including co-manufacturers, due to a natural disaster that affected one of our smaller manufacturing facilities.
Our gross profit margin was 32.1% for the thirteen weeks ended October 1, 2023 versus 32.6% for the thirteen weeks ended October 2, 2022. The decrease in gross profit margin was primarily driven by favorable price realization from pricing initiatives and the impact of productivity initiatives, more than offset by gross input cost inflation, the impact of IO conversions business interruption insurance proceeds and supply chain investments. IO discounts increased to $45.4 million for the thirteen weeks ended October 1, 2023 from $41.2 million for the thirteen weeks ended October 2, 2022. IO conversions contributed to a gross profit decline of $2.3 million, or a gross profit margin of 0.6%, and the remaining IO discount growth was driven by pricing actions.
Selling, distribution, and administrative expense
Selling, distribution, and administrative expenses were $105.5 million and $102.4 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, resulting in an increase of $3.1 million, or 3.0%, over the corresponding period in fiscal year 2022. The increase in expenses for the thirteen weeks ended October 1, 2023 compared to the thirteen weeks ended October 2, 2022 was primarily attributable to higher expenses associated with investments in sales infrastructure and supply chain capabilities to support growth, and share-based compensation, partially offset by lower selling costs from the shift to IOs.
(Loss) gain on sale of assets
(Loss) gain on sale of assets was $(8.5) million and $0.8 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively. During the thirteen weeks ended October 1, 2023, the sale of the Company's manufacturing plant in Bluffton, Indiana generated a loss of $13.4 million, partially offset by gain on sale of land for $4.0 million and the sale of IO routes and other fixed assets.
Other (expense) income, net
Other (expense) income, net was $0.8 million for the thirteen weeks ended October 1, 2023 compared to $(15.1) million for the thirteen weeks ended October 2, 2022. The change in other (expense) income for the thirteen weeks ended October 1, 2023 was primarily due to a $16.0 million gain from the remeasurement of warrant liability for the thirteen weeks ended October 1, 2023 versus a loss of $3.7 million for the thirteen weeks ended October 2, 2022. Also significant was interest expense of $15.5 million for the thirteen weeks ended October 1, 2023 compared to $11.6 million for the thirteen weeks ended October 2, 2022. The increase in interest expense is primarily attributable to the additional equipment loans, Real Estate Term Loan, and higher interest rates, which impacted the portion of debt that the Company has not hedged.
23


Income taxes
Income tax (benefit) was $(10.1) million and $(1.6) million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively.
Thirty-nine weeks ended October 1, 2023 versus thirty-nine weeks ended October 2, 2022
Net sales
Net sales was $1.086 billion and $1.054 billion for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. Net sales for the thirty-nine weeks ended October 1, 2023 increased $32.4 million or 3.1% over the comparable period in 2022. The increase in net sales for the thirty-nine weeks ended October 1, 2023 was primarily related to the flow-through of pricing actions that were taken in 2022 in response to inflationary pressures which accounted for a 6.4% increase in net sales, partially offset by volume/mix decline of 2.6% due to SKU rationalization, as well as 0.7% decline in net sales related to continued IO conversions.
IO discounts increased to $133.5 million for the thirty-nine weeks ended October 1, 2023 from $114.6 million for the corresponding thirty-nine weeks ended October 2, 2022. Excluding the impacts of increased IO discounts related to IO conversions, organic net sales increased 3.8% for the thirty-nine weeks ended October 1, 2023 versus the corresponding period in 2022.
Net sales are evaluated based on brand classification as a Power or Foundation brand. Power brands include our iconic heritage Utz® brand and iconic On The Border® brand; craft brands such as Zapp’s®, Golden Flake® Pork Skins, TORTIYAHS!, and Hawaiian®; "better for you" brands such as Good Health® and Boulder Canyon®; and select licensed brands such as TGI Fridays®. Our Foundation brands are comprised of several regional brands, including Bachman®, Golden Flake® Chips and Cheese, Tim’s Cascade® Snacks, Snyder of Berlin®, and "Dirty" Potato Chips®, R.W. Garcia®, as well as other partner and private label brands.
For the thirty-nine weeks ended October 1, 2023, Power brand sales increased by approximately 10.1%, while Foundation brand sales, which includes co-manufacturing, private label and partner brands sales, decreased by approximately 10.4% from the thirty-nine weeks ended October 2, 2022. The increase in Power brand sales was due primarily to favorable pricing actions and increased volumes, partially offset by the impact of continued IO conversions. Foundation brand sales decrease was primarily driven by volume decline and the impact of continued IO conversion, offset by certain pricing initiatives. The Company's volume declined for the thirty-nine weeks ended October 1, 2023 compared to thirty-nine weeks ended October 2, 2022, and was impacted by significant SKU rationalization focused on a reduction in private label, co-manufactured and partner branded products, as well as by weight outs and changes to price pack architecture.
Cost of goods sold and Gross profit
Gross profit was $341.2 million and $333.6 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. The increase in gross profit for the thirty-nine weeks ended October 1, 2023 was driven by pricing initiatives which were put in place to help reduce the impact of continued commodity costs, transportation, and wage inflation which hindered gross profit, partially offset by volume decline.
Our gross profit margin was 31.4% for the thirty-nine weeks ended October 1, 2023 versus 31.7% for the thirty-nine weeks ended October 2, 2022. The decline in gross profit margin was primarily driven by commodity and wage inflation, transitory higher inbound freight costs and lower fixed overhead absorption due in part to our network optimization, offset by the impact of productivity initiatives. Additionally, IO discounts increased to $133.5 million for the thirty-nine weeks ended October 1, 2023 from $114.6 million for the thirty-nine weeks ended October 2, 2022. IO conversions contributed to a gross profit decline of $7.6 million, or a gross profit margin of 0.7%, and the remaining IO discount growth was driven by pricing actions. During the thirty-nine weeks ended October 2, 2022, gross profit was benefited by $4.0 million recorded as a reduction of cost of goods sold related to proceeds received from a partial settlement of business interruption insurance, which reimbursed certain expenses as we shifted production to other facilities, including co-manufacturers, due to a natural disaster that affected one of our smaller manufacturing facilities.
24


Selling, distribution, and administrative expense
Selling, distribution, and administrative expenses were $326.0 million and $336.7 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively, resulting in a decrease of $(10.7) million, or (3.2)%, over the corresponding period in fiscal year 2022. The decrease in expenses for the thirty-nine weeks ended October 1, 2023 compared to the thirty-nine weeks ended October 2, 2022 was primarily attributable to higher acquisition and integration costs related to the buyout of multiple distributors, which were accounted for as contract terminations, and resulted in expense of $23.0 million during the thirty-nine weeks ended October 2, 2022. The selling, distribution and administrative expense for the thirty-nine weeks ended October 2, 2022 included other contract termination expense and related impairments which totaled $2.6 million. The selling, distribution and administrative expense for the thirty-nine weeks ended October 1, 2023 included impairments of $9.5 million related to the impairment of fixed assets, primarily related to the closing of the Company's manufacturing facility in Birmingham, Alabama. During the thirty-nine weeks ended October 1, 2023, the Company also recognized an expense of $4.7 million related to a contract termination with a co-manufacturer. The termination of this agreement was a continuation of the Company's response to shifting production from a manufacturing facility that was damaged by a natural disaster in 2021. Rising labor and higher stock-based compensation costs were partially offset by the reductions of selling costs related to the continued conversion out of Company owned RSP to IO routes.
(Loss) gain on sale of assets
(Loss) gain on sale of assets was $(9.3) million and $0.9 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. The Company has continued to convert company-owned routes to IO routes during the third fiscal quarter of 2023, offsetting the sales price by the respective route intangible asset. The loss during the thirty-nine weeks ended October 1, 2023 was primarily related to the sale of the Company's manufacturing facility in Bluffton, Indiana which generated a loss of $13.4 million, partially offset by gain on sale of land for $4.0 million and the sale of IO routes and other fixed assets.
Other (expense) income, net
Other expense, net was $(26.1) million and $(27.4) million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. The increase in expense was driven by interest expense of $44.9 million for the thirty-nine weeks ended October 1, 2023 compared to $31.5 million for the thirty-nine weeks ended October 2, 2022. The increase in interest expense is primarily attributable to the additional equipment loans, Real Estate Term Loan, and higher interest rates, which impacted the portion of debt that the Company has not hedged. Also significant was a $16.6 million gain from the remeasurement of warrant liability for the thirty-nine weeks ended October 1, 2023 compared to a gain of $4.0 million for the thirty-nine weeks ended October 2, 2022.
Income taxes
Income tax benefit was $(13.4) million and $(1.7) million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
Non-GAAP Financial Measures
We use certain financial information that is not prepared in accordance with accounting principles generally accepted in the United States (“non-GAAP”) because we believe it is useful to investors as it provides additional information to facilitate comparisons of historical operating results, identifies trends in our underlying operating results and provides additional insight and transparency on how we evaluate the business. We use non-GAAP financial measures to budget, make operating and strategic decisions, and evaluate our performance. We have detailed the non-GAAP adjustments that we make in our non-GAAP definitions below. The adjustments generally fall within the categories of non-cash items, acquisition and integration costs, business transformation initiatives, and financing-related costs. We believe the non-GAAP measures should always be considered along with the related financial measures prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). We have provided the reconciliations between the U.S. GAAP and non-GAAP financial measures below, and we also discuss our underlying U.S. GAAP results throughout this MD&A section.
Our primary non-GAAP financial measures are listed below and reflect how we evaluate our current and prior-year operating results. As new events or circumstances arise, these definitions could change. When the definitions change, we will provide the updated definitions and present the related non-GAAP historical results on a comparable basis.
25


EBITDA and Adjusted EBITDA
We define EBITDA as Net Income before Interest, Income Taxes, and Depreciation and Amortization.
We define Adjusted EBITDA as EBITDA further adjusted to exclude certain non-cash items, such as accruals for long-term incentive programs, hedging and purchase commitments adjustments, remeasurement of warrant liabilities, and asset impairments; acquisition and integration costs; business transformation initiatives; and financing-related costs.
Adjusted EBITDA is one of the key performance indicators we use in evaluating our operating performance and in making financial, operating, and planning decisions. We believe EBITDA and Adjusted EBITDA are useful to investors in the evaluation of our operating performance compared to other companies in the salty snack industry, as similar measures are commonly used by companies in this industry, however, we caution that other companies may use different definitions from us and such figures may not be directly comparable to our figures. We have also historically reported an Adjusted EBITDA metric to investors and lenders for covenant compliance. We also report Adjusted EBITDA as a percentage of Net Sales as an additional measure for investors to evaluate our Adjusted EBITDA margins on Net Sales.
The following table provides a reconciliation from net income (loss) to EBITDA and Adjusted EBITDA for the thirteen and thirty-nine weeks ended October 1, 2023 and October 2, 2022:
(dollars in millions)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Net income (loss)$16.2 $1.5 $(6.8)$(27.9)
Plus non-GAAP adjustments:
Income Tax (Benefit) Expense(10.1)(1.6)(13.4)(1.7)
Depreciation and Amortization19.7 21.8 60.1 66.3 
Interest Expense, Net15.5 11.6 44.9 31.5 
Interest Income (IO loans)(1)
(0.5)(0.4)(1.4)(1.3)
EBITDA40.8 32.9 83.4 66.9 
Certain Non-Cash Adjustments(2)
24.5 0.9 42.2 9.2 
Acquisition and Integration(3)
1.3 4.8 8.7 40.8 
Business Transformation Initiatives(4)
1.4 5.4 19.9 13.3 
Financing-Related Costs(5)
0.1 — 0.2 0.2 
(Gain) Loss on Remeasurement of Warrant Liability(6)
(16.0)3.7 (16.6)(4.0)
Adjusted EBITDA$52.1 $47.7 $137.8 $126.4 
Adjusted EBITDA as a % of Net Sales14.0 %13.1 %12.7 %12.0 %
(1)Interest Income from IO loans refers to Interest Income that we earn from IO notes receivable that have resulted from our initiatives to transition from RSP distribution to IO distribution (“Business Transformation Initiatives”). There is a notes payable recorded that mirrors most of the IO notes receivable, and the interest expense associated with the notes payable is part of the Interest Expense, Net adjustment.
(2)Certain Non-Cash Adjustments are comprised primarily of the following:
Incentive programs – The Company incurred $3.7 million and $1.9 million of share-based compensation expense, that was awarded to associates and directors, and compensation expense associated with the employee stock purchase plan for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively. The Company incurred $11.8 million and $6.7 million of share-based compensation, that was awarded to associates and directors, and compensation expense associated with the employee stock purchase plan for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
26


Asset Impairments and Write-Offs — For the thirteen weeks ended October 1, 2023, the Company recorded an adjustment for a non-cash loss on sale of $13.7 million related to fixed assets for the sale of the Bluffton, Indiana plant along with the transfer of $4.7 million from Business Transformation Initiatives in note (4) below related to the termination of a contract that was settled with the sale. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded impairments and non-cash loss on sale totaling $0.1 million and $23.3 million, respectively. During the thirty-nine weeks ended October 2, 2022, the Company recorded an impairment of $2.0 million related to the termination of a distribution agreements.
Purchase Commitments and Other Adjustments – We have purchase commitments and options for specific quantities at fixed prices for certain of our products’ key ingredients. To facilitate comparisons of our underlying operating results, this adjustment was made to remove the volatility of purchase commitments and options related unrealized gains and losses. The adjustment related to Purchase Commitment and Other non-cash adjustment (gains) losses were $1.4 million and $(1.0) million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively. The thirty-nine weeks ended October 1, 2023 and October 2, 2022 also included $1.4 million and $0.5 million of unrealized purchase commitment losses, respectively. Additionally, we recorded $0.9 million for the amortization of cloud-based computing assets for the thirteen and thirty-nine weeks ended, October 1, 2023.
(3)Adjustment for Acquisition and Integration Costs – This is comprised of consulting, transaction services, and legal fees incurred for acquisitions and certain potential acquisitions, in addition to expenses associated with integrating recent acquisitions. Such expenses were $1.2 million and $9.5 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, as well as $0.1 million of expense and $0.8 million of income for the change of the Tax Receivable Agreement Liability associated with the Business Combination for the thirteen and thirty-nine weeks ended October 1, 2023, respectively. Charges related to the buyout of multiple distributors, which was accounted for as a contract termination resulted in expense of $23.0 million for the thirty-nine week period ended October 2, 2022. Additionally, other acquisitions and integration cost of $4.8 million and $16.8 million were recorded for the thirteen and thirty-nine weeks ended October 2, 2022, respectively, also included are adjustment of $1.0 million of expense for the increase of the Tax Receivable Agreement Liability associated with the Business Combination for the thirty-nine week period ended October 2, 2022.
(4)Business Transformation Initiatives Adjustment – This adjustment is related to consultancy, professional, legal, closure and other expenses incurred for specific initiatives and structural changes to the business that do not reflect the cost of normal business operations. In addition, gains and losses realized from the sale of distribution rights to IOs and the subsequent disposal of trucks, severance costs associated with the elimination of RSP positions, and Enterprise Resource Planning transition costs, fall into this category. The Company incurred such costs of $6.1 million and $5.4 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $24.6 million and $13.3 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively, which included the closure of our Gramercy, Louisiana and Birmingham, Alabama plants along with various other supply chain, commercial and administrative initiatives. Additionally, as noted above, the costs for the thirteen and thirty-nine weeks ended October 1, 2023 also includes a transfer of expense of $(4.7) million related to a contract termination that was not settled in cash. During 2023, we completed the closure of our Gramercy, Louisiana and Birmingham, Alabama manufacturing plants along with the sale of our Bluffton, IN manufacturing plant.
(5)Financing-Related Costs – These costs include adjustments for various items related to raising debt and equity capital or debt extinguishment costs.
(6)Gains and losses related to the changes in the remeasurement of warrant liabilities are not expected to be settled in cash, and when exercised would result in a cash inflow to the Company with the Warrants converting to Class A Common Stock with the liability being extinguished and the fair value of the Warrants at the time of exercise being recorded as an increase to equity.
Liquidity and Capital Resources
The following table presents net cash provided by operating activities, investing activities and financing activities for the thirty-nine weeks ended October 1, 2023 and October 2, 2022:
27


(in thousands)Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Net cash provided by operating activities$49,130 $8,071 
Net cash used in investing activities$(37,505)$(52,940)
Net cash (used in) provided by financing activities$(24,461)$54,776 
For the thirty-nine weeks ended October 1, 2023, our consolidated cash balance, including cash equivalents, was $60.1 million, or $12.8 million higher than the consolidated cash balance as of January 1, 2023. Net cash used in operating activities for the thirty-nine weeks ended October 1, 2023 was $49.1 million compared to $8.1 million for the thirty-nine weeks ended October 2, 2022, with the difference largely driven by the payment of $20.2 million in the first quarter of 2022 related to the buyout of multiple distributors, which were accounted for as contract terminations. During the thirty-nine weeks ended October 1, 2023, the accounts receivable growth and inventory buildup was lower than the buildup that took place during the thirty-nine weeks ended October 2, 2022, but was largely offset by a decrease of accounts payable and accrued expenses and other related expenses as well as a buildup of prepaid expenses and other assets. Cash used in investing activities for the thirty-nine weeks ended October 1, 2023 was $37.5 million, driven by purchases of property and equipment, versus cash used in investing activity of $52.9 million for the thirty-nine weeks ended October 2, 2022. Net cash provided by financing activities was $24.5 million for the thirty-nine weeks ended October 1, 2023, driven by a draw on the line of credit of $20.3 million, offset by the payment of dividends and distribution, and repayments on term debt and notes payable. Comparably, net cash used in financing activities was $54.8 million for the thirty-nine weeks ended October 2, 2022, which was primarily a result of a draw on the line of credit of $40.4 million, proceeds from the issuance of shares of $28.0 million, and other borrowings on term debt and notes payable of $34.0 million, offset by payments on term debt and notes as well as dividends and distributions.
Financing Arrangements
The primary objective of our financing strategy is to maintain a prudent capital structure that provides us flexibility to pursue our growth objectives. We use short-term debt as management determines is reasonable, principally to finance ongoing operations, including our seasonal requirements for working capital (generally accounts receivable, inventory, and prepaid expenses and other current assets, less accounts payable, accrued payroll, and other accrued liabilities), and a combination of equity and long-term debt to finance both our base working capital needs and our non-current assets.
Revolving Credit Facility
On November 21, 2017, UBH entered into an asset based revolving credit facility (as amended, the "ABL facility"), pursuant to the terms of that certain First Lien Term Loan Credit Agreement, dated November 21, 2017 (the "Credit Agreement"). On September 22, 2022, the ABL facility was amended to further increase the credit limit to $175.0 million and replaced the interest rate benchmark from London Interbank Offered Rate (“LIBOR”) to Term SOFR Screen Rate (“SOFR”). Availability under the ABL facility is based on a monthly accounts receivable and inventory borrowing base certification, which is net of outstanding letters of credit. As of October 1, 2023 and January 1, 2023, $149.3 million and $163.0 million, respectively, was available for borrowing, net of letters of credit. The ABL facility is also subject to unused line fees (0.5% at October 1, 2023) and other fees and expenses. On July 20, 2023, the ABL facility was further amended to increase the credit limit to $225.0 million and extend the maturity through the earlier of July 20, 2028, or 91 days prior to the maturity of the Term Loan B (as defined below). The Company incurred fees of $0.7 million in connection with the amendment to the ABL facility.
Standby letters of credit in the amount of $12.2 million and $12.0 million have been issued as of October 1, 2023 and January 1, 2023, respectively. The standby letters of credit are primarily issued for insurance purposes.
Term Loans
On December 14, 2020, the Company entered into a Bridge Credit Agreement with a syndicate of banks, led by Bank of America, N.A. (the "Bridge Credit Agreement"). The Company used $490.0 million from the proceeds of the Bridge Credit Agreement to finance the acquisition of Truco Holdco Inc. ("Truco" and such acquisition, the "Truco Acquisition") and certain intellectual property from OTB Acquisition, LLC (the "IP Purchase"). The Bridge Credit Agreement bears interest at an annual rate based on 4.25% plus 1-month LIBOR with scheduled incremental increases to the base rate, as defined in the Bridge Credit Agreement.
28


On January 20, 2021, the Company entered into Amendment No. 2 to the Bridge Credit Agreement ("Amendment No. 2") which provided additional operating flexibility and revisions to certain restrictive covenants. Pursuant to the terms of Amendment No. 2, the Company raised $720 million in aggregate principal of Term Loan B ("Term Loan B") which then bore interest at LIBOR plus 3.00%, and extended the maturity of the Bridge Credit Agreement to January 20, 2028. The proceeds were used, together with cash on hand and proceeds from the Company's exercised warrants, to redeem the outstanding principal amount of Term Loan B and Bridge Credit Agreement of $410 million and $358 million, respectively. The refinancing was accounted for as an extinguishment. The Company incurred debt issuance costs and original issuance discounts of $8.4 million.
On June 22, 2021, the Company entered into Amendment No. 3 to the Bridge Credit Agreement (“Amendment No. 3”). Pursuant to the terms of Amendment No. 3, the Company increased the principal balance of Term Loan B by $75.0 million to bring the aggregated balance of Term Loan B proceeds to $795.0 million. The Company incurred additional debt issuance costs and original issuance discounts of $0.7 million related to the incremental funding.
On October 12, 2022, the Company, through its subsidiaries UQF, Kennedy Endeavors, LLC (“Kennedy”) and Condor Snack Foods, LLC (together with UQF and Kennedy, the “Real Estate Financing Borrowers”), entered into a loan agreement (the “Real Estate Term Loan”) with City National Bank which was secured by a majority of the Real Estate Financing Borrowers’ real estate assets. The Real Estate Term Loan initially held a principal balance of $88.1 million, with net proceeds of approximately $85.0 million after transaction fees and expenses. The Company used a portion of the proceeds from the Real Estate Term Loan to pay off the ABL facility. The Real Estate Term Loan contains a single financial maintenance covenant consisting of a fixed charge coverage ratio that is tested quarterly only during a covenant trigger period consistent with the existing ABL facility. Concurrent with the closing of the Real Estate Term Loan, UQF entered into an interest rate swap transaction to fix the effective interest rate at approximately 5.929%, as discussed in further detail within Note 8. “Derivative Financial Instruments and Purchase Commitments”. In September 2023, the Company made an additional $4.4 million paydown of the Real Estate Term Loan using net proceeds from the sale of land to a third-party, as discussed within Note 3. “Property, Plant, and Equipment, Net”, as well as cash on hand. Following such paydown, the loan will amortize approximately $3.3 million in principal annually through maturity, subject to any additional advanced paydowns.
The Term Loan B and the ABL facility are collateralized by substantially all of the assets and liabilities of UBH and its subsidiaries, excluding the real estate assets, which secure the Real Estate Term Loan and including equity interests in certain of UBH’s subsidiaries. The credit agreements contain certain affirmative and negative covenants as to operations and the financial condition of UBH and its subsidiaries. UBH and its subsidiaries were in compliance with its financial covenants as of October 1, 2023.
Debt (in thousands)
Issue DatePrincipal BalanceMaturity DateOctober 1, 2023January 1, 2023
Term loan B (1)
June-21$795,000 January-28$773,323 $779,286 
Real Estate Term LoanOctober-2288,140 October-3281,019 88,140 
Equipment loans (2)
50,360 54,053 
ABL facility(3)
October-2720,362 — 
Net impact of debt issuance costs and original issue discounts(9,243)(9,672)
Total long-term debt915,821 911,807 
Less: current portion(20,649)(18,472)
Long term portion of term debt and financing obligations$895,172 $893,335 
(1) On September 22, 2022, the Company entered into Amendment No. 4 to the Bridge Credit Agreement ("Amendment No. 4"), which replaced the interest rate benchmark from LIBOR to SOFR. The weighted average interest rate on the Term Loan B debt, without consideration of the hedge, was 8.36% for the thirteen weeks ended October 1, 2023.
(2) The Company has finance lease obligations with Banc of America Leasing & Capital, LLC, which are treated as secured borrowing. The Company made a series of draws upon these agreements totaling $4.3 million in fiscal year 2023. These draws bear interest ranging from 3.26% through 7.25% and have varying maturities up through 2028.
(3) The facility bore interest at an annual rate based on LIBOR, or SOFR plus a 0.10% credit spread adjustment after the amendment on September 22, 2022, plus an applicable margin of 1.75% (ranging from 1.50% to 2.00% based on availability) or the prime rate plus an applicable margin of 0.75% (ranging from 0.50% to 1.00%). The Company generally utilizes the prime
29


rate for amounts that the Company expects to pay down within 30 days. The interest rate on the facility as of October 1, 2023 would have been 9.25%, under the prime rate. The Company elected to use the LIBOR, prior to the amendment on September 22, 2022 which changed the reference rate to SOFR as described above, for balances that were expected to be carried longer than 30 days. The interest rate on the ABL facility as of October 1, 2023 was 7.17%.
Other Notes Payable and Finance Leases
Amounts outstanding under notes payable consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Note payable – IO notes$16,879 $21,098
Finance lease obligations10,734 10,995
Other200 835
Total notes payable27,813 32,928
Less: current portion(8,317)(12,589)
Long term portion of notes payable$19,496 $20,339
From time to time, the Company sells notes receivable from IOs to a financial institution. During the thirty-nine weeks ended October 1, 2023, the Company sold $4.1 million of notes receivable from IOs to a financial institution. Due to the structure of these transactions, they did not qualify for sale accounting treatment and the Company has recorded the notes payable obligation owed by the IOs to the financial institution as well as the corresponding notes receivable on the Company's books. The Company services the loans for the financial institution by collecting principal and interest from the IOs and passing it through to the institution. The Company partially guarantees the outstanding loans, as discussed in further detail within Note 10. "Contingencies." These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon any event of default.
Interest Expense
Interest expense consisted of the following:
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Company’s term loans, ABL facility, and other long-term debt$14,582 $10,916 $42,971 $29,320 
Amortization of deferred financing fees633 344 1,084 1,028 
IO loans322 388 879 1,130 
Total interest$15,537 $11,648 $44,934 $31,478 
Off-Balance Sheet Arrangements
Purchase Commitments
The Company has outstanding purchase commitments for specific quantities at fixed prices for certain key ingredients to economically hedge commodity input prices. These purchase commitments totaled $84.4 million as of October 1, 2023. The Company accrues for losses on firm purchase commitments in a loss position at the end of each reporting period to the extent that there is an active observable market. The Company has recorded purchase commitment gains (losses) totaling $(1.7) million and $1.0 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $(1.9) million and $0.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
30


IO Guarantees-Off-Balance Sheet
The Company partially guarantees loans made to IOs by Cadence Bank for the purchase of routes. The outstanding balance of loans guaranteed was $0.8 million and $1.5 million as of October 1, 2023 and January 1, 2023, respectively, all of which was recorded by the Company as off balance sheet arrangements. The maximum amount of future payments the Company could be required to make under the guarantees equates to 25% of the outstanding loan balance up to $2.0 million. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company partially guarantees loans made to IOs by Bank of America for the purchase of routes. The outstanding balance of loans guaranteed that were issued by Bank of America was $49.6 million and $36.0 million as of October 1, 2023 and January 1, 2023, respectively, which are off balance sheet arrangements. As discussed in Note 7. "Long-Term Debt", the Company also sold notes receivable on its books to Bank of America during fiscal years 2019, 2021, and 2022, which the Company partially guarantees. The outstanding balance of notes purchased by Bank of America as of October 1, 2023 and January 1, 2023 was $15.3 million and $17.9 million, respectively. Due to the structure of the transactions, the sale did not qualify for sale accounting treatment, and as such the Company records the notes payable obligation owed by the IOs to the financial institution as well as the corresponding note receivable on the Company's Consolidated Balance Sheets. The maximum amount of future payments the Company could be required to make under these guarantees equates to 25% of the outstanding loan balance on the first day of each calendar year plus 25% of the amount of any new loans issued during such calendar year. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company guarantees loans made to IOs by M&T Bank for the purchase of routes. The agreement with M&T Bank was amended in January 2020 so that the Company guaranteed up to 25% of the greater of the aggregate principal amount of loans outstanding on the payment date or January 1st of the subject year. The outstanding balance of loans guaranteed was $2.5 million and $3.4 million as of October 1, 2023 and January 1, 2023, respectively, all of which were included in the Company's Consolidated Balance Sheets. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
31


New Accounting Pronouncements
See Note 1. "Operations and Summary of Significant Accounting Policies," to the unaudited condensed consolidated financial statements contained in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Application of Critical Accounting Policies and Estimates
General
Our consolidated financial statements have been prepared in accordance with U.S. GAAP. While the majority of our revenue, expenses, assets and liabilities are not based on estimates, there are certain accounting principles that require management to make estimates regarding matters that are uncertain and susceptible to change. Critical accounting policies are defined as those policies that are reflective of significant judgments, estimates and uncertainties, which could potentially result in materially different results under different assumptions and conditions. Management regularly reviews the estimates and assumptions used in the preparation of our financial statements for reasonableness and adequacy. Our significant accounting policies are discussed in Note 1. "Operations and Summary of Significant Accounting Policies", of the unaudited Consolidated Financial Statements contained in Part I, Item 1 of this Quarterly Report on Form 10-Q; however, the following discussion pertains to accounting policies we believe are most critical to the portrayal of our financial condition and results of operations and that require significant, difficult, subjective or complex judgments. Other companies in similar businesses may use different estimation policies and methodologies, which may affect the comparability of our financial condition, results of operations and cash flows to those of other companies.
Revenue Recognition
Our revenues primarily consist of the sale of salty snack items that are sold through DSD and direct-to-warehouse distribution methods, either directly to retailers or via distributors. We sell to supermarkets, mass merchandisers, club warehouses, convenience stores and other large-scale retailers, merchants, distributors, brokers, wholesalers, and IOs (which are third party businesses). These revenue contracts generally have a single performance obligation. Revenue, which includes shipping and handling charges billed to the customer, is reported net of variable consideration and consideration payable to customers, including applicable discounts, returns, allowances, trade promotion, consumer coupon redemption, unsaleable product, and other costs. Amounts billed and due from customers are classified as receivables and require payment on a short-term basis and, therefore, we do not have any significant financing components.
We recognize revenue when (or as) performance obligations are satisfied by transferring control of the goods to customers. Control is transferred upon delivery of the goods to the customer. Shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. Applicable shipping and handling are included in customer billing and are recorded as revenue as products’ control is transferred to customers. We assess the goods promised in customers’ purchase orders and identify a performance obligation for each promise to transfer a good that is distinct.
We offer various forms of trade promotions and the methodologies for determining these provisions are dependent on local customer pricing and promotional practices, which range from contractually fixed percentage price reductions to provisions based on actual occurrence or performance. Our promotional activities are conducted either through the retail trade or directly with consumers and include activities such as in store displays and events, feature price discounts, consumer coupons, and loyalty programs. The costs of these activities are recognized at the time the related revenue is recorded, which normally precedes the actual cash expenditure. The recognition of these costs therefore requires management judgment regarding the volume of promotional offers that will be redeemed by either the retail trade or consumer. These estimates are made using various techniques including historical data on performance of similar promotional programs. In 2019, we implemented a system that improves our ability to analyze and estimate the reserve for unpaid costs relating to our promotional activities. Differences between estimated expense and actual redemptions are recognized as a change in management estimate as the actual redemption incurred.
32


Distribution Route Purchase and Sale Transactions
We purchase and sell distribution routes as a part of our maintenance of our DSD network. As new IOs are identified, we either sell our existing routes to the IOs or sell routes that were previously purchased by us to the IOs. Gain/loss from the sale of a distribution route is recorded upon the completion of the sale transaction and signing of the relevant documents and is calculated based on the difference between the sale price of the distribution route and the asset carrying value of the distribution route as of the date of sale. We record intangible assets for distribution routes that we purchase based on the payment that we make to acquire the route and record the purchased distribution routes as indefinite-lived intangible assets under Financial Accounting Standards Board ASC 350, Intangibles – Goodwill and Other. The indefinite lived intangible assets are subject to annual impairment testing.
Goodwill and Indefinite-Lived Intangibles
We allocate the cost of acquired companies to the identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount classified as goodwill. The identification and valuation of these intangible assets and the determination of the estimated useful lives at the time of acquisition, as well as the completion of impairment tests, require significant management judgments and estimates. These estimates are made based on, among other factors, review of projected future operating results and business plans, economic projections, anticipated highest and best use of future cash flows and the cost of capital. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of goodwill and other intangible assets, and potentially result in a different impact to our results of operations. Further, changes in business strategy and/or market conditions may significantly impact these judgments and thereby impact the fair value of these assets, which could result in an impairment of the goodwill or intangible assets.
Finite-lived intangible assets consist of distribution/customer relationships, technology, trademarks and non-compete agreements. These assets are being amortized over their estimated useful lives. Finite-lived intangible assets are tested for impairment only when management has determined that potential impairment indicators are present.
Goodwill and other indefinite-lived intangible assets (including trade names, master distribution rights and Company-owned routes) are not amortized but are tested for impairment at least annually and whenever events or circumstances change that indicate impairment may have occurred. We test goodwill for impairment at the reporting unit level.
As we have early adopted Accounting Standards Update 2017-04, Simplifying the Test for Goodwill Impairment, we will record an impairment charge based on the excess of a reporting unit’s carrying amount over our fair value.
Goodwill and Other Intangible Assets (“ASC 350”) also permits an entity to first assess qualitative factors to determine whether it is necessary to perform quantitative impairment tests for goodwill and indefinite-lived intangibles. If an entity believes, as a result of each qualitative assessment, it is more likely than not that goodwill or an indefinite-lived intangible asset is not impaired, a quantitative impairment test is not required.
We have identified the existing snack food operations as our sole reporting unit. For the qualitative analysis performed, which took place on the first day of the fourth quarter of 2022, we have taken into consideration all the events and circumstances listed in FASB ASC 350, in addition to other entity-specific factors that have taken place. We have determined that there was no significant impact that affected the fair value of the reporting unit through October 1, 2023. Therefore, we have determined that it was not necessary to perform a quantitative goodwill impairment test for the reporting unit.
Income Taxes
We account for income taxes pursuant to the asset and liability method of ASC 740, Income Taxes, which require us to recognize current tax liabilities or receivables for the amount of taxes we estimate are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible.
33


We follow the provisions of ASC 740-10 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.
The benefit of tax positions taken or expected to be taken in our income tax returns is recognized in the financial statements if such positions are more likely than not of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits." A liability is recognized (or amount of net operating loss carryover or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and related penalties related to unrecognized tax benefits are required to be calculated, if applicable. Our policy is to classify assessments, if any, for tax related interest as interest expense and penalties as selling and administrative expenses. As of October 1, 2023 and January 1, 2023, no liability for unrecognized tax benefits was required to be reported. We do not expect any significant changes in our unrecognized tax benefits in the next year.
Business Combinations
We evaluate acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset acquisition. If the screen is not met, further determination is required as to whether or not we have acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is accounted for as a business combination or an acquisition of assets.
We use the acquisition method in accounting for acquired businesses. Under the acquisition method, our financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For quantitative and qualitative disclosures about market risk, see Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K. Our exposures to market risk have not changed materially since the filing of our Annual Report on Form 10-K.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We have established disclosure controls and procedures (as defined in Rules 13a-15e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are designed to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that information relating to the Company is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our current disclosure controls and procedures are effective at a level of reasonable assurance as of the end of the fiscal period covered by this Quarterly Report on Form 10-Q.
Changes in Internal Control over Financial Reporting
There was no other change in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time we are named as a defendant in legal actions arising from our normal business activities. Although we cannot predict with certainty the ultimate resolution of lawsuits, investigations and claims asserted against us, we do not believe any
34


currently pending legal proceeding to which we are a party will have a material adverse effect on our business, prospects, financial condition, cash flows or results of operations.
Item 1A. Risk Factors
Our risk factors are set forth under the "Risk Factors" section of our Annual Report on Form 10-K. There have been no material changes to our risk factors since the filing of the Annual Report on Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
None.
ITEM 5. OTHER INFORMATION
(a) The information below is reported in lieu of information that would be reported under Item 5.02 on Form 8-K.
On November [8], 2023, the Company and Howard Friedman, Chief Executive Officer of the Company, entered into an amendment (the “Amendment”) to the offer letter dated September 30, 2022 by and between the Company and Mr. Friedman (the “Offer Letter”). The Amendment adjusted the annual lump sum stipend described in the Offer Letter to $100,000. The foregoing summary of the Amendment is qualified in its entirety by reference to the full text of the Amendment.
(b) None.
(c) During the three months ended September 30, 2023, no director or officer of the Company adopted or terminated a ‘Rule 10b5-1 trading arrangement’ or ‘non-Rule 10b5-1 trading arrangement,’ as each term is defined in Item 408(a) of Regulation S-K.
ITEM 6. EXHIBITS
The exhibits listed in the following exhibit index are furnished as part of this report.
EXHIBIT INDEX
Exhibit
NumberExhibit Description
35


101.INS*Inline XBRL Instance Document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*Filed herewith
**Furnished herewith
+Indicates a management or compensatory plan.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 9, 2023 UTZ BRANDS, INC.
By:      /s/ Ajay Kataria
Name:     Ajay Kataria
Title: Executive Vice President, Chief Financial Officer

36

November 8, 2023
Howard Friedman
Re: Amendment to Offer of Employment
Dear Howard,
This letter agreement (the “Amendment”) is intended to amend the terms of your employment previously agreed to by you and Utz Brands, Inc. (“Utz” or the “Company”) in the Company’s offer letter to you dated September 30, 2022 (the “Offer Letter”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer Letter.
The second sentence of Section 2 of the Offer Letter shall be amended and restated to read as follows: You will receive an annual lump sum stipend of $100,000 to compensate you for your travel expenses between Chicago, IL and Hanover, PA.
Except as explicitly amended by this Amendment, the Offer Letter shall continue in full force and effect in accordance with its terms.
Sincerely,
/s/ Dylan Lissette
By:    Dylan Lissette
Title:    Chairperson of the Board of Directors
Date:    11/08/2023

I have read and accept this Amendment to my Offer Letter:
/s/ Howard Friedman
By:    Howard Friedman
Date:    11/08/2023
LEGAL\65079937\1
Exhibit 31.1

CERTIFICATION PURSUANT TO RULES 13A-14 AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Howard Friedman, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Utz Brands, Inc. (the “Company”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


Exhibit 31.1
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 9, 2023

By:     /s/ Howard Friedman    
Name:     Howard Friedman
Title:     Chief Executive Officer

Exhibit 31.2

CERTIFICATION PURSUANT TO RULES 13A-14 AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Ajay Kataria, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Utz Brands, Inc. (the “Company”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


Exhibit 31.2
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 9, 2023

By:     /s/ Ajay Kataria
Name:     Ajay Kataria
Title:     Chief Financial Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Utz Brands, Inc. (the “Company”) on Form 10-Q for the period ending October 1, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Howard Friedman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(D) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: November 9, 2023

By:     /s/ Howard Friedman
Name: Howard Friedman
Title:     Chief Executive Officer

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Utz Brands, Inc. (the “Company”) on Form 10-Q for the period ending October 1, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ajay Kataria, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(D) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: November 9, 2023

By:     /s/ Ajay Kataria
Name:     Ajay Kataria
Title:     Chief Financial Officer

v3.23.3
Cover Page - shares
9 Months Ended
Oct. 01, 2023
Nov. 06, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Oct. 01, 2023  
Document Transition Report false  
Entity Registrant Name Utz Brands, Inc.  
Entity Incorporation, State or Country Code DE  
Entity File Number 001-38686  
Entity Tax Identification Number 85-2751850  
Entity Address, Address Line One 900 High Street  
Entity Address, City or Town Hanover  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 17331  
City Area Code 717  
Local Phone Number 637-6644  
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share  
Trading Symbol UTZ  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001739566  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Class A Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   81,141,417
Class V Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   59,349,000
v3.23.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Current Assets    
Cash and cash equivalents $ 60,094 $ 72,930
Accounts receivable, less allowance of $2,638 and $1,815, respectively 132,038 136,985
Inventories 116,674 118,006
Prepaid expenses and other assets 44,196 34,991
Current portion of notes receivable 5,553 9,274
Total current assets 358,555 372,186
Non-current Assets    
Property, plant and equipment, net 329,846 345,198
Goodwill 915,295 915,295
Intangible assets, net 1,070,691 1,099,565
Non-current portion of notes receivable 13,246 12,794
Other assets 109,267 95,328
Total non-current assets 2,438,345 2,468,180
Total assets 2,796,900 2,840,366
Current Liabilities    
Current portion of term debt 20,649 18,472
Current portion of other notes payable 8,317 12,589
Accounts payable 135,931 114,360
Accrued expenses and other 62,714 92,012
Total current liabilities 227,611 237,433
Non-current portion of term debt and revolving credit facility 895,172 893,335
Non-current portion of other notes payable 19,496 20,339
Non-current accrued expenses and other 75,551 67,269
Non-current warrant liability 28,944 45,504
Deferred tax liability 114,059 124,802
Total non-current liabilities 1,133,222 1,151,249
Total liabilities 1,360,833 1,388,682
Commitments and Contingencies
Equity    
Additional paid-in capital 938,898 926,919
Accumulated deficit (265,743) (254,564)
Accumulated other comprehensive income 32,682 30,777
Total stockholders' equity 705,851 703,146
Noncontrolling interest 730,216 748,538
Total equity 1,436,067 1,451,684
Total liabilities and equity 2,796,900 2,840,366
Class A Common Stock    
Equity    
Common stock 8 8
Class V Common Stock    
Equity    
Common stock $ 6 $ 6
v3.23.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, less allowance $ 2,638 $ 1,815
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock authorized (in shares) 1,000,000,000 1,000,000,000
Common stock issued (in shares) 81,141,417 80,882,334
Common stock outstanding (in shares) 81,141,417 80,882,334
Class V Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock authorized (in shares) 61,249,000 61,249,000
Common stock issued (in shares) 59,349,000 59,349,000
Common stock outstanding (in shares) 59,349,000 59,349,000
v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Income Statement [Abstract]        
Net sales $ 371,852 $ 362,818 $ 1,086,138 $ 1,053,732
Cost of goods sold 252,583 244,545 744,980 720,123
Gross profit 119,269 118,273 341,158 333,609
Selling, distribution, and administrative expenses        
Selling and distribution 70,973 69,263 202,888 226,169
Administrative 34,531 33,182 123,155 110,549
Total selling, distribution, and administrative expenses 105,504 102,445 326,043 336,718
(Loss) gain on sale of assets, net (8,488) (823) (9,275) 919
Income (loss) from operations 5,277 15,005 5,840 (2,190)
Other income (expense)        
Interest expense (15,537) (11,648) (44,934) (31,478)
Other income, net 392 205 2,279 80
Gain (loss) on remeasurement of warrant liability 15,984 (3,672) 16,560 4,032
Other income (expense), net 839 (15,115) (26,095) (27,366)
Income (loss) before taxes 6,116 (110) (20,255) (29,556)
Income tax benefit (10,099) (1,595) (13,435) (1,688)
Net income (loss) 16,215 1,485 (6,820) (27,868)
Net (income) loss attributable to noncontrolling interest (222) (2,373) 9,562 12,589
Net income (loss) attributable to controlling interest $ 15,993 $ (888) $ 2,742 $ (15,279)
Earnings (loss) per Class A Common stock: (in dollars)        
Basic (in dollars per share) $ 0.20 $ (0.01) $ 0.03 $ (0.19)
Diluted (in dollars per share) $ 0.19 $ (0.01) $ 0.03 $ (0.19)
Weighted-average shares of Class A Common stock outstanding        
Basic (in shares) 81,141,417 80,812,835 81,060,961 79,852,137
Diluted (in shares) 83,444,275 80,812,835 83,567,756 79,852,137
Net income (loss) $ 16,215 $ 1,485 $ (6,820) $ (27,868)
Other comprehensive income:        
Change in fair value of interest rate swap 4,047 19,655 3,294 50,475
Comprehensive income (loss) 20,262 21,140 (3,526) 22,607
Net comprehensive (income) loss attributable to noncontrolling interest (1,932) (10,696) 8,173 (8,981)
Net comprehensive income attributable to controlling interest $ 18,330 $ 10,444 $ 4,647 $ 13,626
v3.23.3
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class V Common Stock
Total Stockholders' Equity
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Additional Paid-in Capital
Accumulated (Deficit)
Accumulated Other Comprehensive Income
Non-controlling Interest
Beginning balance (in shares) at Jan. 02, 2022         77,644,645 59,349,000        
Beginning balance at Jan. 02, 2022 $ 1,434,673     $ 679,705 $ 8 $ 6 $ 912,574 $ (236,598) $ 3,715 $ 754,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Payments of tax withholding requirements for employee stock awards (6,217)     (6,217)     (6,217)      
Share-based compensation (in shares)         1,062,817          
Share-based compensation 5,779     5,779     5,779      
Issuance of common stock in connection with private placement sale (in shares)         2,105,373          
Issuance of common stock in connection with private placement sale 28,000     28,000     28,000      
Tax impact arising from share issuance (561)     (561)     (561)      
Net income (loss) (29,353)     (14,391)       (14,391)   (14,962)
Other comprehensive income (loss) 30,820     17,573         17,573 13,247
Cash dividend declared (8,604)     (8,604)       (8,604)    
Distribution to noncontrolling interest (6,410)                 (6,410)
Ending balance (in shares) at Jul. 03, 2022         80,812,835 59,349,000        
Ending balance at Jul. 03, 2022 1,448,127     701,284 $ 8 $ 6 939,575 (259,593) 21,288 746,843
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cash dividends declared (in dollars per share)         $ 0.108          
Beginning balance (in shares) at Jan. 02, 2022         77,644,645 59,349,000        
Beginning balance at Jan. 02, 2022 1,434,673     679,705 $ 8 $ 6 912,574 (236,598) 3,715 754,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (27,868)                  
Ending balance (in shares) at Oct. 02, 2022         80,812,835 59,349,000        
Ending balance at Oct. 02, 2022 1,463,498     709,164 $ 8 $ 6 941,375 (264,845) 32,620 754,334
Beginning balance (in shares) at Jul. 03, 2022         80,812,835 59,349,000        
Beginning balance at Jul. 03, 2022 1,448,127     701,284 $ 8 $ 6 939,575 (259,593) 21,288 746,843
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation (in shares)                  
Share-based compensation 1,800     1,800     1,800      
Net income (loss) 1,485     (888)       (888)   2,373
Other comprehensive income (loss) 19,655     11,332         11,332 8,323
Cash dividend declared (4,364)     (4,364)       (4,364)    
Distribution to noncontrolling interest (3,205)                 (3,205)
Ending balance (in shares) at Oct. 02, 2022         80,812,835 59,349,000        
Ending balance at Oct. 02, 2022 1,463,498     709,164 $ 8 $ 6 941,375 (264,845) 32,620 754,334
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cash dividends declared (in dollars per share)         $ 0.054          
Beginning balance (in shares) at Jan. 01, 2023   80,882,334 59,349,000   80,882,334 59,349,000        
Beginning balance at Jan. 01, 2023 1,451,684     703,146 $ 8 $ 6 926,919 (254,564) 30,777 748,538
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Payments of tax withholding requirements for employee stock awards (589)     (589)     (589)      
Share-based compensation (in shares)         259,083          
Share-based compensation 8,939     8,939     8,939      
Net income (loss) (23,035)     (13,251)       (13,251)   (9,784)
Other comprehensive income (loss) (753)     (432)         (432) (321)
Cash dividend declared (9,296)     (9,296)       (9,296)    
Distribution to noncontrolling interest (6,766)                 (6,766)
Ending balance (in shares) at Jul. 02, 2023         81,141,417 59,349,000        
Ending balance at Jul. 02, 2023 1,420,184     688,517 $ 8 $ 6 935,269 (277,111) 30,345 731,667
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cash dividends declared (in dollars per share)         $ 0.114          
Beginning balance (in shares) at Jan. 01, 2023   80,882,334 59,349,000   80,882,334 59,349,000        
Beginning balance at Jan. 01, 2023 1,451,684     703,146 $ 8 $ 6 926,919 (254,564) 30,777 748,538
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (6,820)                  
Ending balance (in shares) at Oct. 01, 2023   81,141,417 59,349,000   81,141,417 59,349,000        
Ending balance at Oct. 01, 2023 1,436,067     705,851 $ 8 $ 6 938,898 (265,743) 32,682 730,216
Beginning balance (in shares) at Jul. 02, 2023         81,141,417 59,349,000        
Beginning balance at Jul. 02, 2023 1,420,184     688,517 $ 8 $ 6 935,269 (277,111) 30,345 731,667
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation (in shares)                  
Share-based compensation 3,629     3,629     3,629      
Net income (loss) 16,215     15,993       15,993   222
Other comprehensive income (loss) 4,047     2,337         2,337 1,710
Cash dividend declared (4,625)     (4,625)       (4,625)    
Distribution to noncontrolling interest (3,383)                 (3,383)
Ending balance (in shares) at Oct. 01, 2023   81,141,417 59,349,000   81,141,417 59,349,000        
Ending balance at Oct. 01, 2023 $ 1,436,067     $ 705,851 $ 8 $ 6 $ 938,898 $ (265,743) $ 32,682 $ 730,216
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cash dividends declared (in dollars per share)         $ 0.057          
v3.23.3
CONSOLIDATED STATEMENTS OF EQUITY (PARENTHETICAL) - $ / shares
3 Months Ended 6 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Jul. 02, 2023
Jul. 03, 2022
Common Stock | Class A Common Stock        
Cash dividends declared (in dollars per share) $ 0.057 $ 0.054 $ 0.114 $ 0.108
v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Cash flows from operating activities    
Net loss $ (6,820) $ (27,868)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment and other charges 9,548 4,678
Depreciation and amortization 60,114 66,345
Gain on remeasurement of warrant liability (16,560) (4,032)
Loss (gain) on sale of assets 9,275 (919)
Share-based compensation 11,808 7,579
Deferred taxes (10,743) (1,315)
Deferred financing costs 1,084 1,047
Changes in assets and liabilities:    
Accounts receivable, net 4,947 (12,628)
Inventories 644 (27,866)
Prepaid expenses and other assets (20,183) (18,308)
Accounts payable and accrued expenses and other 6,016 21,358
Net cash provided by operating activities 49,130 8,071
Cash flows from investing activities    
Acquisitions, net of cash acquired 0 (75)
Purchases of property and equipment (45,707) (68,708)
Proceeds from sale of property and equipment 8,794 4,100
Proceeds from sale of routes 21,683 16,819
Proceeds from the sale of IO notes 4,094 5,017
Proceeds from insurance claims for capital investments 0 3,935
Notes receivable, net (26,369) (14,028)
Net cash used in investing activities (37,505) (52,940)
Cash flows from financing activities    
Line of credit borrowings, net 20,324 40,390
Borrowings on term debt and notes payable 4,273 33,969
Repayments on term debt and notes payable (23,744) (20,692)
Payment of debt issuance cost (655) (1,471)
Payments of tax withholding requirements for employee stock awards (589) (6,217)
Proceeds from issuance of shares 0 28,000
Dividends (13,921) (12,793)
Distribution to noncontrolling interest (10,149) (6,410)
Net cash (used in) provided by financing activities (24,461) 54,776
Net (decrease) increase in cash and cash equivalents (12,836) 9,907
Cash and cash equivalents at beginning of period 72,930 41,898
Cash and cash equivalents at end of period $ 60,094 $ 51,805
v3.23.3
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Oct. 01, 2023
Accounting Policies [Abstract]  
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation – The accompanying consolidated financial statements comprise the financial statements of Utz Brands, Inc. ("UBI" or the "Company", formerly Collier Creek Holdings ("CCH")) and its wholly owned subsidiaries. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). They do not include all information and notes required by U.S. GAAP for annual financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Company’s financial statements for the year ended January 1, 2023. The balance sheet as of January 1, 2023 has been derived from the audited combined financial statements as of and for the year ended January 1, 2023. In the opinion of management, such financial information reflects all normal and recurring adjustments necessary for a fair presentation of the financial position and the results of operations for such interim periods in accordance with the U.S. GAAP. Operating results for the interim period are not necessarily indicative of the results that may be expected for any future period or for the full year. The consolidated interim financial statements, including the Company's significant accounting policies, should be read in conjunction with the audited combined financial statements and notes thereto for the year ended January 1, 2023.
All intercompany transactions and balances have been eliminated in consolidation.
Reclassification – Certain prior year amounts have been reclassified for consistency with the current year presentation.
Operations – The Company through its subsidiary, Utz Quality Foods, LLC ("UQF"), has been a premier producer, marketer and distributor of snack food products since 1921. The Company has steadily expanded its distribution channels to where it now sells products to supermarkets, mass merchants, club stores, dollar and discount stores, convenience stores, independent grocery stores, drug stores, food service, vending, military, and other channels in most regions of the United States through routes to market, that include direct-store-delivery, (“DSD”), direct to warehouse, and third-party distributors. The Company manufactures and distributes a full line of high-quality salty snack items, such as potato chips, tortilla chips, pretzels, cheese balls, pork skins, party mixes, and popcorn. The Company also sells dips, crackers, dried meat products and other snack food items packaged by other manufacturers.
Cash and Cash Equivalents – The Company considers all highly-liquid investments purchased with an original maturity of three months or less to be cash equivalents. The majority of the Company’s cash is held in financial institutions with insurance provided by the Federal Deposit Insurance Corporation ("FDIC") of $250,000 per depositor. At various times, account balances may exceed federally insured limits.
Accounts Receivables – Accounts receivable are reported at net realizable value. The net realizable value is based on Company management’s estimate of the amount of receivables that will be collected based on analysis of historical data and trends, as well as review of significant customer accounts. Accounts receivable are considered to be past due when payments are not received within the customer’s credit terms. The Company’s methodology to measure the provision for credit losses requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include current market conditions, delinquency trends, aging behavior of receivables, and customer classes or individual customers.
The Company’s estimates are reviewed and revised periodically based on the ongoing evaluation of credit quality indicators. Historically, actual write-offs for uncollectible accounts have not significantly differed from prior estimates.
Inventories – Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventory write-downs are recorded for shrinkage, damaged, stale and slow-moving items.
Property, Plant and Equipment – Property, plant and equipment are stated at cost net of accumulated depreciation. Major additions and betterments are recorded to the asset accounts, while maintenance and repairs, which do not improve or extend the lives of the assets, are charged to expense accounts as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in operations in the disposal period. Depreciation is determined utilizing the straight-line method over the estimated useful lives of the various assets, which generally range from 2 to 20 years for machinery and equipment, 3 to 10 years for transportation equipment and 8 to 40 years for buildings. Assets held for sale are reported at the lower of the carrying amount or fair value less costs to sell. The Company assesses for impairment on property, plant and equipment upon the occurrence of a triggering event.
Income Taxes – The Company accounts for income taxes pursuant to the asset and liability method of Accounting Standards Codification (“ASC”) 740, Income Taxes, which requires it to recognize current tax liabilities or receivables for the amount of taxes it estimates are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible.
The Company follows the provisions of ASC 740-10 related to accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.
The benefit of tax positions taken or expected to be taken in the Company’s income tax returns is recognized in the financial statements if such positions are more likely than not capable of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits". A liability is recognized (or the amount of net operating loss carryover or the amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and penalties related to unrecognized tax benefits are required to be calculated, if applicable. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as selling, distribution, and administrative expenses. As of October 1, 2023 and January 1, 2023, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next fiscal year.
Goodwill and Other Identifiable Intangible Assets – The Company allocates the cost of acquired companies to the identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount classified as goodwill. The identification and valuation of these intangible assets and the determination of their estimated useful lives at the time of acquisition, as well as the completion of impairment tests, require significant management judgments and estimates. These estimates are made based on, among other factors, review of projected future operating results and business plans, economic projections, anticipated highest and best use of future cash flows and the cost of capital. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of goodwill and other intangible assets, and potentially result in a different impact to the Company’s results of operations. Further, changes in business strategy and/or market conditions may significantly impact these judgments and thereby impact the fair value of these assets, which could result in an impairment of the goodwill or intangible assets.
Finite-lived intangible assets consist of distribution/customer relationships, technology, certain master distribution rights and certain trademarks. These assets are being amortized over their estimated useful lives. Finite-lived intangible assets are tested for impairment only when management has determined that potential impairment indicators are present.
Goodwill and other indefinite-lived intangible assets (including certain trade names, certain master distribution rights and Company-owned sales routes) are not amortized but are tested for impairment at least annually and whenever events or circumstances change that indicate impairment may have occurred. The Company tests goodwill for impairment at the reporting unit level. The Company has identified the existing snack food operations as its sole reporting unit.
In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2017-04, Intangibles - Goodwill and Other ("Topic 350"): Simplifying the Test for Goodwill Impairment, the Company is required to record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value.
Topic 350 also permits an entity to first assess qualitative factors to determine whether it is necessary to perform quantitative impairment tests for goodwill and indefinite-lived intangibles. If an entity believes, as a result of each qualitative assessment, it is more likely than not that the fair value of goodwill or an indefinite-lived intangible asset exceeds its carrying value then a quantitative impairment test is not required.
For the latest qualitative analysis performed, which took place on the first day of the fourth quarter of 2022, the Company took into consideration all the events and circumstances listed in Topic 350 in addition to other entity-specific factors that had taken place. The Company determined that there was no significant impact that affected the fair value of the reporting unit through October 1, 2023. Therefore, the Company determined that it was not necessary to perform a quantitative goodwill impairment test for the reporting unit.
Fair Value of Financial Instruments – Financial instruments held by the Company include cash and cash equivalents, accounts receivable, hedging instruments, warrants, purchase commitments on commodities, accounts payable and debt. The carrying value of all cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to their short-term nature. The carrying value of the debt is also estimated to approximate its fair value based upon current market conditions and interest rates. The fair values of the hedging instruments are revalued at each reporting period.
Revenue Recognition – The Company’s revenues primarily consist of the sale of salty snack items to customers, including supermarkets, mass merchants, club stores, dollar and discount stores, convenience stores, independent grocery stores, drug stores, food service, vending, military, and other channels. The Company sells its products in most regions of the United States primarily through its DSD network, direct to warehouse shipments, and third-party distributors. These revenue contracts generally have a single performance obligation. Revenue, which includes shipping and handling charges billed to the customer, is reported net of variable consideration and consideration payable to customers, including applicable discounts, returns, allowances, trade promotion, consumer coupon redemption, unsaleable product, and other costs. Amounts billed and due from customers are classified as accounts receivables and require payment on a short-term basis and, therefore, the Company does not have any significant financing components.
The Company recognizes revenue when (or as) performance obligations are satisfied by transferring control of the goods to customers. Control is transferred upon delivery of the goods to the customer. Shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. Applicable shipping and handling are included in customer billing and are recorded as revenue as control of the products’ is transferred to customers. The Company assesses the goods promised in customer purchase orders and identifies a performance obligation for each promise to transfer a good that is distinct.
The Company offers various forms of trade promotions and the methodologies for determining these provisions are dependent on local customer pricing and promotional practices, which range from contractually fixed percentage price reductions to provisions based on actual occurrence or performance. The Company’s promotional activities are conducted either through the retail trade or directly with consumers and include activities such as in store displays and events, feature price discounts, consumer coupons, and loyalty programs. The costs of these activities are recognized at the time the related revenue is recorded, which normally precedes the actual cash expenditure. The recognition of these costs therefore requires management judgment regarding the volume of promotional offers that will be redeemed by either the retail trade customer or consumer. These estimates are made using various techniques including using historical data on performance of similar promotional programs. The Company has reserves in place of $21.9 million as of October 1, 2023, which include adjustments taken by customers of $12.4 million that are awaiting final processing, and reserves of $46.3 million as of January 1, 2023, which include adjustments taken by customers of $32.8 million that are awaiting final processing. Differences between estimated expense and actual redemptions are recognized as a change in management estimate as actual redemptions are incurred.
Business Combinations – The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset acquisition. If the screen is not met, further determination is required as to whether or not the Company has acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is accounted for as a business combination or an acquisition of assets.
The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the Company’s financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill.
Distributor Buyouts - During 2022, the Company bought out and terminated the contracts of multiple third-party distributors who had previously been providing services to the Company. These transactions were accounted for as contract terminations and resulted in expense of $23.0 million for thirty-nine weeks ended October 2, 2022, and are included within selling and distribution expense on the Consolidated Statement of Operations and Comprehensive Income (Loss).
Use of Estimates – Management uses estimates and assumptions in preparing the consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Some examples, but not a comprehensive list, include sales and promotional allowances, customer returns, allowances for doubtful accounts, inventory valuations, useful lives of fixed assets and related impairment, long-term investments, hedge transactions, goodwill and intangible asset valuations and impairments, incentive compensation, income taxes, self-insurance, contingencies, litigation, and inputs used to calculate deferred tax liabilities, tax valuation allowances, and tax receivable agreements. Actual results could vary materially from the estimates that were used.
v3.23.3
INVENTORIES
9 Months Ended
Oct. 01, 2023
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
Inventories consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Finished goods$76,881 $67,386 
Raw materials30,740 42,204 
Maintenance parts9,053 8,416 
Total inventories$116,674 $118,006 
v3.23.3
PROPERTY, PLANT AND EQUIPMENT, NET
9 Months Ended
Oct. 01, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT, NET PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Land$32,448 $30,582 
Buildings126,413 129,824 
Machinery and equipment236,280 255,505 
Land improvements3,828 3,756 
Building improvements4,131 3,709 
Construction-in-progress48,756 21,934 
 451,856 445,310 
Less: accumulated depreciation(122,010)(100,112)
Property, plant and equipment, net$329,846 $345,198 
Depreciation expense was $10.0 million and $12.0 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $30.9 million and $37.1 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively. Depreciation expense is classified in Cost of goods sold and Selling, distribution, and administrative expenses on the Consolidated Statements of Operations and Comprehensive Income (Loss).
The Company recorded expenses of $8.9 million in connection with the closure of the Company's manufacturing facility in Birmingham, Alabama (the "Manufacturing Closure"), which included $1.3 million in severance and related costs and $7.6 million of asset impairments related to fixed assets. The severance and related expenses are recorded in the cost of goods sold line on the Consolidated Statement of Operations and Comprehensive Income (Loss) for the thirty-nine weeks ended October 1, 2023. The fixed asset impairments are recorded in the administrative expenses line on the Consolidated Statement of Operations and Comprehensive Income (Loss). In addition, during the thirty-nine weeks ended October 1, 2023, the Company recognized expense of $1.9 million related to the impairment of property, plant, and equipment unrelated to the Manufacturing Closure.
During the thirteen weeks ended October 1, 2023, the Company completed the sale of the Company's manufacturing facility in Bluffton, Indiana, which resulted in a loss on sale of the assets of $13.4 million. Additionally, the Company entered into a supply agreement with the buyer pursuant to which the buyer is obligated to co-manufacture certain products at below market rates for up to one year. The Company recorded a tolling asset of $0.6 million for the difference between the rate charged and the market rate for these services. If the buyer defaults on its obligations to manufacture any of the committed products, a financial penalty will be assessed based on the contractual terms required in the supply agreement. In a separate transaction, the Company completed the sale of land in Hanover, Pennsylvania to a separate third-party for a gain of $4.0 million.
v3.23.3
GOODWILL AND INTANGIBLE ASSETS, NET
9 Months Ended
Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS, NET GOODWILL AND INTANGIBLE ASSETS, NET
There were no changes to goodwill during the thirty-nine weeks ended October 1, 2023.
Intangible assets, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Subject to amortization:  
Distributor/customer relationships$677,930 $677,930 
Trademarks63,850 63,850 
Amortizable assets, gross741,780 741,780 
Accumulated amortization(110,989)(82,738)
Amortizable assets, net630,791 659,042 
Not subject to amortization:
Trade names434,513 434,513 
Route assets5,387 6,010 
Intangible assets, net$1,070,691 $1,099,565 
Previously, the Company was granted certain exclusive distribution rights for certain products manufactured by another manufacturer. During the first fiscal quarter of 2022, the Company shifted the relationship with that manufacturer and converted that shelf space to Company-branded products. As a result, the Company recorded impairment expense of $2.0 million and the amortizable master distribution rights decreased by $2.2 million during the thirty-nine weeks ended October 2, 2022. There were no significant changes to intangible assets during the thirty-nine weeks ended October 1, 2023, other than those which arise from the normal course of business of buying and selling of Company-owned route assets and amortization.
Amortization of the distributor/customer relationships, technology, and trade names amounted to $9.4 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, and $28.3 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022. The expense related to the amortization of intangibles is classified in administrative expenses on the Consolidated Statements of Operations and Comprehensive Income (Loss).
v3.23.3
NOTES RECEIVABLE
9 Months Ended
Oct. 01, 2023
Receivables [Abstract]  
NOTES RECEIVABLE NOTES RECEIVABLE
The Company has undertaken a program in recent years to sell Company-managed DSD distribution routes to independent operators (“IOs”). Contracts are executed between the Company and the IOs for the sale of the product distribution routes, including a note in favor of the Company, in certain cases. The notes bear interest at rates ranging from 0.00% to 10.40% with terms ranging, generally, from one to ten years. The notes receivable balances due from IOs at October 1, 2023 and January 1, 2023 totaled $18.7 million and $22.0 million, respectively, and are collateralized by the routes for which the loans are made. During the thirty-nine weeks ended October 1, 2023, the loss recorded by the Company on note receivables for which the Company reclaimed the collateral due to credit losses was less than $0.1 million. The Company has a corresponding notes payable liability, related to the IOs notes receivables, of $16.9 million and $21.1 million as of October 1, 2023 and January 1, 2023, respectively. The related notes payable liability is discussed in further detail within Note 7. "Long-Term Debt."
Other notes receivable totaled $0.1 million as of both October 1, 2023 and January 1, 2023.
v3.23.3
ACCRUED EXPENSES AND OTHER
9 Months Ended
Oct. 01, 2023
Payables and Accruals [Abstract]  
ACCRUED EXPENSES AND OTHER ACCRUED EXPENSES AND OTHER
Current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Accrued compensation and benefits$18,300 $38,974 
Operating right of use liability14,868 12,389 
Insurance liabilities8,090 6,701 
Accrued manufacturing related costs3,622 10,817 
Acquisition tax consideration854 1,131 
Accrued dividends and distributions8,006 7,989 
Accrued interest691 1,151 
Other accrued expenses8,283 12,860 
Total accrued expenses and other$62,714 $92,012 
Non-current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Operating right of use liability$44,349 $35,331 
Tax Receivable Agreement liability24,536 25,426 
Supplemental retirement and salary continuation plans6,666 6,512 
Total accrued expenses and other$75,551 $67,269 
v3.23.3
LONG-TERM DEBT
9 Months Ended
Oct. 01, 2023
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT
Revolving Credit Facility
On November 21, 2017, UBH entered into an asset based revolving credit facility (as amended, the "ABL facility"), pursuant to the terms of that certain First Lien Term Loan Credit Agreement, dated November 21, 2017 (the "Credit Agreement"). On September 22, 2022, the ABL facility was amended to further increase the credit limit to $175.0 million and replaced the interest rate benchmark from London Interbank Offered Rate (“LIBOR”) to Term SOFR Screen Rate (“SOFR”). Availability under the ABL facility is based on a monthly accounts receivable and inventory borrowing base certification, which is net of outstanding letters of credit. As of October 1, 2023 and January 1, 2023, $149.3 million and $163.0 million, respectively, was available for borrowing, net of letters of credit. The ABL facility is also subject to unused line fees (0.5% at October 1, 2023) and other fees and expenses. On July 20, 2023, the ABL facility was further amended to increase the credit limit to $225.0 million and extend the maturity through the earlier of July 20, 2028, or 91 days prior to the maturity of the Term Loan B (as defined below). The Company incurred fees of $0.7 million in connection with the amendment to the ABL facility.
Standby letters of credit in the amount of $12.2 million and $12.0 million have been issued as of October 1, 2023 and January 1, 2023, respectively. The standby letters of credit are primarily issued for insurance purposes.
Term Loans
On December 14, 2020, the Company entered into a Bridge Credit Agreement with a syndicate of banks, led by Bank of America, N.A. (the "Bridge Credit Agreement"). The Company used $490.0 million from the proceeds of the Bridge Credit Agreement to finance the acquisition of Truco Holdco Inc. ("Truco" and such acquisition, the "Truco Acquisition") and certain intellectual property from OTB Acquisition, LLC (the "IP Purchase"). The Bridge Credit Agreement bears interest at an annual rate based on 4.25% plus 1-month LIBOR with scheduled incremental increases to the base rate, as defined in the Bridge Credit Agreement.
On January 20, 2021, the Company entered into Amendment No. 2 to the Bridge Credit Agreement ("Amendment No. 2") which provided additional operating flexibility and revisions to certain restrictive covenants. Pursuant to the terms of Amendment No. 2, the Company raised $720 million in aggregate principal of Term Loan B ("Term Loan B") which then bore interest at LIBOR plus 3.00%, and extended the maturity of the Bridge Credit Agreement to January 20, 2028. The proceeds were used, together with cash on hand and proceeds from the Company's exercised warrants, to redeem the outstanding principal amount of Term Loan B and Bridge Credit Agreement of $410 million and $358 million, respectively. The refinancing was accounted for as an extinguishment. The Company incurred debt issuance costs and original issuance discounts of $8.4 million.
On June 22, 2021, the Company entered into Amendment No. 3 to the Bridge Credit Agreement (“Amendment No. 3”). Pursuant to the terms of Amendment No. 3, the Company increased the principal balance of Term Loan B by $75.0 million to bring the aggregated balance of Term Loan B proceeds to $795.0 million. The Company incurred additional debt issuance costs and original issuance discounts of $0.7 million related to the incremental funding.
On October 12, 2022, the Company, through its subsidiaries UQF, Kennedy Endeavors, LLC (“Kennedy”) and Condor Snack Foods, LLC (together with UQF and Kennedy, the “Real Estate Financing Borrowers”), entered into a loan agreement (the “Real Estate Term Loan”) with City National Bank which was secured by a majority of the Real Estate Financing Borrowers’ real estate assets. The Real Estate Term Loan initially held a principal balance of $88.1 million, with net proceeds of approximately $85.0 million after transaction fees and expenses. The Company used a portion of the proceeds from the Real Estate Term Loan to pay off the ABL facility. The Real Estate Term Loan contains a single financial maintenance covenant consisting of a fixed charge coverage ratio that is tested quarterly only during a covenant trigger period consistent with the existing ABL facility. Concurrent with the closing of the Real Estate Term Loan, UQF entered into an interest rate swap transaction to fix the effective interest rate at approximately 5.929%, as discussed in further detail within Note 8. “Derivative Financial Instruments and Purchase Commitments”. In September 2023, the Company made an additional $4.4 million paydown of the Real Estate Term Loan using net proceeds from the sale of land to a third-party, as discussed within Note 3. “Property, Plant, and Equipment, Net”, as well as cash on hand. Following such paydown, the loan will amortize approximately $3.3 million in principal annually through maturity, subject to any additional advanced paydowns.
The Term Loan B and the ABL facility are collateralized by substantially all of the assets and liabilities of UBH and its subsidiaries, excluding the real estate assets, which secure the Real Estate Term Loan and including equity interests in certain of UBH’s subsidiaries. The credit agreements contain certain affirmative and negative covenants as to operations and the financial condition of UBH and its subsidiaries. UBH and its subsidiaries were in compliance with its financial covenants as of October 1, 2023.
Debt (in thousands)
Issue DatePrincipal BalanceMaturity DateOctober 1, 2023January 1, 2023
Term loan B (1)
June-21$795,000 January-28$773,323 $779,286 
Real Estate Term LoanOctober-2288,140 October-3281,019 88,140 
Equipment loans (2)
50,360 54,053 
ABL facility(3)
October-2720,362 — 
Net impact of debt issuance costs and original issue discounts(9,243)(9,672)
Total long-term debt915,821 911,807 
Less: current portion(20,649)(18,472)
Long term portion of term debt and financing obligations$895,172 $893,335 
(1) On September 22, 2022, the Company entered into Amendment No. 4 to the Bridge Credit Agreement ("Amendment No. 4"), which replaced the interest rate benchmark from LIBOR to SOFR. The weighted average interest rate on the Term Loan B debt, without consideration of the hedge, was 8.36% for the thirteen weeks ended October 1, 2023.
(2) The Company has finance lease obligations with Banc of America Leasing & Capital, LLC, which are treated as secured borrowing. The Company made a series of draws upon these agreements totaling $4.3 million in fiscal year 2023. These draws bear interest ranging from 3.26% through 7.25% and have varying maturities up through 2028.
(3) The facility bore interest at an annual rate based on LIBOR, or SOFR plus a 0.10% credit spread adjustment after the amendment on September 22, 2022, plus an applicable margin of 1.75% (ranging from 1.50% to 2.00% based on availability) or the prime rate plus an applicable margin of 0.75% (ranging from 0.50% to 1.00%). The Company generally utilizes the prime
rate for amounts that the Company expects to pay down within 30 days. The interest rate on the facility as of October 1, 2023 would have been 9.25%, under the prime rate. The Company elected to use the LIBOR, prior to the amendment on September 22, 2022 which changed the reference rate to SOFR as described above, for balances that were expected to be carried longer than 30 days. The interest rate on the ABL facility as of October 1, 2023 was 7.17%.
Other Notes Payable and Finance Leases
Amounts outstanding under notes payable consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Note payable – IO notes$16,879 $21,098
Finance lease obligations10,734 10,995
Other200 835
Total notes payable27,813 32,928
Less: current portion(8,317)(12,589)
Long term portion of notes payable$19,496 $20,339
From time to time, the Company sells notes receivable from IOs to a financial institution. During the thirty-nine weeks ended October 1, 2023, the Company sold $4.1 million of notes receivable from IOs to a financial institution. Due to the structure of these transactions, they did not qualify for sale accounting treatment and the Company has recorded the notes payable obligation owed by the IOs to the financial institution as well as the corresponding notes receivable on the Company's books. The Company services the loans for the financial institution by collecting principal and interest from the IOs and passing it through to the institution. The Company partially guarantees the outstanding loans, as discussed in further detail within Note 10. "Contingencies." These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon any event of default.
Interest Expense
Interest expense consisted of the following:
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Company’s term loans, ABL facility, and other long-term debt$14,582 $10,916 $42,971 $29,320 
Amortization of deferred financing fees633 344 1,084 1,028 
IO loans322 388 879 1,130 
Total interest$15,537 $11,648 $44,934 $31,478 
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS
9 Months Ended
Oct. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS
Derivative Financial Instruments
To reduce the effect of interest rate fluctuations, the Company entered into a three-year interest rate swap contract on September 6, 2019, with an effective date of September 30, 2019, with a counter-party to make a series of payments based on a fixed interest rate of 1.339% and receive a series of payments based on the greater of LIBOR or 0.00%. Both the fixed and floating payment streams were based on a notional amount of $250 million. On December 21, 2021, the Company entered into an accreting interest rate swap contract with a counter-party, with an effective date of December 31, 2021, to make a series of payments based on a fixed interest rate of 1.3885% and receive a series of payments based on the greater of LIBOR or 0.00%. Both the fixed and floating payment streams were based on a notional amount of $250 million and have accreted to $500 million, and mature on September 30, 2026. Effective on September 30, 2022, the Company amended the swap contract to reference the 1-month SOFR plus a credit spread adjustment (“CSA”) of 11.448 basis points, as well as setting the new fixed rate to 1.408%. Under the amended swap agreement, the Company will receive a series of payments based on the greater of SOFR plus CSA, or 0.00%.
On October 12, 2022, the Company entered into a 10-year swap contract, with an effective date of November 1, 2022, with a counter-party to make a series of payments based on a fixed interest rate of 3.83% and receive a series of payments based on the greater of the 1-month SOFR or 0.00%. The agreement covers $85.5 million as of October 1, 2023. This swap effectively fixes the rate of the Real Estate Term Loan to 5.93%. The balance that the hedge covers is designed to abate as principal payments on the Real Estate Term Loan are made. The Company entered into these transactions to reduce its exposure to changes in cash flows associated with the Real Estate Term Loan and has designated this derivative as a cash flow hedge.
As of October 1, 2023, the effective fixed interest rate on the long-term debt hedged by these contracts was 5.81%. For further treatment of the Company’s interest rate swap, refer to Note 9. “Fair Value Measurements” and Note 11. “Accumulated Other Comprehensive (Loss) Income.”
Warrant Liabilities
The Company has outstanding warrants which are accounted for as derivative liabilities pursuant to ASC 815-40. See Note 14. "Warrants" for additional information on the Company's warrant liabilities. A reconciliation of the changes in the warrant liability during the thirty-nine weeks ended October 1, 2023 is as follows:
(in thousands)
Fair value of warrant liabilities as of January 1, 2023$45,504 
Gain on remeasurement of warrant liability(576)
Fair value of warrant liabilities as of July 2, 2023$44,928 
Gain on remeasurement of warrant liability(15,984)
Fair value of warrant liabilities as of October 1, 2023$28,944 
Purchase Commitments
The Company has outstanding purchase commitments for specific quantities at fixed prices for certain key ingredients to economically hedge commodity input prices. These purchase commitments totaled $84.4 million as of October 1, 2023. The Company accrues for losses on firm purchase commitments in a loss position at the end of each reporting period to the extent that there is an active observable market. The Company has recorded purchase commitment gains (losses) totaling $(1.7) million and $1.0 million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and $(1.9) million and $0.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
v3.23.3
FAIR VALUE MEASUREMENTS
9 Months Ended
Oct. 01, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
The Company follows the guidance relating to fair value measurements and disclosures with respect to financial assets and liabilities that are re-measured and reported at fair value each reporting period, and with respect to non-financial assets and liabilities that are not required to be measured at fair value on a recurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to the valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable pricing inputs (Level III). A financial asset or liability’s level within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are described below:
Level I - Valuations are based on unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities;
Level II - Valuations are based on quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active. Financial assets or liabilities which are included in this category are securities where all significant inputs are observable, either directly or indirectly; and
Level III - Financial assets or liabilities which are included in this category have prices or valuations that are unobservable or there is little, if any, market activity for these financial assets or liabilities. The inputs into the determination of fair value inputs for these investments require significant management judgment or estimation. The availability of observable inputs can vary depending on the financial asset or liability and is affected by a wide variety of factors. To the extent that valuation is based on inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.
The fair values of the Company’s Level 2 derivative instruments were determined using valuation models that use market observable inputs including interest rate curves and both forward and spot prices for commodities. Derivative assets and liabilities included in Level 2 primarily represent commodity and interest rate swap contracts.
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of October 1, 2023:
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$60,094 $— $— $60,094 
Commodity contracts— 560 — 560 
Interest rate swaps— 48,651 — 48,651 
Total assets$60,094 $49,211 $— $109,305 
Liabilities:
Commodity contracts$— $867 $— $867 
Private placement warrants— 28,944 — 28,944 
Debt— 915,821 — 915,821 
Total liabilities$— $945,632 $— $945,632 
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of January 1, 2023: 
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$72,930 $— $— $72,930 
Commodity contracts— 1,586 — 1,586 
Interest rate swaps— 45,088 — 45,088 
Total assets$72,930 $46,674 $— $119,604 
Liabilities:
Private placement warrants$— $45,504 $— $45,504 
Debt— 911,807 — 911,807 
Total liabilities$— $957,311 $— $957,311 
v3.23.3
CONTINGENCIES
9 Months Ended
Oct. 01, 2023
Commitments and Contingencies Disclosure [Abstract]  
CONTINGENCIES CONTINGENCIES
Litigation Matters
The Company is involved in litigation and other matters incidental to the conduct of its business, the results of which, in the opinion of management, are not likely to be material to the Company’s financial condition, results of operations or cash flows.
Tax Matters
The Company received an assessment from the Commonwealth of Pennsylvania pursuant to a sales and use tax audit for the period from January 1, 2014 through December 31, 2016. As of January 2, 2022, the Company had a reserve of $1.3 million to cover the assessment. On January 7, 2022, the Company settled the audit with the Commonwealth of Pennsylvania for $0.9 million.
Guarantees
The Company partially guarantees loans made to IOs by Cadence Bank for the purchase of routes. The outstanding balance of loans guaranteed was $0.8 million and $1.5 million as of October 1, 2023 and January 1, 2023, respectively, all of which was recorded by the Company as off balance sheet arrangements. The maximum amount of future payments the Company could be required to make under the guarantees equates to 25% of the outstanding loan balance up to $2.0 million. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company partially guarantees loans made to IOs by Bank of America for the purchase of routes. The outstanding balance of loans guaranteed that were issued by Bank of America was $49.6 million and $36.0 million as of October 1, 2023 and January 1, 2023, respectively, which are off balance sheet arrangements. As discussed in Note 7. "Long-Term Debt", the Company also sold notes receivable on its books to Bank of America during fiscal years 2019, 2021, and 2022, which the Company partially guarantees. The outstanding balance of notes purchased by Bank of America as of October 1, 2023 and January 1, 2023 was $15.3 million and $17.9 million, respectively. Due to the structure of the transactions, the sale did not qualify for sale accounting treatment, and as such the Company records the notes payable obligation owed by the IOs to the financial institution as well as the corresponding note receivable on the Company's Consolidated Balance Sheets. The maximum amount of future payments the Company could be required to make under these guarantees equates to 25% of the outstanding loan balance on the first day of each calendar year plus 25% of the amount of any new loans issued during such calendar year. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
The Company guarantees loans made to IOs by M&T Bank for the purchase of routes. The agreement with M&T Bank was amended in January 2020 so that the Company guaranteed up to 25% of the greater of the aggregate principal amount of loans outstanding on the payment date or January 1st of the subject year. The outstanding balance of loans guaranteed was $2.5 million and $3.4 million as of October 1, 2023 and January 1, 2023, respectively, all of which were included in the Company's Consolidated Balance Sheets. These loans are collateralized by the routes for which the loans are made. Accordingly, the Company has the ability to recover substantially all of the outstanding loan value upon default.
v3.23.3
ACCUMULATED OTHER COMPREHENSIVE INCOME
9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME ACCUMULATED OTHER COMPREHENSIVE INCOME
Total accumulated other comprehensive income was $54.3 million as of October 1, 2023 and $51.0 million as of January 1, 2023. Total accumulated other comprehensive income consists solely of unrealized gains from the Company’s derivative financial instruments accounted for as cash flow hedges.
Changes to the balance in accumulated other comprehensive income were as follows:
(in thousands)Gain on
Cash Flow Hedges
Balance as of January 2, 2022$3,715 
Unrealized gain on cash flow hedges30,820 
Balance as of July 3, 202234,535 
Unrealized gain on cash flow hedges19,655 
Balance as of October 2, 2022$54,190 
Less balance attributable to noncontrolling interest as of October 2, 202221,570 
Balance attributable to controlling interest as of October 2, 2022$32,620 
Balance as of January 1, 2023$50,994 
Unrealized loss on cash flow hedges(753)
Balance as of July 2, 202350,241 
Unrealized gain on cash flow hedges4,047 
Balance as of October 1, 2023$54,288 
Less balance attributable to noncontrolling interest as of October 1, 202321,606 
Balance attributable to controlling interest as of October 1, 2023$32,682 
v3.23.3
SUPPLEMENTARY CASH FLOW INFORMATION
9 Months Ended
Oct. 01, 2023
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTARY CASH FLOW INFORMATION SUPPLEMENTARY CASH FLOW INFORMATION
(in thousands)Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Cash paid for interest$44,310 $29,682 
Refunds related to income taxes$387 $4,630 
Payments for income taxes$5,022 $5,463 
v3.23.3
INCOME TAXES
9 Months Ended
Oct. 01, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company is subject to federal and state income taxes with respect to our allocable share of any taxable income or loss of UBH, as well as any standalone income or loss the Company generates. UBH is treated as a partnership for federal income tax purposes, and for most applicable state and local income tax purposes, and generally does not pay income taxes in most jurisdictions. Instead, UBH's taxable income or loss is passed through to its members, including the Company. Despite its partnership treatment, UBH is liable for income taxes in those states not recognizing its pass-through status and for certain of its subsidiaries not taxed as pass-through entities. The Company has acquired various domestic entities taxed as corporations, which are now wholly-owned by us or our subsidiaries. Where required or allowed, these subsidiaries also file and pay taxes as a consolidated group for federal and state income tax purposes. The Company anticipates this structure to remain in existence for the foreseeable future.
The Company recorded income tax (benefit) for the thirteen and thirty-nine weeks ended October 1, 2023 of $(10.1) million and $(13.4) million, respectively. Comparably, the Company recorded income tax (benefit) for the thirteen and thirty-nine weeks ended October 2, 2022 of $(1.6) million and $(1.7) million, respectively. The effective tax rates for the thirteen and thirty-nine weeks ended October 1, 2023 were (165.1)% and 66.3%, respectively. Comparably, the effective tax rates for the thirteen and thirty-nine weeks ended October 2, 2022 were 1450.0% and 5.7%, respectively. The Company’s effective tax rates differ from the federal statutory rate of 21% primarily due to the impact of UBH, which is a partnership, is not taxed at the Company level, and is required to allocate some of its taxable results to the Continuing Members, as well as state taxes and the fair value impact of warrant liabilities. The Company’s effective tax rate for the thirteen and thirty-nine weeks ended October 1, 2023 were 88.5% and 33.0%, respectively, before consideration of any discrete items. During the thirteen and thirty-nine weeks ended October 1, 2023, the effective tax rate was impacted by return to provision items, statutory state tax rate and apportionment changes, and updated apportionment estimates in response to network optimization efforts that included the sale of the Bluffton, Indiana facility which resulted in a discrete tax (benefit) of $(1.4) million and $(1.3) million, respectively.
The Company regularly evaluates valuation allowances established for deferred tax assets (“DTA's”) for which future realization is uncertain. The Company assessed the available positive and negative evidence to estimate whether future taxable income would be generated to permit use of the existing DTA's. As of October 1, 2023, a significant piece of objective negative evidence evaluated was the twelve-quarter cumulative loss before taxes. Such objective evidence limits the ability to consider other subjective evidence, such as projections for future growth. The Company determined that there is uncertainty regarding the utilization of certain DTA's such as the investment in UBH, federal operating losses subject to annual limitations due to “change in ownership” provisions, and state net operating losses where the Company does not expect to continue to have nexus. Therefore, a valuation allowance has been recorded against the DTA's for which it is more likely than not they will not be realized. The Company has DTA’s related to its investment in the partnership that are expected to be realized in the ordinary course of operations or generate future net operating losses for which a portion will have an indefinite carryforward period. Additionally, the Company has deferred tax liabilities (“DTL’s”) related to its investment in the partnership that will not reverse in the ordinary course of business and will only reverse when the partnership is sold or liquidated. The Company has no intention of disposing of or liquidating the partnership and therefore has not considered the indefinite lived DTL as a source of income to offset other DTA’s. In weighing positive and negative evidence, both objective and subjective, including its twelve-quarter cumulative loss, the Company has recorded a valuation allowance against its DTA’s related to net operating losses and deductible book/tax differences and recorded a DTL primarily related to the book over tax basis in the investment in the partnership that will not reverse in the ordinary course of business. The Company considered that an indefinite lived DTL may be considered as a source of taxable income for an indefinite lived DTA; however, given our indefinite lived DTL will only reverse upon sale or liquidation, the Company determined that it was more appropriate to record a valuation allowance against a portion of its DTA’s. The amount of DTA considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as projections for growth.
As of October 1, 2023, tax years 2020 through 2023 remain open and subject to examination by the Internal Revenue Service and in the majority of the states where the Company has nexus, and tax years 2018 through 2023 remain open and subject to examination in selected states that have a longer statute of limitations.
Upon audit, tax authorities may challenge all or part of a tax position. A tax position successfully challenged by a taxing authority could result in an adjustment to our provision for income taxes in the period in which a final determination is made. The Company did not maintain any unrecognized tax benefits as of October 1, 2023 and January 1, 2023.
Tax receivable agreement liability
Pursuant to an election under section 754 of the Internal Revenue Code, the Company obtained an increase in its share of the tax basis in the net assets of UBH when it was deemed to purchase UBH units from third party members and purchased UBH units from the Continuing Members per the Business Combination. Following the Business Combination, the Continuing Members may exchange UBH units along with the forfeiture of a corresponding number of Class V Common Stock of the Company for Class A Common Stock of the Company. The Company intends to treat any such exchanges as direct purchases for U.S. federal income tax purposes, which is expected to further increase its share of the tax basis in the net assets of UBH. The increases in tax basis may reduce the amounts the Company would otherwise pay in the future to various tax authorities. They may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.
Pursuant to the Business Combination Agreement, the Company entered into the Tax Receivable Agreement in connection with the Business Combination (the “TRA”) , which provides for the payment by the Company of 85% of the amount of any tax benefits realized as a result of (i) increases in the share of the tax basis in the net assets of UBH resulting from the Business Combination and any future exchanges by the Continuing Members of UBH units for UBI common stock; (ii) tax basis increases attributable to payments made under the TRA; and (iii) tax amortization deductions attributable to the acquisition of Kennedy Endeavors, LLC and the election to treat the transaction as an asset deal for tax purposes. The rights of each party under the TRA other than the Company are assignable, subject to certain restrictions. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the timing and amount of taxable income generated by the Company each year, as well as the tax rate then applicable, among other factors.
As of October 1, 2023 and January 1, 2023, the Company had a liability of $24.6 million and $25.4 million, respectively, related to its projected obligations under the TRA. The liability is reflected as current and non-current accrued expenses of $0.1 million and $24.5 million in the Consolidated Balance Sheets, respectively.
v3.23.3
WARRANTS
9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
WARRANTS WARRANTS
Prior to the Business Combination, CCH issued 15,833,332 warrants that were initially sold by CCH in its initial public offering of securities (the "Public Warrants"), including 1,166,666 warrants issued at the closing of the Business Combination (“Forward Purchase Warrants”) pursuant to those certain Forward Purchase Agreements entered into by CCH, CCH's Sponsor (the "Sponsor"), and the independent directors of CCH (the "Forward Purchase Agreements"), and 7,200,000 warrants initially sold to the Sponsor simultaneously with the closing of its initial public offering (the "Private Placement Warrants," collectively, with the Public Warrants and Forward Purchase Warrants, the "Warrants"). As a result of the Business Combination, the Company assumed the Warrants and such Warrants are now exercisable for shares of UBI Class A Common Stock instead of Class A ordinary shares of CCH. All other features of the Warrants remain unchanged. On December 14, 2020, the Company provided notice to the holders of the Public Warrants and Forward Purchase Warrants that their warrants would be redeemed in accordance with the original terms on January 14, 2021. As of October 1, 2023 and January 1, 2023, there were 7,200,000 Private Placement Warrants outstanding and all Public Warrants and Forward Purchase Warrants have been exercised (except for the Public Warrants that were redeemed by the Company on January 14, 2021).
The Private Placement Warrants and the shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis, at the holder’s option, and are non-redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Warrants are accounted for as derivative liabilities in accordance with ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity ("ASC 815-40"), due to certain settlement provisions in the corresponding warrant agreement that do not meet the criteria to be classified in stockholders’ equity. Pursuant to ASC 815-40, the Warrants are now classified as a
liability at fair value on the Company’s Consolidated Balance Sheet, and the change in the fair value of such liability in each period is recognized as a non-cash gain or loss in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). The Warrants are deemed equity instruments for income tax purposes, and accordingly, there is no tax accounting relating to changes in the fair value of the Warrants recognized.
The remeasurement of the warrant liability resulted in a gain (loss) of $16.0 million and $(3.7) million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and of $16.6 million and $4.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
EQUITY
Class A Common Stock
The Company is authorized to issue 1,000,000,000 shares of Class A Common Stock, par value $0.0001 per share, of which 81,141,417 and 80,882,334 shares of UBI were issued and outstanding as of October 1, 2023 and January 1, 2023, respectively.
Class V Common Stock
The Company is also authorized to issue 61,249,000 shares of Class V Common Stock, par value of $0.0001 all of which were issued to the Continuing Members in connection with the closing of the Business Combination. Each of the Continuing Members' common limited liability company units of UBH along with a share of Class V Common Stock may be exchanged for one share of Class A Common Stock of the Company upon certain restrictions being satisfied. As of October 1, 2023 and January 1, 2023, there were 59,349,000 shares of Class V Common Stock outstanding.
v3.23.3
EQUITY
9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
EQUITY WARRANTS
Prior to the Business Combination, CCH issued 15,833,332 warrants that were initially sold by CCH in its initial public offering of securities (the "Public Warrants"), including 1,166,666 warrants issued at the closing of the Business Combination (“Forward Purchase Warrants”) pursuant to those certain Forward Purchase Agreements entered into by CCH, CCH's Sponsor (the "Sponsor"), and the independent directors of CCH (the "Forward Purchase Agreements"), and 7,200,000 warrants initially sold to the Sponsor simultaneously with the closing of its initial public offering (the "Private Placement Warrants," collectively, with the Public Warrants and Forward Purchase Warrants, the "Warrants"). As a result of the Business Combination, the Company assumed the Warrants and such Warrants are now exercisable for shares of UBI Class A Common Stock instead of Class A ordinary shares of CCH. All other features of the Warrants remain unchanged. On December 14, 2020, the Company provided notice to the holders of the Public Warrants and Forward Purchase Warrants that their warrants would be redeemed in accordance with the original terms on January 14, 2021. As of October 1, 2023 and January 1, 2023, there were 7,200,000 Private Placement Warrants outstanding and all Public Warrants and Forward Purchase Warrants have been exercised (except for the Public Warrants that were redeemed by the Company on January 14, 2021).
The Private Placement Warrants and the shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are exercisable on a cashless basis, at the holder’s option, and are non-redeemable by the Company so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The Warrants are accounted for as derivative liabilities in accordance with ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity ("ASC 815-40"), due to certain settlement provisions in the corresponding warrant agreement that do not meet the criteria to be classified in stockholders’ equity. Pursuant to ASC 815-40, the Warrants are now classified as a
liability at fair value on the Company’s Consolidated Balance Sheet, and the change in the fair value of such liability in each period is recognized as a non-cash gain or loss in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss). The Warrants are deemed equity instruments for income tax purposes, and accordingly, there is no tax accounting relating to changes in the fair value of the Warrants recognized.
The remeasurement of the warrant liability resulted in a gain (loss) of $16.0 million and $(3.7) million for the thirteen weeks ended October 1, 2023 and October 2, 2022, respectively, and of $16.6 million and $4.0 million for the thirty-nine weeks ended October 1, 2023 and October 2, 2022, respectively.
EQUITY
Class A Common Stock
The Company is authorized to issue 1,000,000,000 shares of Class A Common Stock, par value $0.0001 per share, of which 81,141,417 and 80,882,334 shares of UBI were issued and outstanding as of October 1, 2023 and January 1, 2023, respectively.
Class V Common Stock
The Company is also authorized to issue 61,249,000 shares of Class V Common Stock, par value of $0.0001 all of which were issued to the Continuing Members in connection with the closing of the Business Combination. Each of the Continuing Members' common limited liability company units of UBH along with a share of Class V Common Stock may be exchanged for one share of Class A Common Stock of the Company upon certain restrictions being satisfied. As of October 1, 2023 and January 1, 2023, there were 59,349,000 shares of Class V Common Stock outstanding.
v3.23.3
EARNINGS (LOSS) PER SHARE
9 Months Ended
Oct. 01, 2023
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share is based on the weighted average number of shares of Class A Common Stock issued and outstanding during the periods. Diluted earnings (loss) per share is based on the weighted average number shares of Class A Common Stock issued and outstanding and the effect of all dilutive common stock equivalents and potentially dilutive share-based awards outstanding during the periods.
The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:
(in thousands, except share data)Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 2, 2022
Basic and diluted earnings per share:
Numerator:
Net loss attributable to common stockholders$(888)$(15,279)
Denominator:
Weighted average Class A Common Stock shares, basic80,812,835 79,852,137 
Basic and diluted earnings (loss) per share$(0.01)$(0.19)
Anti-dilutive securities excluded from diluted earnings per share calculation:
Warrants2,093,271 1,772,271 
RSUs168,081 61,946 
PSUs75,866 53,290 
Stock options— — 
Total2,337,218 1,887,507 
Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net income (loss) attributable to noncontrolling interest$2,373 $(12,589)
(in thousands, except share data)Thirteen weeks ended October 2, 2023Thirty-nine weeks ended October 2, 2023
Basic and diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Basic earnings per share$0.20 $0.03 
Diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Dilutive securities included in diluted earnings per share calculation:
Warrants1,828,748 2,142,492 
RSUs338,373 242,903 
PSUs135,737 121,083 
Stock options— 317 
Total83,444,275 83,567,756 
Diluted earnings per share$0.19 $0.03 
Weighted average Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net (income) loss attributable to noncontrolling interest$(222)$9,562 
The diluted earnings (loss) per share computation excludes the effect of certain restricted stock units ("RSUs"), performance stock units ("PSUs"), and stock options granted to directors and management which convert to Class A Common Stock upon vesting or being exercised, as their inclusion would have been anti-dilutive.
Shares of the Company’s Class V Common Stock do not participate in earnings or losses of the Company and, therefore, are not participating securities. The PSUs and RSUs, were not considered participating securities in the Successor period despite the holders of these stock-based compensation awards being entitled to participate in dividends declared on Class A Common Stock, if and when declared, on a one-to-one per-share basis, because the dividends are only payable upon full vesting the awards, and as such, the dividend is forfeitable. As of October 1, 2023 and January 1, 2023, the Continuing Members held all 59,349,000 shares of Class V Common Stock issued and outstanding and also held an equal number of common limited liability company units of UBH, which comprise the noncontrolling interest.
v3.23.3
SUBSEQUENT EVENTS
9 Months Ended
Oct. 01, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTSThe Company performed a review of events subsequent to the balance sheet date through the date the financial statements were issued and determined that there were no such events requiring recognition or disclosure in the financial statements.
v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ 15,993 $ (888) $ 2,742 $ (15,279)
v3.23.3
Insider Trading Arrangements
3 Months Ended
Oct. 01, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.23.3
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Oct. 01, 2023
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation – The accompanying consolidated financial statements comprise the financial statements of Utz Brands, Inc. ("UBI" or the "Company", formerly Collier Creek Holdings ("CCH")) and its wholly owned subsidiaries. The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). They do not include all information and notes required by U.S. GAAP for annual financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Company’s financial statements for the year ended January 1, 2023. The balance sheet as of January 1, 2023 has been derived from the audited combined financial statements as of and for the year ended January 1, 2023. In the opinion of management, such financial information reflects all normal and recurring adjustments necessary for a fair presentation of the financial position and the results of operations for such interim periods in accordance with the U.S. GAAP. Operating results for the interim period are not necessarily indicative of the results that may be expected for any future period or for the full year. The consolidated interim financial statements, including the Company's significant accounting policies, should be read in conjunction with the audited combined financial statements and notes thereto for the year ended January 1, 2023.
Consolidation All intercompany transactions and balances have been eliminated in consolidation.
Reclassification Reclassification – Certain prior year amounts have been reclassified for consistency with the current year presentation.
Cash and Cash Equivalents Cash and Cash Equivalents – The Company considers all highly-liquid investments purchased with an original maturity of three months or less to be cash equivalents. The majority of the Company’s cash is held in financial institutions with insurance provided by the Federal Deposit Insurance Corporation ("FDIC") of $250,000 per depositor. At various times, account balances may exceed federally insured limits.
Accounts Receivable
Accounts Receivables – Accounts receivable are reported at net realizable value. The net realizable value is based on Company management’s estimate of the amount of receivables that will be collected based on analysis of historical data and trends, as well as review of significant customer accounts. Accounts receivable are considered to be past due when payments are not received within the customer’s credit terms. The Company’s methodology to measure the provision for credit losses requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include current market conditions, delinquency trends, aging behavior of receivables, and customer classes or individual customers.
The Company’s estimates are reviewed and revised periodically based on the ongoing evaluation of credit quality indicators. Historically, actual write-offs for uncollectible accounts have not significantly differed from prior estimates.
Inventories Inventories – Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventory write-downs are recorded for shrinkage, damaged, stale and slow-moving items.
Property, Plant and Equipment Property, Plant and Equipment – Property, plant and equipment are stated at cost net of accumulated depreciation. Major additions and betterments are recorded to the asset accounts, while maintenance and repairs, which do not improve or extend the lives of the assets, are charged to expense accounts as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in operations in the disposal period. Depreciation is determined utilizing the straight-line method over the estimated useful lives of the various assets, which generally range from 2 to 20 years for machinery and equipment, 3 to 10 years for transportation equipment and 8 to 40 years for buildings. Assets held for sale are reported at the lower of the carrying amount or fair value less costs to sell. The Company assesses for impairment on property, plant and equipment upon the occurrence of a triggering event.
Income Taxes
Income Taxes – The Company accounts for income taxes pursuant to the asset and liability method of Accounting Standards Codification (“ASC”) 740, Income Taxes, which requires it to recognize current tax liabilities or receivables for the amount of taxes it estimates are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible.
The Company follows the provisions of ASC 740-10 related to accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.
The benefit of tax positions taken or expected to be taken in the Company’s income tax returns is recognized in the financial statements if such positions are more likely than not capable of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits". A liability is recognized (or the amount of net operating loss carryover or the amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and penalties related to unrecognized tax benefits are required to be calculated, if applicable. The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as selling, distribution, and administrative expenses. As of October 1, 2023 and January 1, 2023, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next fiscal year.
Goodwill and Other Identifiable Intangible Assets
Goodwill and Other Identifiable Intangible Assets – The Company allocates the cost of acquired companies to the identifiable tangible and intangible assets acquired and liabilities assumed, with the remaining amount classified as goodwill. The identification and valuation of these intangible assets and the determination of their estimated useful lives at the time of acquisition, as well as the completion of impairment tests, require significant management judgments and estimates. These estimates are made based on, among other factors, review of projected future operating results and business plans, economic projections, anticipated highest and best use of future cash flows and the cost of capital. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of goodwill and other intangible assets, and potentially result in a different impact to the Company’s results of operations. Further, changes in business strategy and/or market conditions may significantly impact these judgments and thereby impact the fair value of these assets, which could result in an impairment of the goodwill or intangible assets.
Finite-lived intangible assets consist of distribution/customer relationships, technology, certain master distribution rights and certain trademarks. These assets are being amortized over their estimated useful lives. Finite-lived intangible assets are tested for impairment only when management has determined that potential impairment indicators are present.
Goodwill and other indefinite-lived intangible assets (including certain trade names, certain master distribution rights and Company-owned sales routes) are not amortized but are tested for impairment at least annually and whenever events or circumstances change that indicate impairment may have occurred. The Company tests goodwill for impairment at the reporting unit level. The Company has identified the existing snack food operations as its sole reporting unit.
In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update ("ASU") No. 2017-04, Intangibles - Goodwill and Other ("Topic 350"): Simplifying the Test for Goodwill Impairment, the Company is required to record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value.
Topic 350 also permits an entity to first assess qualitative factors to determine whether it is necessary to perform quantitative impairment tests for goodwill and indefinite-lived intangibles. If an entity believes, as a result of each qualitative assessment, it is more likely than not that the fair value of goodwill or an indefinite-lived intangible asset exceeds its carrying value then a quantitative impairment test is not required.
For the latest qualitative analysis performed, which took place on the first day of the fourth quarter of 2022, the Company took into consideration all the events and circumstances listed in Topic 350 in addition to other entity-specific factors that had taken place. The Company determined that there was no significant impact that affected the fair value of the reporting unit through October 1, 2023. Therefore, the Company determined that it was not necessary to perform a quantitative goodwill impairment test for the reporting unit.
Fair Value of Financial Instruments Fair Value of Financial Instruments – Financial instruments held by the Company include cash and cash equivalents, accounts receivable, hedging instruments, warrants, purchase commitments on commodities, accounts payable and debt. The carrying value of all cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to their short-term nature. The carrying value of the debt is also estimated to approximate its fair value based upon current market conditions and interest rates. The fair values of the hedging instruments are revalued at each reporting period.
Revenue Recognition
Revenue Recognition – The Company’s revenues primarily consist of the sale of salty snack items to customers, including supermarkets, mass merchants, club stores, dollar and discount stores, convenience stores, independent grocery stores, drug stores, food service, vending, military, and other channels. The Company sells its products in most regions of the United States primarily through its DSD network, direct to warehouse shipments, and third-party distributors. These revenue contracts generally have a single performance obligation. Revenue, which includes shipping and handling charges billed to the customer, is reported net of variable consideration and consideration payable to customers, including applicable discounts, returns, allowances, trade promotion, consumer coupon redemption, unsaleable product, and other costs. Amounts billed and due from customers are classified as accounts receivables and require payment on a short-term basis and, therefore, the Company does not have any significant financing components.
The Company recognizes revenue when (or as) performance obligations are satisfied by transferring control of the goods to customers. Control is transferred upon delivery of the goods to the customer. Shipping and/or handling costs that occur before the customer obtains control of the goods are deemed to be fulfillment activities and are accounted for as fulfillment costs. Applicable shipping and handling are included in customer billing and are recorded as revenue as control of the products’ is transferred to customers. The Company assesses the goods promised in customer purchase orders and identifies a performance obligation for each promise to transfer a good that is distinct.
The Company offers various forms of trade promotions and the methodologies for determining these provisions are dependent on local customer pricing and promotional practices, which range from contractually fixed percentage price reductions to provisions based on actual occurrence or performance. The Company’s promotional activities are conducted either through the retail trade or directly with consumers and include activities such as in store displays and events, feature price discounts, consumer coupons, and loyalty programs. The costs of these activities are recognized at the time the related revenue is recorded, which normally precedes the actual cash expenditure. The recognition of these costs therefore requires management judgment regarding the volume of promotional offers that will be redeemed by either the retail trade customer or consumer. These estimates are made using various techniques including using historical data on performance of similar promotional programs. The Company has reserves in place of $21.9 million as of October 1, 2023, which include adjustments taken by customers of $12.4 million that are awaiting final processing, and reserves of $46.3 million as of January 1, 2023, which include adjustments taken by customers of $32.8 million that are awaiting final processing. Differences between estimated expense and actual redemptions are recognized as a change in management estimate as actual redemptions are incurred.
Business Combinations
Business Combinations – The Company evaluates acquisitions of assets and other similar transactions to assess whether or not the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the screen is met, the transaction is accounted for as an asset acquisition. If the screen is not met, further determination is required as to whether or not the Company has acquired inputs and processes that have the ability to create outputs which would meet the definition of a business. Significant judgment is required in the application of the screen test to determine whether an acquisition is accounted for as a business combination or an acquisition of assets.
The Company uses the acquisition method of accounting for acquired businesses. Under the acquisition method, the Company’s financial statements reflect the operations of an acquired business starting from the completion of the acquisition. The assets acquired and liabilities assumed are recorded at their respective estimated fair values at the date of the acquisition. Any excess of the purchase price over the estimated fair values of the identifiable net assets acquired is recorded as goodwill.
Distributor Buyouts Distributor Buyouts - During 2022, the Company bought out and terminated the contracts of multiple third-party distributors who had previously been providing services to the Company. These transactions were accounted for as contract terminations and resulted in expense of $23.0 million for thirty-nine weeks ended October 2, 2022, and are included within selling and distribution expense on the Consolidated Statement of Operations and Comprehensive Income (Loss).
Use of Estimates Use of Estimates – Management uses estimates and assumptions in preparing the consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Some examples, but not a comprehensive list, include sales and promotional allowances, customer returns, allowances for doubtful accounts, inventory valuations, useful lives of fixed assets and related impairment, long-term investments, hedge transactions, goodwill and intangible asset valuations and impairments, incentive compensation, income taxes, self-insurance, contingencies, litigation, and inputs used to calculate deferred tax liabilities, tax valuation allowances, and tax receivable agreements. Actual results could vary materially from the estimates that were used.
v3.23.3
INVENTORIES (Tables)
9 Months Ended
Oct. 01, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Finished goods$76,881 $67,386 
Raw materials30,740 42,204 
Maintenance parts9,053 8,416 
Total inventories$116,674 $118,006 
v3.23.3
PROPERTY, PLANT AND EQUIPMENT, NET (Tables)
9 Months Ended
Oct. 01, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment, Net
Property, plant and equipment, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Land$32,448 $30,582 
Buildings126,413 129,824 
Machinery and equipment236,280 255,505 
Land improvements3,828 3,756 
Building improvements4,131 3,709 
Construction-in-progress48,756 21,934 
 451,856 445,310 
Less: accumulated depreciation(122,010)(100,112)
Property, plant and equipment, net$329,846 $345,198 
v3.23.3
GOODWILL AND INTANGIBLE ASSETS, NET (Tables)
9 Months Ended
Oct. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Indefinite-Lived Intangible Assets
Intangible assets, net, consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Subject to amortization:  
Distributor/customer relationships$677,930 $677,930 
Trademarks63,850 63,850 
Amortizable assets, gross741,780 741,780 
Accumulated amortization(110,989)(82,738)
Amortizable assets, net630,791 659,042 
Not subject to amortization:
Trade names434,513 434,513 
Route assets5,387 6,010 
Intangible assets, net$1,070,691 $1,099,565 
v3.23.3
ACCRUED EXPENSES AND OTHER (Tables)
9 Months Ended
Oct. 01, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other
Current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Accrued compensation and benefits$18,300 $38,974 
Operating right of use liability14,868 12,389 
Insurance liabilities8,090 6,701 
Accrued manufacturing related costs3,622 10,817 
Acquisition tax consideration854 1,131 
Accrued dividends and distributions8,006 7,989 
Accrued interest691 1,151 
Other accrued expenses8,283 12,860 
Total accrued expenses and other$62,714 $92,012 
Non-current accrued expenses and other consisted of the following:
(in thousands)As of October 1, 2023As of January 1, 2023
Operating right of use liability$44,349 $35,331 
Tax Receivable Agreement liability24,536 25,426 
Supplemental retirement and salary continuation plans6,666 6,512 
Total accrued expenses and other$75,551 $67,269 
v3.23.3
LONG-TERM DEBT (Tables)
9 Months Ended
Oct. 01, 2023
Debt Disclosure [Abstract]  
Schedule of Long-term Debt Instruments
Debt (in thousands)
Issue DatePrincipal BalanceMaturity DateOctober 1, 2023January 1, 2023
Term loan B (1)
June-21$795,000 January-28$773,323 $779,286 
Real Estate Term LoanOctober-2288,140 October-3281,019 88,140 
Equipment loans (2)
50,360 54,053 
ABL facility(3)
October-2720,362 — 
Net impact of debt issuance costs and original issue discounts(9,243)(9,672)
Total long-term debt915,821 911,807 
Less: current portion(20,649)(18,472)
Long term portion of term debt and financing obligations$895,172 $893,335 
(1) On September 22, 2022, the Company entered into Amendment No. 4 to the Bridge Credit Agreement ("Amendment No. 4"), which replaced the interest rate benchmark from LIBOR to SOFR. The weighted average interest rate on the Term Loan B debt, without consideration of the hedge, was 8.36% for the thirteen weeks ended October 1, 2023.
(2) The Company has finance lease obligations with Banc of America Leasing & Capital, LLC, which are treated as secured borrowing. The Company made a series of draws upon these agreements totaling $4.3 million in fiscal year 2023. These draws bear interest ranging from 3.26% through 7.25% and have varying maturities up through 2028.
(3) The facility bore interest at an annual rate based on LIBOR, or SOFR plus a 0.10% credit spread adjustment after the amendment on September 22, 2022, plus an applicable margin of 1.75% (ranging from 1.50% to 2.00% based on availability) or the prime rate plus an applicable margin of 0.75% (ranging from 0.50% to 1.00%). The Company generally utilizes the prime
rate for amounts that the Company expects to pay down within 30 days. The interest rate on the facility as of October 1, 2023 would have been 9.25%, under the prime rate. The Company elected to use the LIBOR, prior to the amendment on September 22, 2022 which changed the reference rate to SOFR as described above, for balances that were expected to be carried longer than 30 days. The interest rate on the ABL facility as of October 1, 2023 was 7.17%.
Schedule of Amounts Outstanding Under Notes Payable
Amounts outstanding under notes payable consisted of the following:
(in thousands)
As of
October 1, 2023
As of January 1, 2023
Note payable – IO notes$16,879 $21,098
Finance lease obligations10,734 10,995
Other200 835
Total notes payable27,813 32,928
Less: current portion(8,317)(12,589)
Long term portion of notes payable$19,496 $20,339
Schedule of Interest Expense
Interest expense consisted of the following:
(in thousands)Thirteen weeks ended October 1, 2023Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Company’s term loans, ABL facility, and other long-term debt$14,582 $10,916 $42,971 $29,320 
Amortization of deferred financing fees633 344 1,084 1,028 
IO loans322 388 879 1,130 
Total interest$15,537 $11,648 $44,934 $31,478 
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS (Tables)
9 Months Ended
Oct. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Reconciliation of the Changes in the Warrant Liability A reconciliation of the changes in the warrant liability during the thirty-nine weeks ended October 1, 2023 is as follows:
(in thousands)
Fair value of warrant liabilities as of January 1, 2023$45,504 
Gain on remeasurement of warrant liability(576)
Fair value of warrant liabilities as of July 2, 2023$44,928 
Gain on remeasurement of warrant liability(15,984)
Fair value of warrant liabilities as of October 1, 2023$28,944 
v3.23.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Oct. 01, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of October 1, 2023:
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$60,094 $— $— $60,094 
Commodity contracts— 560 — 560 
Interest rate swaps— 48,651 — 48,651 
Total assets$60,094 $49,211 $— $109,305 
Liabilities:
Commodity contracts$— $867 $— $867 
Private placement warrants— 28,944 — 28,944 
Debt— 915,821 — 915,821 
Total liabilities$— $945,632 $— $945,632 
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of January 1, 2023: 
(in thousands)Level 1Level 2Level 3Total
Assets:
Cash and cash equivalents$72,930 $— $— $72,930 
Commodity contracts— 1,586 — 1,586 
Interest rate swaps— 45,088 — 45,088 
Total assets$72,930 $46,674 $— $119,604 
Liabilities:
Private placement warrants$— $45,504 $— $45,504 
Debt— 911,807 — 911,807 
Total liabilities$— $957,311 $— $957,311 
v3.23.3
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)
9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
Schedule of Changes to the Balance in Accumulated Other Comprehensive (Loss)
Changes to the balance in accumulated other comprehensive income were as follows:
(in thousands)Gain on
Cash Flow Hedges
Balance as of January 2, 2022$3,715 
Unrealized gain on cash flow hedges30,820 
Balance as of July 3, 202234,535 
Unrealized gain on cash flow hedges19,655 
Balance as of October 2, 2022$54,190 
Less balance attributable to noncontrolling interest as of October 2, 202221,570 
Balance attributable to controlling interest as of October 2, 2022$32,620 
Balance as of January 1, 2023$50,994 
Unrealized loss on cash flow hedges(753)
Balance as of July 2, 202350,241 
Unrealized gain on cash flow hedges4,047 
Balance as of October 1, 2023$54,288 
Less balance attributable to noncontrolling interest as of October 1, 202321,606 
Balance attributable to controlling interest as of October 1, 2023$32,682 
v3.23.3
SUPPLEMENTARY CASH FLOW INFORMATION (Tables)
9 Months Ended
Oct. 01, 2023
Supplemental Cash Flow Elements [Abstract]  
Schedule of Cash Flow, Supplemental
(in thousands)Thirty-nine weeks ended October 1, 2023Thirty-nine weeks ended October 2, 2022
Cash paid for interest$44,310 $29,682 
Refunds related to income taxes$387 $4,630 
Payments for income taxes$5,022 $5,463 
v3.23.3
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Oct. 01, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table reconciles the numerators and denominators used in the computations of both basic and diluted earnings per share:
(in thousands, except share data)Thirteen weeks ended October 2, 2022Thirty-nine weeks ended October 2, 2022
Basic and diluted earnings per share:
Numerator:
Net loss attributable to common stockholders$(888)$(15,279)
Denominator:
Weighted average Class A Common Stock shares, basic80,812,835 79,852,137 
Basic and diluted earnings (loss) per share$(0.01)$(0.19)
Anti-dilutive securities excluded from diluted earnings per share calculation:
Warrants2,093,271 1,772,271 
RSUs168,081 61,946 
PSUs75,866 53,290 
Stock options— — 
Total2,337,218 1,887,507 
Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net income (loss) attributable to noncontrolling interest$2,373 $(12,589)
(in thousands, except share data)Thirteen weeks ended October 2, 2023Thirty-nine weeks ended October 2, 2023
Basic and diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Basic earnings per share$0.20 $0.03 
Diluted earnings per share:
Numerator:
Net income attributable to common stockholders$15,993 $2,742 
Denominator:
Weighted average Class A Common Stock shares, basic81,141,417 81,060,961 
Dilutive securities included in diluted earnings per share calculation:
Warrants1,828,748 2,142,492 
RSUs338,373 242,903 
PSUs135,737 121,083 
Stock options— 317 
Total83,444,275 83,567,756 
Diluted earnings per share$0.19 $0.03 
Weighted average Class V Common Stock not subject to earnings per share calculation59,349,000 59,349,000 
Net (income) loss attributable to noncontrolling interest$(222)$9,562 
v3.23.3
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant and Equipment (Details)
Oct. 01, 2023
Minimum | Machinery and equipment  
Property, Plant and Equipment [Line Items]  
Useful life 2 years
Minimum | Transportation Equipment  
Property, Plant and Equipment [Line Items]  
Useful life 3 years
Minimum | Buildings  
Property, Plant and Equipment [Line Items]  
Useful life 8 years
Maximum | Machinery and equipment  
Property, Plant and Equipment [Line Items]  
Useful life 20 years
Maximum | Transportation Equipment  
Property, Plant and Equipment [Line Items]  
Useful life 10 years
Maximum | Buildings  
Property, Plant and Equipment [Line Items]  
Useful life 40 years
v3.23.3
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)
$ in Millions
9 Months Ended
Jan. 01, 2023
Oct. 01, 2023
Accounting Policies [Abstract]    
Promotional program reserve $ 46.3 $ 21.9
Promotional program reserve increase (decrease) during period $ 32.8 $ 12.4
v3.23.3
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Distributor Buyouts (Details)
$ in Millions
9 Months Ended
Oct. 02, 2022
USD ($)
Accounting Policies [Abstract]  
Distributors' assets accounted for as contract termination expense $ 23.0
v3.23.3
INVENTORIES (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 76,881 $ 67,386
Raw materials 30,740 42,204
Maintenance parts 9,053 8,416
Total inventories $ 116,674 $ 118,006
v3.23.3
PROPERTY, PLANT AND EQUIPMENT, NET - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment $ 451,856 $ 445,310
Less: accumulated depreciation (122,010) (100,112)
Property, plant and equipment, net 329,846 345,198
Land    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 32,448 30,582
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 126,413 129,824
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 236,280 255,505
Land improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 3,828 3,756
Building improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 4,131 3,709
Construction-in-progress    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment $ 48,756 $ 21,934
v3.23.3
PROPERTY, PLANT AND EQUIPMENT, NET - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Property, Plant and Equipment [Line Items]        
Depreciation expense $ 10,000 $ 12,000 $ 30,900 $ 37,100
Impairment and other charges     9,548 4,678
(Loss) gain on sale of assets, net (8,488) $ (823) $ (9,275) $ 919
Supply agreement term     1 year  
Tolling assets 600      
Bluffon, Indiana Manufacturing Facility        
Property, Plant and Equipment [Line Items]        
(Loss) gain on sale of assets, net (13,400)      
Hanover, PA Land        
Property, Plant and Equipment [Line Items]        
(Loss) gain on sale of assets, net 4,000      
Birmingham Facility | Non Cash Expenses        
Property, Plant and Equipment [Line Items]        
Impairment and other charges 7,600      
Birmingham Facility | Manufacturing Closure        
Property, Plant and Equipment [Line Items]        
Restructuring charges 8,900      
Birmingham Facility | Employee Severance        
Property, Plant and Equipment [Line Items]        
Restructuring charges 1,300      
Birmingham Facility | Facility Closing        
Property, Plant and Equipment [Line Items]        
Impairment loss $ 1,900   $ 1,900  
v3.23.3
GOODWILL AND INTANGIBLE ASSETS, NET - Intangible Assets (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets $ 741,780 $ 741,780
Accumulated amortization (110,989) (82,738)
Amortizable assets, net 630,791 659,042
Indefinite-lived Intangible Assets [Line Items]    
Intangible assets, net 1,070,691 1,099,565
Trade names    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 434,513 434,513
Route assets    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 5,387 6,010
Distributor/customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets 677,930 677,930
Trademarks    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets $ 63,850 $ 63,850
v3.23.3
GOODWILL AND INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Acquired Finite-Lived Intangible Assets [Line Items]        
Impairment and other charges     $ 9,548 $ 4,678
Amortization of intangible assets $ 9,400 $ 9,400 28,300 28,300
Distribution Rights        
Acquired Finite-Lived Intangible Assets [Line Items]        
Impairment and other charges     $ 2,000  
Distributor/customer relationships decrease amount       $ 2,200
v3.23.3
NOTES RECEIVABLE (Details) - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2023
Jan. 01, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Other notes receivable $ 5,553 $ 9,274
Notes Receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Other notes receivable 16,900 21,100
Other Notes Receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Other notes receivable 100 100
IO Notes Receivable | Notes Receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Other notes receivable 18,700 $ 22,000
Credit loss (less than $0.1 million) $ 100  
IO Notes Receivable | Minimum    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Interest rate 0.00%  
Term of agreement 1 year  
IO Notes Receivable | Maximum    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Interest rate 10.40%  
Term of agreement 10 years  
v3.23.3
ACCRUED EXPENSES AND OTHER - Current Accrued Expenses (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Payables and Accruals [Abstract]    
Accrued compensation and benefits $ 18,300 $ 38,974
Operating right of use liability 14,868 12,389
Insurance liabilities 8,090 6,701
Accrued manufacturing related costs 3,622 10,817
Acquisition tax consideration 854 1,131
Accrued dividends and distributions 8,006 7,989
Accrued interest 691 1,151
Other accrued expenses 8,283 12,860
Total accrued expenses and other $ 62,714 $ 92,012
v3.23.3
ACCRUED EXPENSES AND OTHER - Noncurrent Accrued Expenses (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Payables and Accruals [Abstract]    
Operating right of use liability $ 44,349 $ 35,331
Tax Receivable Agreement liability 24,536 25,426
Supplemental retirement and salary continuation plans 6,666 6,512
Total accrued expenses and other $ 75,551 $ 67,269
v3.23.3
LONG-TERM DEBT - Additional Information (Details) - USD ($)
1 Months Ended 9 Months Ended
Oct. 12, 2022
Jun. 22, 2021
Jan. 20, 2021
Dec. 14, 2020
Sep. 30, 2023
Oct. 01, 2023
Oct. 02, 2022
Jul. 20, 2023
Jan. 01, 2023
Sep. 22, 2022
Debt Instrument [Line Items]                    
Borrowings on term debt and notes payable           $ 4,273,000 $ 33,969,000      
Payment of debt issuance cost           655,000 $ 1,471,000      
Long-term debt related to buyback of distributors           915,821,000     $ 911,807,000  
Other                    
Debt Instrument [Line Items]                    
Long-term debt related to buyback of distributors           200,000     835,000  
Bridge Credit Agreement | Line of Credit                    
Debt Instrument [Line Items]                    
Amount withdrawn from line of credit       $ 490,000,000            
Bridge Credit Agreement | Line of Credit | LIBOR                    
Debt Instrument [Line Items]                    
Basis spread on variable rate       4.25%            
Bridge Credit Agreement | Secured Debt                    
Debt Instrument [Line Items]                    
Repurchased amount of debt     $ 358,000,000              
Term Loan B | Secured Debt                    
Debt Instrument [Line Items]                    
Principal Balance   $ 795,000,000 720,000,000     795,000,000        
Repurchased amount of debt     410,000,000              
Finance fees     $ 8,400,000              
Borrowings on term debt and notes payable   75,000,000                
Payment of debt issuance cost   $ 700,000                
Long-term debt related to buyback of distributors           $ 773,323,000     779,286,000  
Term Loan B | Secured Debt | LIBOR                    
Debt Instrument [Line Items]                    
Basis spread on variable rate     3.00%              
Real Estate Term Loan                    
Debt Instrument [Line Items]                    
Principal Balance $ 88,100,000                  
Additional Paydown         $ 4,400,000          
Draws on long-term debt obligation $ 85,000,000                  
Interest rate 5.93%         5.929%        
principal annual maturity         $ 3,300,000          
Long-term debt related to buyback of distributors           $ 85,500,000        
IO Notes Payable                    
Debt Instrument [Line Items]                    
Notes receivable sold           4,100,000        
Revolving Credit Facility | ABL Facility                    
Debt Instrument [Line Items]                    
Amendment fee​               $ 700,000    
Revolving Credit Facility | ABL Facility | Line of Credit                    
Debt Instrument [Line Items]                    
Long-term debt related to buyback of distributors           20,362,000     0  
Revolving Credit Facility | ABL Facility | Line of Credit                    
Debt Instrument [Line Items]                    
Principal amount               $ 225,000,000   $ 175,000,000
Available for borrowing, net of letters of credit           $ 149,300,000     163,000,000  
Unused line fees           0.50%        
Revolving Credit Facility | ABL Facility | Line of Credit | SOFR plus 0.10%                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           0.10%        
Revolving Credit Facility | ABL Facility | Line of Credit | LIBOR                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           1.75%        
Revolving Credit Facility | ABL Facility | Line of Credit | LIBOR | Minimum                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           1.50%        
Interest rate           7.17%        
Revolving Credit Facility | ABL Facility | Line of Credit | LIBOR | Maximum                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           2.00%        
Revolving Credit Facility | ABL Facility | Line of Credit | Prime Rate                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           0.75%        
Revolving Credit Facility | ABL Facility | Line of Credit | Prime Rate | Minimum                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           0.50%        
Interest rate           9.25%        
Revolving Credit Facility | ABL Facility | Line of Credit | Prime Rate | Maximum                    
Debt Instrument [Line Items]                    
Basis spread on variable rate           1.00%        
Standby Letters of Credit | ABL Facility | Line of Credit                    
Debt Instrument [Line Items]                    
Principal Balance           $ 12,200,000     $ 12,000,000  
v3.23.3
LONG-TERM DEBT - Schedule of Long-term Debt Instruments (Details) - USD ($)
$ in Thousands
9 Months Ended
Jan. 20, 2021
Oct. 01, 2023
Jan. 01, 2023
Jun. 22, 2021
Debt Instrument [Line Items]        
Total long-term debt   $ 915,821 $ 911,807  
Net impact of debt issuance costs and original issue discounts   (9,243) (9,672)  
Less: current portion   (20,649) (18,472)  
Long term portion of term debt and financing obligations   895,172 893,335  
Equipment Loans        
Debt Instrument [Line Items]        
Total long-term debt   50,360 54,053  
Draws on long-term debt obligation   $ 4,300    
Equipment Loans | Minimum        
Debt Instrument [Line Items]        
Interest rate   3.26%    
Equipment Loans | Maximum        
Debt Instrument [Line Items]        
Interest rate   7.25%    
Term Loan B        
Debt Instrument [Line Items]        
Weighted average interest rate   8.36%    
Term Loan B | Secured Debt        
Debt Instrument [Line Items]        
Principal Balance $ 720,000 $ 795,000   $ 795,000
Total long-term debt   773,323 779,286  
Term Loan B | Secured Debt | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate 3.00%      
Real Estate Term Loan        
Debt Instrument [Line Items]        
Principal Balance   88,140    
Total long-term debt   81,019 88,140  
ABL Facility | Revolving Credit Facility | Line of Credit        
Debt Instrument [Line Items]        
Total long-term debt   $ 20,362 $ 0  
ABL Facility | Line of Credit | Revolving Credit Facility | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.75%    
ABL Facility | Line of Credit | Revolving Credit Facility | Prime Rate        
Debt Instrument [Line Items]        
Basis spread on variable rate   0.75%    
Maturity of variable rate basis   30 days    
ABL Facility | Line of Credit | Revolving Credit Facility | Minimum | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.50%    
Interest rate   7.17%    
ABL Facility | Line of Credit | Revolving Credit Facility | Minimum | Prime Rate        
Debt Instrument [Line Items]        
Basis spread on variable rate   0.50%    
Interest rate   9.25%    
ABL Facility | Line of Credit | Revolving Credit Facility | Maximum | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate   2.00%    
ABL Facility | Line of Credit | Revolving Credit Facility | Maximum | Prime Rate        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.00%    
v3.23.3
LONG-TERM DEBT - Schedule of Amounts Outstanding Under Notes Payable (Details) - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Debt Instrument [Line Items]    
Total non-current liabilities $ 915,821 $ 911,807
Finance lease obligations 10,734 10,995
Note payable – IO notes    
Debt Instrument [Line Items]    
Total non-current liabilities 16,879 21,098
Other    
Debt Instrument [Line Items]    
Total non-current liabilities 200 835
Total notes payable    
Debt Instrument [Line Items]    
Total notes payable 27,813 32,928
Less: current portion (8,317) (12,589)
Long term portion of notes payable $ 19,496 $ 20,339
v3.23.3
LONG-TERM DEBT - Schedule of Interest Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Debt Disclosure [Abstract]        
Company’s term loans, ABL facility, and other long-term debt $ 14,582 $ 10,916 $ 42,971 $ 29,320
Amortization of deferred financing fees 633 344 1,084 1,028
IO loans 322 388 879 1,130
Total interest $ 15,537 $ 11,648 $ 44,934 $ 31,478
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 12, 2022
Sep. 06, 2019
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Jan. 01, 2023
Sep. 30, 2022
Dec. 21, 2021
Derivative [Line Items]                  
Total non-current liabilities     $ 915,821   $ 915,821   $ 911,807    
Purchase commitments     84,400   84,400        
Purchase commitment (gains) losses     (1,700) $ 1,000 (1,900) $ 0      
Real Estate Term Loan                  
Derivative [Line Items]                  
Total non-current liabilities     $ 85,500   $ 85,500        
Interest rate 5.93%   5.929%   5.929%        
Interest rate swaps | Cash Flow Hedging | Designated as Hedging Instrument                  
Derivative [Line Items]                  
Derivative, term of contract 10 years 3 years              
Fixed interest rate 3.83% 1.339% 5.81%   5.81%     1.408% 1.3885%
Variable interest rate 0.00% 0.00%           0.00% 0.00%
Notional amount   $ 250,000             $ 250,000
Notional amount, accreted                 $ 500,000
Derivative, basis spread               0.11448%  
v3.23.3
DERIVATIVE FINANCIAL INSTRUMENTS AND PURCHASE COMMITMENTS - Schedule of Reconciliation of the Changes in the Warrant Liability (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Jul. 02, 2023
Oct. 01, 2023
Oct. 02, 2022
Reconciliation Of Changes In Warrant Liability [Roll Forward]          
Fair value of warrant liabilities, beginning balance $ 44,928   $ 45,504 $ 45,504  
Gain on remeasurement of warrant liability (15,984) $ 3,672 (576) (16,560) $ (4,032)
Fair value of warrant liabilities, ending balance $ 28,944   $ 44,928 $ 28,944  
v3.23.3
FAIR VALUE MEASUREMENTS (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Oct. 01, 2023
Jan. 01, 2023
Assets:    
Cash and cash equivalents $ 60,094 $ 72,930
Total assets 109,305 119,604
Liabilities:    
Debt 915,821 911,807
Total liabilities 945,632 957,311
Interest rate swaps    
Assets:    
Interest rate swaps 48,651 45,088
Commodity contracts    
Assets:    
Commodity contracts 560 1,586
Liabilities:    
Derivative liabilities 867  
Private placement warrants    
Liabilities:    
Derivative liabilities 28,944 45,504
Level 1    
Assets:    
Cash and cash equivalents 60,094 72,930
Total assets 60,094 72,930
Liabilities:    
Debt 0 0
Total liabilities 0 0
Level 1 | Interest rate swaps    
Assets:    
Interest rate swaps 0 0
Level 1 | Commodity contracts    
Assets:    
Commodity contracts 0 0
Liabilities:    
Derivative liabilities 0  
Level 1 | Private placement warrants    
Liabilities:    
Derivative liabilities 0 0
Level 2    
Assets:    
Cash and cash equivalents 0 0
Total assets 49,211 46,674
Liabilities:    
Debt 915,821 911,807
Total liabilities 945,632 957,311
Level 2 | Interest rate swaps    
Assets:    
Interest rate swaps 48,651 45,088
Level 2 | Commodity contracts    
Assets:    
Commodity contracts 560 1,586
Liabilities:    
Derivative liabilities 867  
Level 2 | Private placement warrants    
Liabilities:    
Derivative liabilities 28,944 45,504
Level 3    
Assets:    
Cash and cash equivalents 0 0
Total assets 0 0
Liabilities:    
Debt 0 0
Total liabilities 0 0
Level 3 | Interest rate swaps    
Assets:    
Interest rate swaps 0 0
Level 3 | Commodity contracts    
Assets:    
Commodity contracts 0 0
Liabilities:    
Derivative liabilities 0  
Level 3 | Private placement warrants    
Liabilities:    
Derivative liabilities $ 0 $ 0
v3.23.3
CONTINGENCIES (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 07, 2022
Jan. 02, 2022
Oct. 01, 2023
Jan. 01, 2023
Other Commitments [Line Items]        
Loss contingency accrual, payments $ 0.9      
Cadence Bank        
Other Commitments [Line Items]        
Maximum future payment of guaranteed loans     25.00%  
Maximum future payment amount     $ 2.0  
Cadence Bank | Payment Guarantee        
Other Commitments [Line Items]        
Outstanding balance of guaranteed loans     $ 0.8 $ 1.5
Bank Of America        
Other Commitments [Line Items]        
Maximum future payment of guaranteed loans     25.00%  
Bank Of America | Payment Guarantee        
Other Commitments [Line Items]        
Outstanding balance of guaranteed loans     $ 49.6 36.0
Notes purchased     $ 15.3 17.9
M&T Bank        
Other Commitments [Line Items]        
Maximum future payment of guaranteed loans     25.00%  
M&T Bank | Payment Guarantee        
Other Commitments [Line Items]        
Outstanding balance of guaranteed loans     $ 2.5 $ 3.4
Commonwealth Of Pennsylvania Tax Assessment        
Other Commitments [Line Items]        
Reserve for tax assessment   $ 1.3    
v3.23.3
ACCUMULATED OTHER COMPREHENSIVE INCOME - Schedule of Changes to the Balance in Accumulated Other Comprehensive (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Jul. 02, 2023
Jul. 03, 2022
Jan. 01, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Accumulated other comprehensive income $ 54,300       $ 51,000
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Beginning balance 1,420,184 $ 1,448,127 $ 1,451,684 $ 1,434,673  
Unrealized gain (loss) on cash flow hedges 4,047 19,655 (753) 30,820  
Ending balance 1,436,067 1,463,498 1,420,184 1,448,127  
Gains/(Losses) on Cash Flow Hedges          
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Ending balance 32,682 32,620      
Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest          
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Beginning balance 50,241 34,535 50,994 3,715  
Unrealized gain (loss) on cash flow hedges 4,047 19,655 (753) 30,820  
Ending balance 54,288 54,190 $ 50,241 $ 34,535  
Accumulated Gain (Loss), Net, Cash Flow Hedge, Noncontrolling          
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Ending balance $ 21,606 $ 21,570      
v3.23.3
SUPPLEMENTARY CASH FLOW INFORMATION - Schedule of Cash Flow, Supplemental (Details) - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Supplemental Cash Flow Elements [Abstract]    
Cash paid for interest $ 44,310 $ 29,682
Refunds related to income taxes 387 4,630
Payments for income taxes $ 5,022 $ 5,463
v3.23.3
INCOME TAXES (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Jan. 01, 2023
Operating Loss Carryforwards [Line Items]          
Income tax benefit $ (10,099) $ (1,595) $ (13,435) $ (1,688)  
Effective income tax rate (165.10%) 1450.00% 66.30% 5.70%  
Effective income tax rate, before discrete items 88.50%   33.00%    
Discrete tax , expense (benefit) $ (1,400)   $ (1,300)    
Long-term accrued expenses and other 24,600   24,600   $ 25,400
Current Accrued Expenses          
Operating Loss Carryforwards [Line Items]          
Long-term accrued expenses and other 100   100    
Non-current Accrued Expenses          
Operating Loss Carryforwards [Line Items]          
Long-term accrued expenses and other $ 24,500   $ 24,500    
v3.23.3
WARRANTS (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Jul. 02, 2023
Oct. 01, 2023
Oct. 02, 2022
Jan. 01, 2023
Class of Warrant or Right [Line Items]            
Gain (loss) on remeasurement of warrant liability $ (15,984) $ 3,672 $ (576) $ (16,560) $ (4,032)  
Warrants            
Class of Warrant or Right [Line Items]            
Issuance of common stock in connection with private placement sale (in shares)       15,833,332    
Forward Purchase Warrant            
Class of Warrant or Right [Line Items]            
Issuance of common stock in connection with private placement sale (in shares)       1,166,666    
Private Placement Warrants            
Class of Warrant or Right [Line Items]            
Issuance of common stock in connection with private placement sale (in shares)       7,200,000    
Warrants outstanding (in shares) 7,200,000     7,200,000   7,200,000
v3.23.3
EQUITY (Details)
9 Months Ended
Oct. 01, 2023
$ / shares
shares
Jan. 01, 2023
$ / shares
shares
Class of Stock [Line Items]    
Common stock, conversion ratio 1  
Class A Common Stock    
Class of Stock [Line Items]    
Common stock authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common stock issued (in shares) 81,141,417 80,882,334
Common stock outstanding (in shares) 81,141,417 80,882,334
Class V Common Stock    
Class of Stock [Line Items]    
Common stock authorized (in shares) 61,249,000 61,249,000
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Common stock issued (in shares) 59,349,000 59,349,000
Common stock outstanding (in shares) 59,349,000 59,349,000
Common stock, conversion ratio 1  
v3.23.3
EARNINGS (LOSS) PER SHARE (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2023
USD ($)
$ / shares
shares
Oct. 02, 2022
USD ($)
$ / shares
shares
Oct. 01, 2023
USD ($)
$ / shares
shares
Oct. 02, 2022
USD ($)
$ / shares
shares
Jan. 01, 2023
shares
Basic and diluted earnings per share:          
Net income attributable to common stockholders | $ $ 15,993 $ (888) $ 2,742 $ (15,279)  
Denominator:          
Weighted average Class A Common Stock shares, basic (in shares) 81,141,417 80,812,835 81,060,961 79,852,137  
Basic earnings (loss) per share (in dollars per share) | $ / shares $ 0.20 $ (0.01) $ 0.03 $ (0.19)  
Diluted earnings (loss) per share (in dollars per share) | $ / shares $ 0.19 $ (0.01) $ 0.03 $ (0.19)  
Antidilutive securities excluded from diluted earnings per share calculation (in shares)   2,337,218   1,887,507  
Net income (loss) attributable to noncontrolling interest | $ $ 222 $ 2,373 $ (9,562) $ (12,589)  
Common stock, conversion ratio     1    
Diluted (in shares) 83,444,275 80,812,835 83,567,756 79,852,137  
Class V Common Stock          
Denominator:          
Class V Common Stock not subject to earnings per share calculation (in shares) 59,349,000 59,349,000 59,349,000 59,349,000  
Common stock, conversion ratio     1    
Common stock outstanding (in shares) 59,349,000   59,349,000   59,349,000
Common stock issued (in shares) 59,349,000   59,349,000   59,349,000
Warrants          
Denominator:          
Antidilutive securities excluded from diluted earnings per share calculation (in shares)   2,093,271   1,772,271  
Dilutive securities (in shares) 1,828,748   2,142,492    
RSUs          
Denominator:          
Antidilutive securities excluded from diluted earnings per share calculation (in shares)   168,081   61,946  
Dilutive securities (in shares) 338,373   242,903    
PSUs          
Denominator:          
Antidilutive securities excluded from diluted earnings per share calculation (in shares)   75,866   53,290  
Dilutive securities (in shares) 135,737   121,083    
Stock options          
Denominator:          
Antidilutive securities excluded from diluted earnings per share calculation (in shares)   0   0  
Dilutive securities (in shares) 0   317    

Utz Brands (NYSE:UTZ)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Utz Brands Charts.
Utz Brands (NYSE:UTZ)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Utz Brands Charts.